TUESDAY, 28 AUGUST 2012 – MORNING SESSIONS

Transcription

08:30–10:00 | Munich - Central Village
2012 UPDATE OF THE ESC GUIDELINES ON THE MANAGEMENT OF ATRIAL FIBRILLATION
The Committee for Practice Guidelines
Symposium
Chairperson(s): A.J. Camm (London, GB); D. Atar (Oslo, NO)
08:30
08:45
09:05
09:25
09:40
Risk prediction for stroke in atrial fibrillation.
– R. De Caterina (Chieti, IT)
Selection of antithrombotic therapy for atrial fibrillation. Integration of stroke and bleeding risk.
– G.Y.H. Lip (Birmingham, GB)
Antiarrhythmic drug therapy for prevention of atrial fibrillation recurrences.
– S.H. Hohnloser (Frankfurt, DE)
Cardioversion of atrial fibrillation.
– I. Savelieva (London, GB)
Interventional techniques for the management of atrial fibrillation.
– P. Kirchhof (Birmingham, GB)
3754
3755
3756
3757
3758
08:30–10:00 | Tbilisi - Central Village
THE CARDIOVASCULAR MEDICINE IN EUROPE TODAY: THE ESC REGISTRIES
Symposium
Chairperson(s): M. Komajda (Paris, FR); L. Tavazzi (Cotignola, IT)
08:30
08:37
08:47
09:02
09:12
09:22
09:37
09:42
Ongoing and forthcoming registries. Update.
– L. Tavazzi (Cotignola, IT)
Chronic Ischaemic Cardiovascular Disease Pilot Registry.
– R. Ferrari (Ferrara, IT)
EUROASPIRE IV.
– G. De Backer (St. Martens Latem, BE)
Cardiomyopathy Registry.
– P.M. Elliott (London, GB)
Peripartum Cardiomyopathy Registry.
– K. Sliwa-Hahnle (Cape Town, ZA)
Atrial Fibrillation Pilot Registry.
– G.Y.H. Lip (Birmingham, GB)
Prospective considerations.
– M. Komajda (Paris, FR)
Discussion.
3759
3760
3761
3762
3763
3764
3765
08:30–10:00 | Tirana - Central Village
THE CURRENT SITUATION AND EXPERIENCE OF ST-ELEVATION MYOCARDIAL INFARCTION
REPERFUSION THERAPY IN CHINA AND EUROPE
ESC and the Chinese Society of Cardiology
Symposium
Chairperson(s): F.J. Pinto (Lisbon, PT); D. Hu (Beijing, CN)
08:52
09:15
09:37
Treatment of ST-elevation myocardial infarction in Europe.
– K. Huber (Vienna, AT)
Chest pain units in Europe.
– T.F. Munzel (Mainz, DE)
The treatment of ST-elevation myocardial infarction in China: where are we?
– Y.H. Sun (Peking, CN)
The experience of chest pain centres: in China, what have we got?
– D.C. Xiang (Guangzhou, CN)
3766
3767
3768
3769
TUESDAY – MORNING
08:30
08:30–10:00 | Beirut - Village 1
INTERFERING WITH THE IMMUNE SYSTEM IN ATHEROSCLEROSIS: THERAPIES OF THE
FUTURE?
ESC and the European Atherosclerosis Society
Symposium
Chairperson(s): P. Libby (Boston, US); L. Tokgozoglu (Ankara, TR)
08:30
08:52
09:15
09:37
The immune system and atherosclerosis - a complex relationship.
– C.J. Binder (Vienna, AT)
The atherosclerotic lesion, a meeting place for inflammatory cells.
– G.K. Hansson (Stockholm, SE)
B-cell modification in atherogenesis.
– H. Ait-Oufella (Paris, FR)
Immunisation for atherosclerosis: promise and reality.
– J. Nilsson (Malmo, SE)
3770
3771
3772
3773
223
08:30–10:00 | Riga - Village 1
DESTROYING AND RESTORING CARDIOMYOCYTE ARCHITECTURE
Symposium
Chairperson(s): S.E. Lehnart (Göttingen, DE); K. Dibb (Manchester, GB)
08:30
08:52
09:15
09:37
Sarcolemmal disorganisation leads to dyssynchrony of calcium release.
– K.R. Sipido (Leuven, BE)
Remodelling of the cardiac sarcoplasmic reticulum and t-tubules following conditional SERCA2
knockout.
– F. Swift (Oslo, NO)
T-tubule remodelling during transition from hypertrophy to heart failure.
– M.E. Anderson (Iowa, US)
Reversing the loss of t-tubule structure by mechanical unloading.
– C. Terracciano (Harefield, GB)
3774
3775
3776
3777
08:30–10:00 | Tripoli - Village 1
MITOCHONDRIAL DYNAMICS IN CARDIOVASCULAR HEALTH AND DISEASE
ESC and the International Society for Heart Research
Symposium
Chairperson(s): D. Garcia-Dorado Garcia (Barcelona, ES); P. Ferdinandy (Szeged, HU)
08:30
08:52
09:15
09:37
Mitochondrial dynamics in ischaemia and reperfusion.
– D.J. Hausenloy (London, GB)
Modulation of the oxidative and phosphorylation post-translational modifications and their impact
on mitochondria-myofilament.
– V. Kooij (Baltimore, US)
Mitochondrial dynamics and autophagy.
– L. Scorrano (Geneva, CH)
Mitofusins and cardiovascular health and disease.
– C. Maack (Homburg/Saar, DE)
3778
3779
3780
3781
08:30–10:00 | Algiers - Village 2
NOVEL ASPECTS ON PROGNOSIS IN HYPERTENSION
Abstract Session
Chairperson(s): A. Coca (Barcelona, ES); A. Persu (Brussels, BE)
08:30
08:45
09:00
09:15
09:30
09:45
Relation between blood pressure lowering therapy and cardiovascular events and mortality in
hypertensive patients with coronary artery disease and type 2 diabetes: the HIJ-CREATE
sub-study.
– H. Ogawa, R. Koyanagi, E. Kawada-Watanabe, J. Yamaguchi, A. Takagi, N. Hagiwara (Tokyo, JP)
The effect of visit-to-visit variability in blood pressure on stroke and coronary events in the TNT,
IDEAL and CARDS trials.
– P.C. Deedwania, D.A. Demicco, A. Breazna, C.C. Wun, T. Pedersen, H.M. Colhoun, A. Neil, G. Hitman
(Fresno and New York, US; Oslo, NO; Dundee, Oxford and London, GB)
Low attenuation coronary plaque on multidetector computed tomography predicts three-year
acute coronary syndrome events in patients with hypertension.
– K. Nakanishi, S. Fukuda, K. Shimada, S. Ehara, H. Inanami, K. Matsumoto, H. Taguchi, T. Muro,
J. Yoshikawa, M. Yoshiyama (Osaka, Higashiosaka and Nishinomiya, JP)
Pulse wave velocity as independent predictor of stroke in patients with essential hypertension:
data from a Greek 6-year-follow-up study.
– K. Dimitriadis, C. Tsioufis, I. Tatsis, G. Chlapoutakis, L. Lioni, V. Tzamou, A. Kasiakogias, C. Thomopoulos,
D. Tousoulis, C. Stefanadis (Athens, GR)
Prediction of cardiovascular events and all-cause mortality with brachial-ankle pulse wave
velocity: a systematic review and meta-analysis of cohort studies.
– D. Terentes-Printzios, C. Vlachopoulos, K. Aznaouridis, N. Ioakeimidis, C. Stefanadis (Athens, GR)
Influence of family history of hypertension and hypertension per se on overall and cardiovascular
mortality in the Seven Countries Studies: the 40 years’ follow up results.
– B. Parapid, V. Vukcevic, B. Obrenovic-Kircanski, D.V. Simic, N.M. Milic, V. Stojanov, B. Beleslin,
I. Nedeljkovic, O.M.S. Nedeljkovic-Arsenovic, M.C. Ostojic (Belgrade, RS)
3782
3783
3784
3785
3786
3787
08:30–10:00 | Berlin - Village 2
OFF TARGET – CHEMOTHERAPEUTICS AND THE CARDIOVASCULAR SYSTEM
ESC and the American Heart Association
Symposium
Chairperson(s): D. Cardinale (Milan, IT); D. Arnett (Birmingham, US)
08:30
08:52
09:15
09:37
224
Anthracycline-induced cardiomyopathy - novel mechanistic insight.
– M. Jessup (Philadelphia, US)
Imaging techniques for early diagnosis of cardiotoxicity.
– T. Lopez Fernandez (Majadahonda, ES)
Tyrosine kinase inhibitors - from cancer drugs to study drugs into the cardiovascular system.
– T.L. Force (Philadelphia, US)
Cardiotoxicity. Beyond antracicline.
– R. Giuliani (Rome, IT)
3788
3789
3790
3791
08:30–10:00 | Zagreb - Village 2
CENTRAL BLOOD PRESSURE AND PERIPHERAL VESSELS IN HYPERTENSION
Abstract Session
Chairperson(s): C. Vlachopoulos (Athens, GR); S. Laurent (Paris, FR)
08:30
08:45
09:00
09:15
09:30
09:45
Validation and clinical application of systolic and diastolic central pressures derived from pulse
wave analysis.
– D. Kotecha, H. Krum, G. New, D. Eccleston, P. Collins, M. Flather, J. Pepper (London and Norwich, GB;
Melbourne, AU)
Central blood pressure: a possible powerful predictor of the development of hypertension.
– H. Tomiyama, M. Odaira, M. Yoshida, K. Shiina, C. Matsumoto, A. Yamashina (Tokyo, JP)
N- terminal fragment of brain natriuretic peptide predicts vascular health and subclinical
atherosclerosis: results from MEHLP study.
– L.E. Pastormerlo, S. Maffei, V. Chubuchny, A.M. Mazzone, C. Susini, C. Passino, D. Chiappino, M. Emdin,
A. Clerico (Pisa, IT)
Selective serotonin reuptake inhibitors exert a negative effect on peripheral wave reflections.
– V. Katsi, G. Souretis, I. Vlasseros, D. Vrachatis, D. Tousoulis, C. Stefanadis, I. Kallikazaros (Athens, GR)
Renin-angiotensin aldosterone system gene polymorphisms and their association with vascular
impairment in patients with essential hypertension.
– E. Androulakis, D. Tousoulis, E. Chatzistamatiou, N. Papageorgiou, A. Miliou, C. Vlachopoulos, G. Siasos,
G. Moustakas, I. Kallikazaros, C. Stefanadis (Athens, GR)
Insulin resistance is associated with increased large artery stiffness in normotensive healthy
adults.
– J.E. Ochoa, J.K. Balparda, M.M. Correa, A.M. Valencia, M. Alvarez, J.G. Mcewen, G. Bilo, P. Salvi,
D. Aristizabal, G. Parati (Milan, IT; Medellin, CO)
3792
3793
3794
3795
3796
3797
08:30–10:00 | Athens - Village 3
MODERN CARDIAC REHABILITATION MOVING BEYOND FUNDAMENTALS
Abstract Session
Chairperson(s): S. Gielen (Halle, DE); J.P. Ribeiro (Porto Alegre, BR)
08:45
09:00
09:15
09:30
09:45
Multidisciplinary cardiac rehabilitation and survival in The Netherlands.
– H. De Vries, M. Engen-Verheul, H.M.C. Kemps, R. Kraaijenhagen, N. Peek (Amsterdam and Veldhoven, NL)
Cardiovascular rehabilitation after a first acute coronary syndrome and the risk of recurrence and
death in patients from the French MONICA registries.
– P.L. Vervueren, V. Bongard, D. Arveiler, J. Dallongeville, J.B. Ruidavets, A. Wagner, P. Amouyel,
A. Bingham, M. Elbaz, J. Ferrieres (Toulouse, Strasbourg, Lille and Paris, FR)
Phase II comprehensive cardiac rehabilitation prevents readmission for heart failure in patients
with chronic heart failure and high brain natriuretic peptide levels.
– K. Kamiya, A. Mezzani, K. Hotta, M. Tabata, C. Noda, K. Ohori, T. Inomata, M. Yamaoka-Tojo,
A. Matsunaga, T. Masuda (Sagamihara, JP; Veruno, IT)
Compliance to a cardiac rehabilitation program: what benefits and prognosis impact?
– I. Rangel, A. Rocha, C. Sousa, A. Sousa, A.S. Correia, M. Paiva, F. Melao, V. Araujo, F. Parada-Pereira,
M.J. Maciel (Porto, PT)
The effects of respiratory muscle trainings on systemic inflammation and fibrosis process in
patients with heart failure.
– E.A. Kolesnikova, G.P. Arutyunov, A.K. Rylova, N.V. Rylova, V.I. Lobzeva (Moscow, RU)
Beneficial effects of rehabilitation in comparison with resychronization therapy in patients with
NYHA III heart failure.
– T. Chwyczko, E. Smolis-Bak, R. Dabrowski, M. Sterlinski, A. Maciag, A. Borowiec, I. Kowalik, M. Pytkowski,
H. Szwed (Warsaw, PL)
3798
3799
3800
3801
3802
3803
TUESDAY – MORNING
08:30
225
08:30–10:00 | Nicosia - Village 3
NOVEL APPROACHES TO EXERCISE TRAINING
Abstract Session
Chairperson(s): M. Halle (Munich, DE); M. Mendes (Carnaxide, PT)
08:30
08:45
09:00
09:15
09:30
09:45
Biventricular filling impairment limits cardiac performance during exercise in healthy subjects.
– G. Claessen, A. La Gerche, A. Van De Bruaene, M. Gewillig, S. Dymarkowski, P. Claus, H. Heidbuchel
(Leuven, BE)
Evaluation of a newly designed shirt-based ECG and breathing sensor for home based training as
part of cardiac rehabilitation for coronary artery disease.
– E. Skobel, C. Knackstedt, A. Martinez Romero, B. Scheibe-Schmidt, P. Schauerte (Aachen, DE; Maastricht,
NL; Valencia, ES)
Music as additional therapeutic option to exercise training for endothelial dysfunction in patients
with stable coronary artery disease.
– M. Deljanin Ilic, S. Ilic, G. Kocic, R. Pavlovic, V. Stoickov, V. Ilic (Niska Banja and Nis, RS)
Exercise capacity in patients with coronary artery disease: what is beyond global left ventricular
systolic function?
– A.S. Correia, A. Goncalves, A. Rocha, S. Costa, F. Guilherme, M. Paiva, A. Sousa, V. Araujo, F.P. Pereira,
Passive whole-body exercise training with periodic acceleration improves endothelial function in
sedentary subjects.
– T. Matsumoto, M. Fujita, H. Hayashi, I. Nakae, M. Horie (Kashiwara, Kyoto and Otsu, JP)
Exercise echocardiography - effects of endurance training and ageing.
– R.H. Olsen, T. Monk-Hansen, C. Couppe, U.R. Mikkelsen, A. Karlsen, C.H. Dall, P. Magnusson, E. Prescott
(Copenhagen, DK)
3804
3805
3806
3807
3808
3809
08:30–10:00 | Yerevan - Village 3
EAT, DRINK AND BE MERRY?
Symposium
Chairperson(s): C.S. Jennings (London, GB); E. Bruckert (Paris, FR)
08:30
08:52
09:15
09:37
Dark chocolate and cardiovascular health.
– S. Desch (Leipzig, DE)
Red wine: ready for prescription?
– E.J.G. Sijbrands (Rotterdam, NL)
Laughter and other positive emotions on the heart.
– S.S. Pedersen (Tilburg, NL)
Eat well and live long?
– F. Sofi (Florence, IT)
3810
3811
3812
3813
08:30–10:00 | Budapest - Village 4
OPTIMISATION OF MYOCARDIAL REPERFUSION IN STEMI
Abstract Session
Chairperson(s): E.M. Antman (Boston, US); J.-P. Collet (Paris, FR)
08:30
08:45
09:00
09:15
09:30
09:45
226
Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation
myocardial infarction.
– A. Szymanowski, L. Nilsson, E. Swahn, L. Jonasson (Linköping, SE)
Hemostatic and fibrinolytic profile in patients with ST-segment elevation myocardial infarction
resistant to fibrinolysis.
– M. Mutuberria, A. Sambola, J. Francisco Pascual, J. Figueras, B. Garcia Del Blanco, G. Marti,
M. Ruiz-Meana, I. Otaegui, J. Barrabes, D. Garcia-Dorado (Barcelona, ES)
Long term effect of minimising pain-to-balloon time on mortality in ST- elevation infarction. The
ANIN Myocardial Infarction Registry.
– M. Polanska-Skrzypczyk, M. Karcz, P. Bekta, C. Kepka, J. Przyluski, M. Kruk, E. Ksiezycka, A. Ciszewski,
A. Witkowski, W. Ruzyllo (Warsaw, PL)
Left bundle branch block and suspected myocardial infarction: an under-treated patient group?
– T. Kellerth, V. Liakopoulos, K. Christensen (Örebro, SE)
Primary percutaneous coronary intervention with and without thrombus aspiration.
– M. Tariq Farman, S. Tahir, S. Nadeem Hasan Rizvi, K. Naveedullah, S. Jawaid Akbar (Karachi and Larkana,
PK)
Drug eluting stents are associated with lower MACE rates compared to bare metal stents in small
coronary arteries treated by primary PCI for STEMI.
– D. Bromage, K.S. Rathod, D.A. Jones, R. Sen, J. Patel, A. Jain, C. Knight, A. Mathur, A. Wragg (London,
GB)
3814
3815
3816
3817
3818
3819
08:30–10:00 | Prague - Village 4
FROM BENCH TO PRACTICE: REMOTE ISCHAEMIC CONDITIONING FOR CARDIO- AND
NEUROPROTECTION
Symposium
Chairperson(s): M. Ovize (Lyon, FR); R. Schulz (Giessen, DE)
08:30
08:52
09:15
09:37
Update on mechanisms of cardio- and neuroprotection.
– A. Redington (Toronto, CA)
Effects of conditioning on tissue perfusion.
– R. Kharbandar (Oxford, GB)
Influence of ageing, risk factors and comorbidities.
– G. Niccoli (Rome, IT)
Remote conditioning in myocardial infarction and stroke.
– H.E. Botker (Aarhus, DK)
3820
3821
3822
3823
08:30–10:00 | Vienna - Village 4
FROM BENCH TO PRACTICE: ANAEMIA IN ACUTE CORONARY SYNDROMES
Clinical Seminar
Chairperson(s): H. Bueno (Madrid, ES); E. Swahn (Linköping, SE)
08:30
08:52
09:15
09:37
Red blood cells and vascular function.
– M. Kelm (Düsseldorf, DE)
Anaemia and prognosis in acute coronary syndromes.
– J.-P. Bassand (Besançon, FR)
Bleeding complications: different definitions and treatment.
– C.J.M. Vrints (Edegem, BE)
Management of pre-existing anaemia.
– S.D. Anker (Berlin, DE)
3824
3825
3826
3827
08:30–10:00 | Baku - Village 5
HEART FAILURE IN THE ELDERLY: A DIFFERENT SYNDROME?
Clinical Seminar
Chairperson(s): A.W. Hoes (Utrecht, NL); T.A. McDonagh (London, GB)
08:30
08:52
09:15
09:37
Causes of death and hospitalisation.
– A.P. Maggioni (Florence, IT)
Diagnostic challenges.
– S.J. Goodlin (Portland, US)
Biomarkers in the elderly: useful or meaningless?
– D.J. van Veldhuisen (Groningen, NL)
Therapeutic peculiarities: are there any?
– M.R. Cowie (London, GB)
3828
3829
3830
3831
08:30–10:00 | Copenhagen - Village 5
MYOCARDIAL REGENERATION: WHAT CELL SOURCES TO USE?
Clinical Seminar
Chairperson(s): S. Janssens (Leuven, BE); C.A. Beltrami (Udine, IT)
08:52
09:15
09:37
Embryonic stem cells?
– W.-H. Zimmermann (Göttingen, DE)
Inducible progenitor stem cells?
– W. Wojakowski (Katowice, PL)
Adult heart cells?
– P.A.F.M. Doevendans (Utrecht, NL)
Clinical perspective.
– A.M. Zeiher (Frankfurt, DE)
3832
3833
3834
TUESDAY – MORNING
08:30
3835
227
08:30–10:00 | Reykjavik - Village 5
IMPORTANCE OF CO-MORBIDITIES IN HEART FAILURE
Abstract Session
Chairperson(s): P. Van Der Meer (Groningen, NL); G.M.C. Rosano (Rome, IT)
08:30
08:45
09:00
09:15
09:30
09:45
Prognostic impact of the timing/degree of Acute Kidney Injury for Acute Heart Failure: an
evaluation of the RIFLE Criteria.
– A. Shirakabe, N. Hata, N. Kobayashi, T. Shinada, K. Tomita, M. Tsurumi, M. Matsushita, T. Shimura,
K. Asai, K. Mizuno (Chiba and Tokyo, JP)
Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart
failure: the SchlaHF-Registry.
– H. Woehrle, M. Arzt, O. Oldenburg, E. Erdmann, H. Teschler, A. Graml, K. Wegscheider (Blaubeuren,
Regensburg, Bad Oeynhausen, Cologne, Essen, Martinsried and Hamburg, DE)
Incidence of impaired pulmonary function in men with systolic heart failure and its clinical
significance.
– B. Krakowiak, M. Olesinska, B. Paleczny, K. Ludwikowska, W. Banasiak, P. Ponikowski, E.A. Jankowska
(Wroclaw, PL)
Are functional and absolute iron deficiencies equally detrimental in heart failure?
– M. De Antonio, J. Lupon, J. Comin, A. Galan, B. Gonzalez, L. Cano, R. Cabanes, A. Urrutia, E. Zamora,
A. Bayes-Genis (Badalona and Barcelona, ES)
Glycometabolic imbalance is a main determinant of neurohormonal activation and cardiac
mortality in mild systolic heart failure.
– L.E. Pastormerlo, C. Mammini, A. Gabutti, R. Poletti, G. Mirizzi, S. Chiappino, C. Passino, M. Emdin (Pisa,
IT)
Prognostic value of atrial fibrillation pattern in heart failure.
– S. Taillandier, L. Fauchier, B. Lallemand, N. Clementy, A. Bernard, B. Pierre, E. Simeon, S. Taillandier,
D. Babuty (Tours, FR)
3836
3837
3838
3839
3840
3841
08:30–10:00 | Cairo - Village 6
MANAGEMENT OF ACUTE AORTIC SYNDROMES
Clinical Seminar
Chairperson(s): M. Czerny (Berne, CH); V. Riambau (Barcelona, ES)
08:30
08:52
09:15
09:37
Natural history.
– G. Rocchi (Bologna, IT)
Predictors of complications.
– A. Evangelista Masip (Barcelona, ES)
Indications for endovascular treatment.
– C.A. Nienaber (Rostock, DE)
Indications for surgical or hybrid intervention.
– M. Grabenwoeger (Vienna, AT)
3842
3843
3844
3845
08:30–10:00 | Dublin - Village 6
SURGERY FOR VALVULAR HEART DISEASE: PREDICTORS OF OUTCOME
Abstract Session
Chairperson(s): D. Adams (New York, US); M. De Bonis (Milan, IT)
08:30
08:45
09:00
09:15
09:30
09:45
228
Do mitral valve replacement versus repair in patients with severe ischemic mitral regurgitation
affect survival?
– V. Shumaviec, Y. Ostrovski, A. Shket, A. Janushko, A. Lysjonok, O. Jdanovich, A. Beresneva (Minsk, BY)
Different surgical techniques of mitral valve repair for Ischemic mitral regurgitation: predictors of
efficacy.
– V. Shumaviec, Y. Ostrovski, N. Moroz-Vodolajskaja, S. Kurganovich, N. Semenova, I. Grinchuk, A. Shket,
A. Janushko (Minsk, BY)
Comparison of risk scores for predicting early mortality after Aortic Valve Replacement for aortic
stenosis.
– K. Kuwaki, A. Amano, H. Inaba, T. Yamamoto, T. Morita, S. Dohi, T. Matsumura, R. Tsuruta, A. Oishi,
Y. Sato (Tokyo, JP)
Aortic valve replacement: relationship between aortic stenosis severity and perioperative mortality
risk scores.
– M. Floria, I.M. Mariciuc Bucur, L. Gabriel, M. Gerard, M. Buche, P. Eucher, Y. Louagie, J. Jamart,
B. Marchandise, E. Schroeder (Yvoir, BE; Iasi, RO)
Predictors of persistent severe diastolic dysfunction after aortic valve replacement in aortic
stenosis compared with aortic regurgitation.
– L. Iliuta (Bucharest, RO)
Need for permanent pacemaker implantation after corevalve, sapien and surgical aortic valve
replacement: incidence, time course and predictive factors.
– I. Franzoni, A. Latib, A. Chieffo, G.L. Buchanan, M. Slavich, F. Maisano, M. Montorfano, A. Radinovic,
O. Alfieri, A. Colombo (Milan, IT)
3846
3847
3848
3849
3850
3851
08:30–10:00 | Minsk - Village 6
TRANSRADIAL CORONARY INTERVENTIONS
Clinical Seminar
Chairperson(s): C. Trani (Rome, IT); R.-L. Gao (Beijing, CN)
08:30
08:52
09:15
09:37
Left main and bifurcations lesions.
– G. Stankovic (Belgrade, RS)
Chronic total occlusion: when to go transradial?
– Y. Ikari (Kanagawa, JP)
Ad-hoc and outpatient angioplasty.
– F. Kiemeney (Amsterdam, NL)
Complications management.
– V. Velchev (Sofia, BG)
3852
3853
3854
3855
08:30–10:00 | Brussels - Village 7
SYNCOPE MANAGEMENT: FILLING GAPS BETWEEN GUIDELINES AND PRACTICE
Symposium
Chairperson(s): E. Kanoupakis (Heraklion, GR); J. Gajek (Wroclaw, PL)
08:30
08:52
09:15
09:37
The standardised management.
– A. Moya I Mitjans (Barcelona, ES)
Syncope clinic and interactive decison-making softwares.
– R.A. Kenny (Dublin, IE)
The role of continuous ECG monitoring.
– M. Brignole (Lavagna, IT)
The role of pacing: how to identify responders.
– R. Sutton (Monte Carlo, MC)
3856
3857
3858
3859
08:30–10:00 | Tallinn - Village 7
E-HEALTH AND REMOTE MONITORING USING IMPLANTABLE DEVICES
Symposium
Chairperson(s): E. Simantirakis (Heraklion, GR); G. Boriani (Bologna, IT)
08:30
08:52
09:15
09:37
Continuous ECG telemonitoring with implantable devices: the expected clinical benefits.
– C.W. Israel (Bielefeld, DE)
Pacemaker and implantable cardioverter-defibrillator follow-up. Current developments.
– R. Hatala (Bratislava, SK)
Data bulk, analysis and coherent problems.
– L. Van Erven (Bussum, NL)
The cost, the taxpayers and the care protagonists.
– P.E. Vardas (Heraklion, GR)
3860
3861
3862
3863
08:30–10:00 | Tel Aviv - Village 7
OUTCOMES AND COMPLICATIONS OF CATHETER ABLATION FOR ATRIAL FIBRILLATION
Abstract Session
Chairperson(s): H. Puererfellner (Linz, AT); S. Ernst (London, GB)
08:45
09:00
09:15
09:30
09:45
Five years follow up of patients undergoing catheter ablation of persistent atrial fibrillation using
the stepwise approach: BLOC-AF study.
– D. Scherr, S. Miyazaki, V. Aurillac-Lavignolle, Y. Komatsu, P. Pascale, H. Cochet, F. Sacher, M. Hocini,
P. Jais, M. Haissaguerre (Bordeaux, FR)
Additional ablation of complex fractionated atrial electrograms in long-lasting persistent atrial
fibrillation. Does it change the ablation success? Results from the German ablation registry.
– M. Schloesser, R. Becker, J. Tebbenjohanns, J. Brachmann, D. Andresen, B.D. Gonska, G. Richardt,
M. Horack, J. Senges, C. Stellbrink (Bielefeld, Heidelberg, Hildesheim, Coburg, Berlin, Karlsruhe, Segeberg
and Ludwigshafen, DE)
Rhythm control in elderly patients with persistent atrial fibrillation: a randomized comparison of
catheter ablation versus antiarrhythmic drugs.
– A. Blandino, E. Toso, M. Anselmino, D. Sardi, A. Battaglia, M. Scaglione, F. Gaita (Turin and Asti, IT)
Incidence and management of potentially fatal peri-procedural tamponade in patients undergoing
pulmonary vein isolation for atrial fibrillation.
– C.I. Park, A. Jadidi, R. Weber, H. Lehrmann, J. Schiebeling, J. Allgeier, C. Herrera Siklody, M. Haissaguerre,
P. Jais, T. Arentz (Bad Krozingen, DE; Bordeaux-Pessac, FR)
Asymptomatic cerebral lesions in pulmonary vein isolation under therapeutic anticoagulation.
– M. Martinek, E. Sigmund, C.H. Lemes, M. Derndorfer, J. Aichinger, S. Winter, H.J. Nesser, H. Puererfellner
(Linz, AT)
Long-term results of transcatheter atrial fibrillation ablation in patients with impaired left
ventricular systolic function.
– M. Anselmino, S. Grossi, M. Scaglione, D. Castagno, F. Bianchi, G. Senatore, M. Matta, F. Ferraris,
Y. Cristoforetti, F. Gaita (Turin, Asti and Ciriè, IT)
3864
3865
TUESDAY – MORNING
08:30
3866
3867
3868
3869
229
08:30–10:00 | Helsinki - Village 8
DIAGNOSIS AND MANAGEMENT OF CARDIAC TAMPONADE
Clinical Seminar
Chairperson(s): Y. Adler (Rannana, IL); B.A. Popescu (Bucharest, RO)
08:30
08:52
09:15
09:37
Clinical presentation and differential diagnosis.
– M. Imazio (Turin, IT)
Echocardiography in diagnosis and management.
– L. Badano (Padua, IT)
State of the art of percutaneous procedures for the management.
– B. Maisch (Marburg, DE)
Surgical treatment.
– P. Seferovic (Belgrade, RS)
3870
3871
3872
3873
08:30–10:00 | Rome - Village 8
TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) IN CURRENT AND FUTURE
CLINICAL PRACTICE
Abstract Session
Chairperson(s): A.H.P. Linke (Leipzig, DE); C. Lotan (Jerusalem, IL)
08:30
08:45
09:00
09:15
09:30
09:45
Early experience with the JenaValve transapical aortic valve implantation system.
– M. Ferrari, H.R. Figulla, M. Breuer, H. Treede, S. Baldus, A. Rastan, S. Ensminger, M. Arnold, T. Walther,
F.W. Mohr (Jena, Hamburg, Rotenburg, Bad Oeynhausen, Erlangen, Bad Nauheim and Leipzig, DE)
The impact of pulmonary hypertension on outcome in TAVI patients: a two-centre experience.
– M. Vasa-Nicotera, J.M. Sinning, D. Chin, C. Hammerstingl, A. Ghanem, R. Schueler, E. Grube, J. Kovac,
G. Nickenig, N. Werner (Bonn, DE; Leicester, GB)
Is mitral regurgitation reversible in patients undergoing transcatheter aortic valve implantation?
– D. Rosenmann, Y. Almagor, M. Klutstein, J. Balkin, R. Farkash, D. Tzivoni (Jerusalem, IL)
Perivalvular aortic regurgitation: a major predictor of 1-year mortality after a successful TAVI
procedure - insights from the FRANCE2 registry.
– E. Van Belle, N. Dumonteil, F. Juthier, B. Iung, H. Eltchaninoff, D. Carrie, M. Laskar, M. Gilard, A. Prat,
E. Teiger (Lille, Toulouse, Paris, Rouen, Limoges, Brest and Créteil, FR)
The impact of transcatheter aortic valve implantation on quality of life. Results from the German
transcatheter aortic valve interventions registry.
– J. Biermann, M. Horack, P. Kahlert, T. Konorza, B. Plicht, J. Wasem, R. Zahn, J. Senges, R. Erbel,
T. Neumann (Essen and Ludwigshafen, DE)
The impact of transcatheter aortic valve implantation on resource use. Results from the German
transcatheter aortic valve interventions registry.
– J. Biermann, M. Horack, P. Kahlert, T. Konorza, B. Plicht, J. Wasem, R. Zahn, J. Senges, R. Erbel,
T. Neumann (Essen and Ludwigshafen, DE)
3874
3875
3876
3877
3878
3879
08:30–10:00 | Sarajevo - Village 8
HOW TO DEAL WITH HIGH-RISK PREGNANCY
Symposium
Chairperson(s): J.W. Roos-Hesselink (Rotterdam, NL); G. Simonneau (Clamart, FR)
08:30
08:52
09:15
09:37
Risk stratification in congenital heart disease.
– F. Walker (London, GB)
Risk stratification of patients with pulmonary hypertension.
– To be announced
Management of pulmonary arterial hypertension.
– M. Gomberg-Maitland (Chicago, US)
Severe aortic stenosis.
– P. Tornos Mas (Barcelona, ES)
3880
3881
3882
3883
08:30–10:00 | Paris - Village 9
HIGHLIGHTS OF EUROCMR 2012
Symposium
Chairperson(s): H. Mahrholdt (Stuttgart, DE); H. Frank (Tulln, AT)
08:30
08:52
09:15
09:37
230
Insights in Tako-Tsubo syndrome.
– M.G. Friedrich (Montreal, CA)
Clinical value in acute coronary syndrome.
– H. Thiele (Leipzig, DE)
Ongoing imaging trials that may change clinical practice.
– E. Nagel (London, GB)
Cardiovascular magnetic resonance to guide cardiac resynchronisation therapy.
– J. Schulz-Menger (Berlin, DE)
3884
3885
3886
3887
08:30–10:00 | Pristina - Village 9
NEW INSIGHTS IN MYOCARDIAL INFARCTION BY MULTIMODALITY IMAGING
Abstract Session
Chairperson(s): A.N. Neskovic (Belgrade, RS); A. Hagendorff (Leipzig, DE)
08:30
08:45
09:00
09:15
09:30
09:45
Effect of manual thrombus aspiration during primary percutaneous coronary intervention on
infarct size: a delayed enhancement MDCT study.
– D.S. Sim, Y.K. Ahn, Y.H. Kim, Y.J. Hong, H.W. Park, J.H. Kim, M.H. Jeong, J.G. Cho, J.C. Park, J.C. Kang
(Gwangju, KR)
In vivo non invasive quantitative assessment of passive diastolic stiffness of infarcted
myocardium using shear wave imaging.
– M. Pernot, W.N. Lee, M. Couade, P. Mateo, B. Crozatier, A. Bel, M. Tanter, E. Messas (Paris and
Chatenay-Malabry, FR)
Myocardial fibrosis and fat may be substrates of critical ventricular arrhythmia. comparison of 320
slice CT images in subjects who had ventricular fibrillation with sustained ventricular tachycardia.
– K. Ozawa, N. Funabashi, H. Takaoka, A. Kataoka, M. Uehara, Y. Kobayashi (Chiba, JP)
Association between left ventricular longitudinal function and neurohormonal activation after
acute myocardial infarction. A two dimensional speckle tracking study.
– M.K. Ersboll, N. Valeur, U.M. Mogensen, M.J. Andersen, R.G. Greibe, J.E. Moller, C. Hassager, P. Sogaard,
L. Kober (Copenhagen, DK)
Two-dimensional longitudinal strain is more accurate than three-dimensional longitudinal strain to
identify infarcted LV segments in STEMI patients.
– D. Muraru, L.P. Badano, D. Ermacora, R. Bellu, M. De Lazzari, M.P. Marra, L. Dal Bianco, D. Peluso,
F. Boccalini, S. Iliceto (Padua, IT)
Necrosis and ischemia for risk stratification in patients with known or suspected ischemic
cardiomyophaty. Study with stress cardiac magnetic resonance.
– C. Bonanad, J.V. Monmeneu, M.P. Lopez-Lereu, J. Sanchis, J. Nunez, M.J. Bosch, C. Gomez,
F. Chaustre, F.J. Chorro, V. Bodi Peris (Valencia, ES)
3888
3889
3890
3891
3892
3893
08:30–10:00 | Sofia - Village 9
STRESS CARDIOVASCULAR MAGNETIC RESONANCE (CMR) IN CORONARY HEART DISEASE
Symposium
Chairperson(s): F.E. Rademakers (Leuven, BE); S. Plein (Leeds, GB)
08:30
08:52
09:15
09:37
Pathophysiological considerations on stress CMR.
– A.M.G. Almeida (Lisbon, PT)
Long-term prognostic value of dobutamine stress CMR.
– S. Kelle (Berlin, DE)
Prognostic implications of dipyridamole CMR: a prospective multicentre registry.
– O. Husser (Regensburg, DE)
CMR imaging to guide complex revascularisation in stable coronary artery disease.
– J. Schwitter (Lausanne, CH)
3894
3895
3896
3897
08:30–10:00 | London - Village 10
THE CARDIAC RESYNCHRONISATION THERAPY NON RESPONDER.
LIVE FROM LEIPZIG.
Focus Imaging Intervention
Chairperson(s): G. Hindricks (Leipzig, DE); A. Auricchio (Lugano, CH)
What is a non responder: definitions and clinicalreality.
Management of non-response: device programming.
TUESDAY – MORNING
Prevention of non-response during index implantation.
Management of non-response: left-ventricular lead optimization.
Live case: cardiovascular resynchronisation therapy optimization for clinical non response.
– G. Hindricks (Leipzig, DE)
Panel.
– J.C. Daubert (Rennes, FR), G. Hindricks (Leipzig, DE), C. Piorkowski (Leipzig, DE), F. Ruschitzka (Zurich,
CH), J. Singh (Boston, US)
3898
3899
08:30–10:00 | The Hague - Village 10
PREVENTION IN THE MULTI-RISK PATIENT: HOW TO PUT GUIDELINES INTO
CLINICAL REALITY
Focus Cardiology Practice
Chairperson(s): V. Conraads (Edegem, BE); M.C. Deaton (Manchester, GB)
Primary prevention. Not a patient yet: what’s the point?
Secondary prevention and physical activity: never too late?
Changing lifestyle: easier said than done.
Panel.
– M.C. Deaton (Manchester, GB), F.D.R. Hobbs (Oxford, GB), J. Niebauer (Salzburg, AT)
3900
231
08:30–10:00 | Case Corner - Village 10
CASE-BASED LEARNING FROM THE ESC CARDIOLOGISTS OF TOMORROW: WHAT CAN
DEATH TEACH US?
Clinical Cases
Chairperson(s): R.C. Vidal Perez (Santiago de Compostela, ES); U. Sechtem (Stuttgart, DE)
08:30
Introduction by the Chairpersons.
08:33
Sinus arrest as a mechanism of sudden cardiac death in a heart transplant patient for more than
five years.
– M.-T. Liao (Tapei, TW)
ST-segment Elevation Myocardial Infarction (STEMI) by air embolism complicating an
Atriooesophageal Fistula caused by transcatheter ablation of atrial fibrillation.
– F. Seguro (Toulouse, FR)
Ventricular tachycardia revealing cardiac infiltration by mycosis fungoides.
– P. Carrilho-Ferreira (Lisbon, PT)
An autopsy that saves a family: A rare cause of ventricular hypertrophy.
– J. Francisco Pascual (Caldes De Montbui, ES)
Choronic myocarditis mimicking acute coronary syndrome due to eosinophilic state which is
produced by pancreatic cancer.
– D.-H. Jang (Buchen, KR)
Exceptional cause of sudden cardiac death.
– M. Llano (Santander, ES)
A case of isolated coronary vasculitis.
– K. Prakash (North Yorkshire, GB)
Conclusion by the Chairpersons.
08:45
08:57
09:09
09:21
09:33
09:45
09:57
3901
3902
3903
3904
3905
3906
3907
10:00–11:00 | Moderated Posters - Village 10
MODIFIERS OF OUTCOME IN CORONARY ARTERY DISEASE
Moderated Posters
Chairperson(s): A.H.P. Linke (Leipzig, DE); F. Andreotti (Rome, IT)
Posters must be set up between 08:00 and 08:30, removed between 12:30 and 13:00 and be on display from 08:30 to 12:30.
The following abstracts were chosen for their outstanding quality and will be discussed in a special area in the Poster hall during
the Moderated Poster Session chaired by the two above-mentioned chairpersons between 10:00 and 11:00.
10:00
10:07
10:15
10:22
10:30
10:37
10:45
10:52
232
NSAID use is associated with an increase in adverse cardiac events: 4-year results from the
REACH registry.
– P. Kohli, P.G. Steg, K. Crowley, S.A. Murphy, S. Goto, D.L. Bhatt (Boston, US; Paris, FR; Isehara, JP)
History of stroke in patients with coronary artery disease in the REACH Registry: impact on
cardiovascular and bleeding event rates.
– G. Ducrocq, P. Amarenco, J. Labreuche, M. Alberts, J.L. Mas, M. Ohman, S. Goto, P. Lavallee, D.L. Bhatt,
P.G. Steg (Paris, FR; Chicago, Durham and Boston, US; Kanagawa, JP)
Triple anticoagulant therapy following an acute coronary syndrome: prevalence, bleeding rate and
utility of the HAS-BLED score.
– J. Van Der Pals, J.G. Smith, M. Wieloch, S. Koul, J. Lumsden, E. Rydell, J. Ohman, F. Schersten,
P. Svensson (Lund and Malmo, SE)
Women and men with stable coronary artery disease have similar cardiovascular outcomes:
observations from an international prospective cohort of 30 977 patients from 45 countries.
– R. Ferrari, I. Ford, K. Fox, N. Greenlaw, H. Abergel, S. Kaab, J.C. Tardif, M. Tendera, G. Steg, on behalf of
the Clarify Registry Investigators (Lumezzan, IT; Glasgow and London, GB; Paris, FR; Munich, DE; Quebec,
CA; Katowice, PL)
Prognosis of unrecognized myocardial infarction in elderly men and women: the Rotterdam Study.
– A. Dehghan, M.J.G. Leening, E. Boersma, J.W. Dekkers, J. Heeringa, J.A. Kors, A. Hofman, O.H. Franco,
A. Ikram, J.C.M. Witteman (Rotterdam, NL)
Impact of positive airway pressure therapy for cardiovascular outcomes in patients with coronary
artery disease and sleep-disordered breathing.
– K. Kato, Y. Takata, Y. Usui, K. Shiina, Y. Nishihata, A. Yamashina (Tokyo, JP)
Time course of depressive symptoms and first coronary heart disease and stroke in older adults.
A prospective observational study cohort: the Three-City study.
– R. Pequignot, M.C.P. Perier, J.F.D. Dartigues, K.R. Ritchie, C.T. Tzourio, J.P.E. Empana (Paris, Bordeaux
and Montpellier, FR)
Prasugrel 5mg in the very elderly is non-inferior to prasugrel 10mg in non-elderly patients: the
generations trial, a pharmacodynamic (PD) study in stable CAD patients.
– D. Erlinge, P. Gurbel, S. James, T.L. Lindahl, P. Svensson, P.B. Brown, C. Zhou, J.A. Jakubowski, J.M. Ten
Berg, D.J. Angiolillo (Lund, Uppsala, Linköping and Malmo, SE; Baltimore, Indianapolis and Jacksonville,
US; Nieuwegein, NL)
P3908
P3909
P3910
P3911 (W)
P3912
P3913
P3914
P3915
HEART FAILURE: WHAT CAN WE DO FOR YOU TODAY?
Moderated Posters
Chairperson(s): M.O. Dias Aguiar (São Paulo, BR); G. Ertl (Wurzburg, DE)
10:00
10:07
10:15
10:22
10:30
10:37
10:45
10:52
Two-dimensional strain measures of left ventricular systolic function are new independent
predictors of ventricular arrhythmic events in chronic heart failure patients.
– M. Iacoviello, A. Puzzovivo, C. Forleo, M.S. Lattarulo, F. Monitillo, V. Antoncecchi, G. Malerba,
V. Marangelli, S. Favale (Bari, IT)
Incremental prognostic value of left ventricular global longitudinal strain in patients with heart
failure.
– H. Motoki, A. Borowski, K. Shrestha, W. Tang, A. Klein (Cleveland, US)
Quantitative left ventricular flow vortex analysis is superior to conventional echo-doppler to
predict exercise capacity in patients with systolic heart failure.
– G.R. Hong, Y.J. Choi, J.S. Lee, S.M. Kim, W.J. Park, J.W. Son, J.H. Choi, H. Houle, J.W. Ha, N.S. Chung
(Seoul, Daegu and Busan, KR; Mountain View, US)
The incremental prognostic value of inotropic contractile reserve combined with advanced mitral
regurgitation in identifying responders to cardiac resynchronization therapy.
– C. Aggeli, E. Poulidakis, I. Felekos, S. Sideris, P. Dilaveris, K. Gatzoulis, A. Katsaros, E. Sfendouraki,
G. Roussakis, C. Stefanadis (Athens, GR)
Improved differential diagnosis between left ventricular non-compaction and dilated
cardiomyopathy.
– B.E. Staehli, C. Gebhard, M. Greutmann, R. Jenni, F.C. Tanner (Zurich, CH)
Visual assessment of apical rocking predicts response and long-term survival following cardiac
resynchronization therapy.
– I. Stankovic, M. Aarones, A. Ciarka, C. Prinz, M. Szulik, T. Kukulski, R. Willems, L. Faber, S. Aakhus,
J.-U. Voigt (Leuven, BE; Oslo, NO; Bad Oeynhausen, DE; Zabrze, PL)
Diagnostic and prognostic role of global longitudinal strain in patients with heart failure and
normal ejection fraction.
– P. Pellicori, A. Bennett, O. Khaleva, S. Hurren, V. Carubelli, N. Sherwi, K. Wong, A.L. Clark, J.G.F. Cleland
(Hull, GB)
Comparison of left ventricular discoordination and dyssynchrony assessment by radial strain
imaging in candidates for cardiac resynchronization therapy.
– Y.H. Chan, L.S. Wu, Y.H. Yeh, C.L. Wang, Y.J. Ho, L.A. Hsu, C.T. Kuo (Taoyuan, TW)
P3916
P3917 (W)
P3918
P3919
P3920
P3921
P3922
P3923
EUROPEAN UNION RESEARCH GRANT: HOW TO WRITE, APPLY AND SUCCEED
Live streaming session
How-to tutorial
Chairperson(s): V. Dambrauskaite (Brussels, BE)
10:20
10:35
Introduction: rules, requirements and process.
– V. Dambrauskaite (Brussels, BE)
The role of peer review.
– W.H. van Gilst (Groningen, NL)
Questions and answers.
3924
3925
TUESDAY – MORNING
10:10
MEET THE GUIDELINES TASK FORCE II
Special Session
Chairperson(s): J.J. Bax (Leiden, NL); U. Sechtem (Stuttgart, DE)
10:10
10:30
Acute myocardial infarction in patients presenting with ST-segment elevation: questions and
answers to the panellists.
– P.G. Steg (Paris, FR), S. James (Uppsala, SE), D. Atar (Oslo, NO), M.A. Borger (Leipzig, DE), A.H. Gershlick
(Leicester, GB), A. Kastrati (Munich, DE), J.M. Knuuti (Turku, FI), P. Widimsky (Prague, CZ)
Third universal definition of myocardial infarction: questions and answers to the panellists.
– K. Thygesen (Aarhus, DK), J.S. Alpert (Tucson, US), B. Chaitman (St. Louis, US), A. Jaffe (Rochester, US),
M.L. Simoons (Rotterdam, NL), H.D. White (Auckland, NZ)
3926
3927
233
11:00–12:30 | Munich - Central Village
HOT LINE III: LATE BREAKING TRIALS ON ARRHYTHMIAS AND CAD
Hot Line
Chairperson(s): K.A.A. Fox (Edinburgh, GB); D. Holmes (Rochester, US)
11:00
11:10
11:15
11:25
11:30
11:40
11:45
11:55
12:00
12:10
12:15
12:25
PRAGUE-12: Randomized open multicenter study comparing cardiac surgery with MAZE versus
cardiac surgery without MAZE in patients with coronary and/or valvular heart disease and with
atrial fibrillation.
– P. Widimsky (Prague, CZ)
Discussant.
– R. Cappato (San Donato, IT)
WOEST: First randomised trial that compares two different regimens with and without aspirin in
patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI).
– W.J.M. Dewilde (Maaseik, BE)
Discussant.
– M. Valgimigli (Ferrara, IT)
AFib Ablation Pilot: ESC-EURObservational Research Programme: 1-year follow-up of the Atrial
Fibrillation Ablation Conducted by the European Heart Rhythm Association.
– E. Arbelo (Las Palmas De Gran Canaria, ES)
Discussant.
– C. Leclercq (Rennes, FR)
The Great East Japan Earthquake Disaster and Cardiovascular Diseases.
– H. Shimokawa (Sendai, JP)
Discussant.
– G. Steinbeck (Munich, DE)
CORE320: Diagnostic Performance of Combined Noninvasive Coronary Angiography and
Myocardial Perfusion Imaging Using 320-row Detector Computed Tomography : The CORE320
Multicenter, Multinational Study.
– J.A.C. Lima (Baltimore, US)
Discussant.
– G. Maurer (Vienna, AT)
FAME II: Fractional Flow Reserve-Guided Percutaneous Coronary Intervention plus Optimal
Medical Treatment versus Optimal Medical Treatment Alone in Patients with Stable Coronary
Artery Disease.
– B. De Bruyne (Aalst, BE)
Discussant.
– F. Van de Werf (Leuven, BE)
3928
3929
3930
3931
3932
3933
3934
3935
3936
3937
3938
3939
ESC GEOFFREY ROSE LECTURE ON POPULATION SCIENCES
Named Lecture
Chairperson(s): E. Swahn (Linköping, SE); V. Conraads (Edegem, BE)
11:00
Announcement by the chairpersons.
11:02
Presentation of the awardee.
– J.E. Deanfield (London, GB)
3940
11:07
Cholesterol and risk: past, present and future.
– R.E. Collins (Oxford, GB)
3941
11:43
Diploma by the chairpersons.
ESC RENE LAENNEC LECTURE ON CLINICAL CARDIOLOGY
Named Lecture
Chairperson(s): E. Swahn (Linköping, SE); V. Conraads (Edegem, BE)
234
11:45
Announcement by the chairpersons.
11:47
Presentation of the awardee.
– T.F. Luescher (Zurich, CH)
3942
11:52
New look at atrial fibrillation: lessons from drug, pacemaker and ablation therapies.
– L. Kappenberger (Lausanne, CH)
3943
12:28
Diploma by the chairpersons.
TAKE HOME MESSAGE FOR PRACTITIONERS
In collaboration with the Council for Cardiology Practice
Symposium
Chairperson(s): P.A. Sirnes (Moss, NO); G. Baron Esquivias (Seville, ES)
11:00
11:18
11:36
11:54
12:12
Prevention, hypertension and peripheral artery disease - update 2012.
– D.L. Clement (Ghent, BE)
Heart failure update 2012.
– B. Pieske (Graz, AT)
Coronary artery disease update 2012.
– S. Silber (Munich, DE)
Cardiovascular imaging update 2012.
– A. Yilmaz (Ostfildern, DE)
Arrhythmia and pacing update 2012.
– A. Moya I Mitjans (Barcelona, ES)
3944
3945
3946
3947
3948
FROM BENCH TO PRACTICE: UNDERSTANDING ARRHYTHMIAS – LESSONS FROM GENETICS
Symposium
Chairperson(s): K.R. Sipido (Leuven, BE); S.G. Priori (Pavia, IT)
11:00
11:22
11:45
12:07
Genomic approaches to Brugada syndrome.
– C.R. Bezzina (Amsterdam, NL)
From genome-wide association studies to atrial fibrilation.
– D. Franco (Jaen, ES)
Rare variants associated with sick sinus syndrome.
– H. Holm (Mosfellsbaer, IS)
Strengths and limitations of genomic approaches.
– S. Kaab (Munich, DE)
3949
3950
3951
3952
11:00–12:30 | Riga - Village 1
FROM BENCH TO PRACTICE: CHEMOTHERAPY-INDUCED CARDIOTOXICITY – THE PARADOX OF
DAMAGED HEARTS AND PROLONGED LIVES
Symposium
Chairperson(s): T.M. Suter (Berne, CH); S. Engelhardt (Munich, DE)
11:00
11:22
11:45
12:07
Alterations in myocardial energy metabolism induced by anti-cancer drugs.
– M. Tokarska-Schlattner (Grenoble, FR)
Type I and type II cardiotoxicity - does bench work explain the clinical findings?
– S. Zbinden (Berne, CH)
Induction of myocardial regeneration to attenuate cardiotoxicity.
– D. Hilfiker-Kleiner (Hannover, DE)
State of the art: reducing cardiotoxicity.
– T.L. Force (Philadelphia, US)
3953
3954
3955
3956
11:00–12:30 | Tripoli - Village 1
THE ENDOTHELIUM: KEY PLAYER IN VASCULAR CONTROL
Abstract Session
Chairperson(s): J.D. Pearson (London, GB); F.A. Snyders (Pretoria, ZA)
11:15
11:30
11:45
12:00
12:15
Reduced leukocyte telomere length are associated with increased levels of vascular oxidative
stress in patients with acute myocardial infarction.
– J. Lorin, S. Saliques, J.C. Guilland, S. Ragot, A. Donzel, J.R. Teyssier, Y. Cottin, L. Rochette, C. Vergely,
M. Zeller (Dijon, FR)
Circulating plasma free heme levels correlate with endothelial injury and atherosclerotic lesions
extent in patients with stable coronary artery disease.
– N. Amabile, C. Guerin, C. Caussin, O. Blanc-Brude, C.M. Boulanger (Le Plessis-Robinson and Paris, FR)
Changes in blood flow determine endothelial vasomotor responses: insight into the meaning of
flow-mediated constriction and dilation.
– F. Fasola, A. Beutel, S. Muxel, S. Schaefer, A. Damaske, M. Vosseler, J.D. Parker, T. Munzel, T. Gori
(Mainz, DE; Toronto, CA)
Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in
human endothelial cells.
– H. Dreger, A. Ludwig, A. Weller, V. Stangl, G. Baumann, S. Meiners, K. Stangl (Berlin and Munich, DE)
The effects of AdVEGF-B and AdVEGF-D on angiogenesis and arteriogenesis in a novel porcine
model of percutaneous bottleneck stent induced chronic myocardial ischemia.
– J. Nurro, P.J. Halonen, T.T. Rissanen, A. Kuivanen, K.M. Honkonen, H. Karvinen, S. Yla-Herttuala (Kuopio,
FI)
Protection against stroke through preservation of vascular integrity by angiopoietin-like 4
(ANGPTL4).
– C. Bouleti, T. Mathivet, B. Coqueran, C. Monnot, I. Margaill, S. Germain (Paris, FR)
3957
TUESDAY – MORNING
11:00
3958
3959
3960
3961
3962
235
LESSONS LEARNT FROM NEGATIVE TRIALS
Clinical Seminar
Chairperson(s): S.E. Kjeldsen (Oslo, NO); G.M.C. Rosano (Rome, IT)
11:00
11:22
11:45
12:07
Intense blood pressure lowering.
– B. Dahlof (Gothenburg, SE)
Intense glycaemic control.
– A. Cicero (Bologna, IT)
Selective high-density lipoprotein targeting.
– P.J. Barter (Sydney, AU)
Antiarrhythmic drugs.
– S.H. Hohnloser (Frankfurt, DE)
3963
3964
3965
3966
DRUG TREATMENT AND COMPLIANCE IN HYPERTENSION
Abstract Session
Chairperson(s): J. Brguljan (Ljubljana, SI); To be announced
11:00
11:15
11:30
11:45
12:00
12:15
A national, multicentre, randomized controlled trial of the efficacy of structured care algorithm in
achieving individual blood pressure targets at 26 weeks in primary care.
– S. Stewart, M.J. Carrington, C.H. Swemmer, N.P. Kurstjens, G.J. Jennings (Melbourne and Sydney, AU)
Antihypertensive and laxative effects by inhibition of NHE3-mediated sodium absorption in the
gut.
– D. Linz, K. Wirth, W. Linz, P. Arndt, U. Schwahn, M. Böhm, H. Ruetten (Homburg and Frankfurt/Main, DE)
Predictive factors of adherence in uncontrolled hypertensive patients in France: results of the
observational real life survey HBP-ADHERENCE.
– J.-J. Mourad, C. Mounier-Vehier, F. Liard, F. Beauvais (Paris, Lille and Saint Epain, FR)
Valsartan suppresses cardiovascular events in hypertensive subjects with diabetes mellitus (DM)
comparable to those with impaired glucose tolerance (IGT).
– T. Kondo, K. Yamashita, T. Muramatsu, K. Matsushita, T. Nagahiro, K. Maeda, S. Shintani, T. Murohara
(Nagoya, JP)
Impact of intensive blood pressure lowering therapy on left atrial volume and function and the
incidence of first atrial fibrillation in elderly hypertensive patients with preserved systolic function.
– T. Watanabe, R. Tanaka, K. Ono, S. Minatoguchi, S. Abe, M. Iwama, T. Noda, S. Watanabe, M. Kawasaki,
S. Minatoguchi (Gifu, JP)
Pilot analysis of the effect of the SGLT2 inhibitor dapagliflozin on blood pressure in patients with
type 2 diabetes mellitus: a pooled analysis of placebo controlled trials.
– C.D. Sjostrom, J. Sugg, C. Tjoen, A. Salsali, A. Ptaszynska, S. Parikh (Molndal, SE; Wilmington and
Princeton, US; Braine l’Alleud, BE)
3967
3968
3969
3970
3971
3972
HOW TO PREVENT BRAIN DAMAGE IN HYPERTENSION?
Clinical Seminar
Chairperson(s): G. Kamensky (Bratislava, SK); N.V. Deshpande (Nagpur, IN)
11:00
11:22
11:45
12:07
236
How to prevent stroke in hypertension?
– E. Agabiti-Rosei (Brescia, IT)
How to manage blood pressure in acute ischaemic stroke?
– E. Berge (Oslo, NO)
Management of blood pressure after stroke.
– S. Lueders (Cloppenburg, DE)
Progression of white matter lesions, microbleeds and cognitive decline in hypertensive patients.
– A. Coca (Barcelona, ES)
3973
3974
3975
3976
SPORT CARDIOLOGY – PRE-PARTICIPATION SCREENING: CONSEQUENCES AND PITFALLS
Abstract Session
Chairperson(s): T. Meyer (Saarbrücken, DE); F. Carre (Rennes, FR)
11:00
11:15
11:30
11:45
12:00
12:15
Exercise related out-of-hospital cardiac arrest: incidence, prognosis, and prevention of sudden
death.
– J. Berdowski, M.F. De Beus, A. Bardai, M.L. Bots, P.A. Doevendans, D.E. Grobbee, H.L. Tan,
J.G.P. Tijssen, R.W. Koster, A. Mosterd (Amsterdam, Utrecht and Amersfoort, NL)
Costs of cardiovascular screening with ECG in young athletes in Switzerland.
– A. Menafoglio, M. Di Valentino, P. Siragusa, M. Maggi, G.A. Romano, R. Pezzoli, G. Moschovitis, A. Gallino
(Bellinzona, Locarno and Lugano, CH)
Concentric remodelling of the right ventricle in African football players.
– G.F. Gjerdalen, J. Hisdal, E.E. Solberg, T.E. Andersen, Z. Radunovic, K. Steine (Oslo, NO)
Prevalence of significant ECG abnormalities in elite Australian athletes.
– M. Brosnan, A. La Gerche, J. Kalman, K. Fallon, A. Mac Isaac, W. Lo, D. Prior (Melbourne and Canberra,
AU)
Prevalence of Brugada ECG-pattern recorded with V1 and V2 in the third intercostals space in
young athletes.
– A. Menafoglio, M. Di Valentino, M. Siragusa, G. Moschovitis, A. Gallino (Bellinzona, Locarno and Lugano,
CH)
Sudden cardiac death risk assessment, combining cardiorespiratory fitness with cardiovascular
risk factors.
– M. Hagnas, S. Kurl, R. Rauramaa, T.H. Makikallio, J.A. Laukkanen (Rovaniemi, Kuopio and Oulu, FI)
3977
3978
3979
3980
3981
3982
IMPLANTABLE DEFIBRILLATORS: TREATING THE PATIENT NOT THE DEVICE
Clinical Seminar
Chairperson(s): G. Hamilton (Svartskog, NO); J. Boyne (Maastricht, NL)
11:00
11:22
11:45
12:07
Comprehensive rehabilitation.
– S. Kikkenborg Berg (Copenhagen, DK)
Reducing psychological distress for patients with implantable cardioverter-defibrillators.
– S.S. Pedersen (Tilburg, NL)
Promoting exercise in patients with implantable cardioverter-defibrillators.
– M. Wilhelm (Berne, CH)
Decisions at the end of life.
– J.M. Beattie (Birmingham, GB)
3983
3984
3985
3986
11:00–12:30 | Yerevan - Village 3
HOW TO IMPROVE ASSESSMENT OF CARDIOVASCULAR RISK?
Symposium
Chairperson(s): T. Zdrojewski (Sopot, PL); F.D.R. Hobbs (Oxford, GB)
11:22
11:45
12:07
Principles of cardiovascular disease risk prediction.
– D.A. Wood (London, GB)
The role of genetics in cardiovascular risk assessment.
– R. Ploski (Warsaw, PL)
Promising strategies - American perspective.
– M. Pencina (Boston, US)
Promising strategies - European perspective.
– I.M. Graham (Dublin, IE)
3987
3988
3989
3990
TUESDAY – MORNING
11:00
UPDATE ON ANTITHROMBOTICS IN ACUTE CORONARY SYNDROMES
Clinical Seminar
Chairperson(s): J.C.A. Morais (Leiria, PT); F.W.A. Verheugt (Amsterdam, NL)
11:00
11:22
11:45
12:07
P2Y12 blockade. To load or not to load before the cath lab?
– F.J. Neumann (Bad Krozingen, DE)
Intravenous anticoagulants.
– G. Montalescot (Paris, FR)
Oral anti-Xa agents. A new opportunity?
– J. Alexander (Durham, US)
Thrombus aspiration. The best antithrombotic?
– F. Burzotta (Rome, IT)
3991
3992
3993
3994
237
FROM BENCH TO PRACTICE: CORONARY MICROVASCULAR DYSFUNCTION
Clinical Seminar
Chairperson(s): C. De Wit (Lübeck, DE); M. Yamagishi (Kanazawa, JP)
11:00
11:22
11:45
12:07
Pathophysiology of coronary microvascular dysfunction.
– F. Crea (Rome, IT)
Clinical assessment of coronary microcirculation.
– U. Sechtem (Stuttgart, DE)
Coronary microvascular dysfunction in stable coronary artery disease.
– C.J. Pepine (Gainesville, US)
Coronary microvascular dysfunction in acute coronary syndromes.
– R. Bugiardini (Bologna, IT)
3995
3996
3997
3998
FROM BENCH TO PRACTICE: MODULATION OF THE SYMPATHETIC NERVOUS SYSTEM
Clinical Seminar
Chairperson(s): M. Böhm (Homburg/Saar, DE); K. Swedberg (Gothenburg, SE)
11:00
11:22
11:45
12:07
Spinal cord stimulation for refractory angina.
– G.A. Lanza (Rome, IT)
Vagal stimulation for heart failure: an example of translational cardiology.
– P.J. Schwartz (Pavia, IT)
Renal denervation for refractory hypertension.
– H. Krum (Melbourne, AU)
Sympathetic cardiac denervation for refractory spasm.
– A. Abbate (Richmond, US)
3999
4000
4001
4002
11:00–12:30 | Baku - Village 5
HEART FAILURE THERAPIES: LATEST EVIDENCE
Symposium
Chairperson(s): G. Jondeau (Paris, FR); G. Sinagra (Trieste, IT)
11:00
11:22
11:45
12:07
Patient monitoring.
– M.R. Cowie (London, GB)
Medical therapy.
– J.R. Teerlink (San Francisco, US)
Electrical devices.
– K. Dickstein (Stavanger, NO)
Ventricular assist devices.
– A. Pitsis (Thessaloniki, GR)
4003
4004
4005
4006
VALVE DISEASE IN PATIENTS WITH HEART FAILURE
Symposium
Chairperson(s): N. Moat (London, GB); G.C. Schuler (Leipzig, DE)
11:00
11:22
11:45
12:07
238
The assessment of aortic stenosis in patient with myocardial dysfunction.
– J.-L. Monin (Créteil, FR)
Transcatheter aortic valve implantation or surgery?
– M. Sousa Uva (Lisbon, PT)
Mitral regurgitation: when is a procedure needed?
– P. Lancellotti (Liège, BE)
Surgical or interventional therapy for mitral regurgitation in heart failure.
– O. Alfieri (Brescia, IT)
4007
4008
4009
4010
11:00–12:30 | Reykjavik - Village 5
HEART FAILURE: FEAST OR FAMINE?
Abstract Session
Chairperson(s): W. Doehner (Berlin, DE); M. Lainscak (Golnik, SI)
11:00
11:15
11:30
11:45
12:00
12:15
Alteration of gene expression profiling of the murine intestine suffering from heart failure.
– A. Takahashi, M. Asakura, K.D. Min, S. Ito, K. Shindo, Y. Yan, H. Liu, H. Asanuma, N. Mochizuki,
M. Kitakaze (Suita and Kyoto, JP)
Preceding starvation prevents acute doxorubicin cardiotoxicity via autophagy activation.
– T. Kawaguchi, G. Takemura, H. Kanamori, A. Tsujimoto, T. Takeyama, T. Watanabe, K. Morishita,
H. Fujiwara, T. Fujiwara, S. Minatoguchi (Gifu, JP)
Obesity paradox in patients with acute heart failure: application of propensity score methodology
in an acute heart failure database AHEAD.
– S. Littnerova, J. Jarkovsky, J. Parenica, J. Spinar, J. Vitovec, P. Widimsky, A. Linhart, M. Fedorco, F. Malek,
C. Cihalik (Brno, Prague and Olomouc, CZ)
Does admission pre-albumin predict in-hospital mortality in acute heart failure patients?
– P. Lourenco, S. Silva, F. Frioes, M. Alvelos, P. Torres Ramalho, T. Guimaraes, P. Bettencourt (Porto, PT)
Are total cholesterol levels important for hospital and long time prognosis of patients with acute
heart failure?
– L. Spinarova, J. Spinar, A. Linhart, P. Widimsky, M. Fedorco, F. Malek, C. Cihalik, L. Dusek, J. Jarkovsky,
J. Parenica (Brno, Prague, Olomouc and Zlin, CZ)
The prognostic importance of evaluating nutritional status in patients with chronic heart failure.
– T. Narumi, T. Arimoto, T. Watanabe, S. Kadowaki, Y. Otaki, H. Takahashi, T. Shishido, T. Miyashita,
T. Miyamoto, I. Kubota (Yamagata, JP)
4011
4012
4013
4014
4015
4016
11:00–12:30 | Cairo - Village 6
CONTROVERSIES IN VALVULAR HEART SURGERY
Symposium
Chairperson(s): K. Vanermen (Aalst, BE); V. Falk (Zurich, CH)
11:00
11:22
11:45
12:07
Mitral valve annuloplasty in ischaemic mitral regurgitation.
– J.-F. Avierinos (Marseille, FR)
Patient-prosthesis mismatch.
– J. Magne (Liège, BE)
When and how to treat.
– M.A. Borger (Leipzig, DE)
Mitral repair in asymptomatic patients.
– M. De Bonis (Milan, IT)
4017
4018
4019
4020
11:00–12:30 | Dublin - Village 6
RESTENOSIS: STILL THE ACHILLES HEEL OF PERCUTANEOUS CORONARY
INTERVENTIONS?
Abstract Session
Chairperson(s): S.T. Lim (Singapore, SG); D. Locca (Lausanne, CH)
11:15
11:30
11:45
12:00
12:15
Impact of stent fracture on long-term clinical outcomes after sirolimus-eluting stent implantation.
– Y. Fuku, K. Kadota, K. Mitsudo, T. Goto, N. Oka, H. Tanaka, T. Tada, S. Habara, Y. Shigemoto,
D. Hasegawa (Kurashiki, JP)
Stent fracture and restenosis at stent fracture site after sirolimus-eluting stent and
everolimus-eluting stent implantations: impact of stented vessel.
– K. Miyake, K. Kadota, T. Tada, H. Tanaka, Y. Fuku, N. Oka, H. Katoh, H. Yamamoto, T. Goto, K. Mitsudo
(Kurashiki, JP)
Decreased interleukin-33 serum levels after coronary stent implantation are protective against
in-stent restenosis.
– S. Demyanets, R. Jarai, K. Katsaros, S. Farhan, A. Wonnerth, G. Maurer, W.S. Speidl, J. Wojta, K. Huber
(Vienna, AT)
Efficiency of statin treatment on EPC recruitment depends on baseline EPC titer, and does not
improve angiographic outcome in coronary artery disease patients treated with the Genous stent.
– W. Den Dekker, J.H. Houtgraaf, S.M. Rowland, S.P.M. De Boer, R.J. De Winter, P. Den Heijer, F. Zijlstra,
P.W. Serruys, C. Cheng, H.J. Duckers (Rotterdam, Amsterdam and Breda, NL; Fort lauderdale, US)
Drug-eluting stents for the treatment of chronic total occlusion: a comparison with sirolimus,
paclitaxel, zotarolimus, biolimusA9, EPC capture and everolimus-eluting stent: multicenter
registry.
– S. Nakamura, H. Ogawa, J.H. Bae, Y.H. Cahyadi, W. Udayachalerm, D. Tresukosol, S. Tansuphaswadikul
(Chiba and Kumamoto, JP; Daejeon, KR; Jakarta, ID; Bangkok, TH)
Differences in progression pattern of late restenosis after drug-eluting stent implantation.
– S. Otsuru, K. Kadota, D. Hasegawa, S. Habara, T. Tada, H. Tanaka, Y. Fuku, N. Oka, T. Goto, K. Mitsudo
(Kurashiki, JP)
4021
4022
4023
TUESDAY – MORNING
11:00
4024
4025
4026
239
11:00–12:30 | Minsk - Village 6
BURNING ISSUES IN PERCUTANEOUS CORONARY IMAGING FOR ACUTE CORONARY
SYNDROMES
Main Session
Chairperson(s): M. Haude (Neuss, DE); T.-H. Koh (Singapore, SG)
11:00
11:22
11:45
12:07
Role of risk scores.
– A. Lerman (Rochester, US)
Should non ST-elevation myocardial infarction be treated as rapidly as ST-elevation myocardial
infarction?
– M. Dalby (Harefield, GB)
Antiplatelet therapy: which drugs and for how long?
– F. Weidinger (Vienna, AT)
Specifics of acute coronary syndrome management in the elderly.
– S. Savonitto (Reggio Emilia, IT)
4027
4028
4029
4030
11:00–12:30 | Brussels - Village 7
UPDATE ON CONSENSUS STATEMENT ON MANAGEMENT OF ATRIAL FIBRILLATION: EUROPEAN
HEART RHYTHM ASSOCIATION 2012
Symposium
Chairperson(s): A. Auricchio (Lugano, CH); P. Kirchhof (Birmingham, GB)
11:00
11:22
11:45
12:07
Atrial fibrillation ablation: in whom and how. Update of HRS/EHRA AF/ECAS ablation document
2012.
– A. Gillis (Calgary, CA)
Update on ESC AF guidelines on medical therapy 2012.
– A.J. Camm (London, GB)
Management of patients with cardiac resynchronisation devices: consensus recommendations
from EHRA, HFA, HRS, and HFSA.
– J.C. Daubert (Rennes, FR)
Electrophysiological procedures in children - who, when, and how? Consensus EHRA/Association
for European Paediatric Cardiology statement.
– J. Brugada Terradellas (Barcelona, ES)
4031
4032
4033
4034
11:00–12:30 | Tallinn - Village 7
CONTROVERSIAL ISSUES: IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATION
Debate Session
Chairperson(s): L. Mont (Barcelona, ES); L. Jordaens (Rotterdam, NL)
Defibrillation testing should be routinely performed at the time of implantable
cardioverter-defibrillator implantation
11:00
11:15
11:30
11:35
11:40
Pro.
– J. Healey (Hamilton, CA)
Contra.
– F. Arribas (Madrid, ES)
Rebuttal.
4035
Pro.
– J. Healey (Hamilton, CA)
Contra.
– F. Arribas (Madrid, ES)
Conclusion.
4037
4036
4038
Warfarin should be stopped before implantable cardioverter-defibrillator implantation
11:45
12:00
12:15
12:20
12:25
240
Pro.
– A. Da Costa (Saint Etienne, FR)
Contra.
– C. Wolpert (Ludwigsburg, DE)
Rebuttal.
4039
Pro.
– A. Da Costa (Saint Etienne, FR)
Contra.
– C. Wolpert (Ludwigsburg, DE)
Conclusion.
4041
4040
4042
11:00–12:30 | Tel Aviv - Village 7
BALANCING STROKE PREVENTION VERSUS BLEEDING RISK IN ATRIAL FIBRILLATION
Abstract Session
Chairperson(s): B. Gorenek (Eskisehir, TR); E. Hoffmann (Munich, DE)
11:00
11:15
11:30
11:45
12:00
12:15
Regional differences in the use of antithrombotic therapy for stroke prevention in atrial fibrillation:
European and Asian insights from the Global Anticoagulant Registry in the FIELD (GARFIELD).
– S. Goto, I. Mueller, D.A. Fitzmaurice, S. Haas, G.Y.H. Lip, A.G.G. Turpie, S.Z. Goldhaber, S. Rushton-Smith,
A.K. Kakkar (Kanagawa, JP; London and Birmingham, GB; Munich, DE; Hamilton, CA; Boston, US)
The HEMORR2HAGES, ATRIA and the HAS-BLED bleeding risk prediction scores in
anticoagulated atrial fibrillation patients: the AMADEUS study.
– S. Apostolakis, D.A. Lane, H. Buller, G.Y.H. Lip (Birmingham, GB; Amsterdam, NL)
Events after discontinuation of randomized treatment at the end of the ARISTOTLE trial.
– C.B. Granger, J.H. Alexander, M. Hanna, J. Wang, P. Mohan, J. Lawrence, E. Hylek, J.E. Ansell,
L. Wallentin (Durham, Princeton, Boston and New York, US; Uppsala, SE)
CHA2DS2VASc score and thromboembolic and bleeding complications after successful
cardioversion of acute atrial fibrillation.
– T. Gronberg, J. Hartikainen, I. Nuotio, M. Nikkinen, A. Ylitalo, J. Airaksinen (Turku, Kuopio and Pori, FI)
Stroke prevention in non-valvular atrial fibrillation: long-term results after 6 years of the
watchman left atrial appendage occlusion pilot study.
– P.B. Sick, Z. Turi, E. Grube, S. Moebius-Winkler, G. Schuler, G. Mishkel, S. Yakubov, S. Almany, D. Holmes
(Regensburg, Bonn and Leipzig, DE; Camden, Springdale, Columbus, Michigan and Rochester, US)
Apixaban and warfarin are associated with a low risk of stroke following cardioversion for atrial
fibrillation: results from the ARISTOTLE Trial.
– G. Flaker, R. Lopes, S. Al-Khatib, A. Hermosillo, L. Thomas, J. Zhu, W. Ruzyllo, P. Mohan, C. Granger,
L. Wallentin (Columbia, Durham and New York, US; Mexico City, MX; Beijing, CN; Warsaw, PL; Uppsala,
Sweden, SE)
4043
4044
4045
4046
4047
4048
HOW TO MANAGE IDIOPATHIC PULMONARY HYPERTENSION IN AN EMERGENCY
How-to Session
Chairperson(s): M. Delcroix (Leuven, BE); J.S.R. Gibbs (London, GB)
11:00
11:45
Pulmonary arterial hypertension with frequent syncope.
– J.L. Vachiery (Brussels, BE)
Emergency management of acute deterioration of pulmonary arterial hypertension.
– N. Galie (Bologna, IT)
4049
4050
11:00–12:30 | Rome - Village 8
GENETIC TESTING FOR CARDIOMYOPATHIES IN CLINICAL PRACTICE
ESC and the European Society of Human Genetics
Symposium
Chairperson(s): P.M. Elliott (London, GB); J. Schmidtke (Hannover, DE)
11:18
11:36
11:54
12:12
Twenty years of genetic research.
– P. Charron (Paris, FR)
The impact of genetic testing on clinical management.
– J. Mogensen (Aarhus, DK)
Molecular testing: strategies, pitfalls and future perspectives.
– S. Fokstuen (Geneva, CH)
Genetic counselling and ethical aspects of genetic testing.
– I. Christiaans (Amsterdam, NL)
Towards cardiomyopathy units integrating genetics.
– P.P. McKeown (Belfast, GB)
4051
4052
4053
4054
4055
TUESDAY – MORNING
11:00
11:00–12:30 | Sarajevo - Village 8
UPDATE OF THE TASK FORCE ON MYOCARDITIS
Clinical Seminar
Chairperson(s): W.J. McKenna (London, GB); Y. Pinto (Amsterdam, NL)
11:00
11:22
11:45
12:07
Clinical diagnostic criteria.
– A.L.P. Caforio (Padua, IT)
Molecular diagnostic criteria.
– S. Pankuweit (Marburg, DE)
Primary and secondary arrhythmia management.
– F. Hidden Lucet (Paris, FR)
Aetiology-directed therapy: current gaps and future directions.
– S. Heymans (Maastricht, NL)
4056
4057
4058
4059
241
11:00–12:30 | Paris - Village 9
Symposium
ADVANCES IN E-CARDIOLOGY
Chairperson(s): G. Krstacic (Zagreb, HR); E.G. Caiani (Milan, IT)
11:00
11:22
11:45
12:07
In image processing.
– N. Bruining (Rotterdam, NL)
In cardiac signal analyses.
– M. Malik (Purley, GB)
In telecardiology.
– E.T. van der Velde (Leiden, NL)
In cardiac risk stratification.
– G. Schmidt (Munich, DE)
4060
4061
4062
4063
11:00–12:30 | Pristina - Village 9
CORONARY ARTERY DISEASE: FROM THE DARK TO THE LIGHT OF MULTIDETECTOR
COMPUTED TOMOGRAPHY
Abstract Session
Chairperson(s): K. Nieman (Rotterdam, NL); H.J. Ukkonen (Turku, FI)
11:00
11:15
11:30
11:45
12:00
12:15
Ring-like sign on coronary computed tomographic angiography is associated with near-future
acute coronary syndrome in patients with coronary artery disease.
– K. Otsuka, S. Fukuda, A. Tanaka, K. Nakanishi, M. Sakamoto, H. Taguchi, J. Yoshikawa, K. Shimada,
M. Yoshiyama (Osaka, Tanabe and Nishinomiya, JP)
Combined CT angiography and CT myocardial perfusion imaging to detect functionally significant
stenoses in patients with suspected coronary artery disease - comparison with fractional flow
reserve.
– B.S.H. Ko, J.D. Cameron, I.T. Meredith, M. Leung, P.R. Antonis, M. Crossett, S.K. Seneviratne (Melbourne,
AU)
Prevalence of coronary artery anomalies in 8,002 consecutive patients: study with coronary
computed tomography angiography.
– M.P. Opolski, C. Kepka, J. Pregowski, M. Kruk, S. Kwiecinska, E. Lubienska, M. Demkow, W. Ruzyllo,
A. Witkowski (Warsaw, PL)
Association between findings of multidetector computed tomography and coronary flow
throughout Percutaneous Coronary Intervention.
– Y. Osaka, S. Kimura, S. Kuroda, N. Kawaguchi, E. Nakashima, T. Sugiyama, D. Akiyama, T. Kamiishi,
H. Hikita, M. Isobe (Yokosuka and Tokyo, JP)
Prognostic significance of pre-test probability of coronary artery disease to coronary CT
angiography in patients with coronary calcium score zero.
– N. Yokoyama, R.I. Iino, K.K. Kumiko Konno, T.I. Takaaki Isshiki (Tokyo, JP)
Impact of lipid lowering on prevention of plaque progression detected by coronary computed
tomography angiography.
– H. Ito, S. Motoyama, M. Sarai, H. Kawai, H. Harigaya, H. Naruse, S. Kan, S. Kato, J. Ishii, Y. Ozaki
(Toyoake, JP)
4064
4065
4066
4067
4068
4069
11:00–12:30 | Sofia - Village 9
IMAGING IN THE DECISION MAKING OF CHRONIC CORONARY ARTERY DISEASE
ESC and the American College of Cardiology
Symposium
Chairperson(s): L. Badano (Padua, IT); M.A. Quinones (Houston, US)
11:00
11:22
11:45
12:07
Does the STICH trial provide a definitive answer?
– J. Panza (Washington, US)
Stress echo: usefulness and limitations.
– R. Sicari (Pisa, IT)
What information can single-photon emission computed tomography and/or positron emission
tomography provide?
– M.F. Di Carli (Boston, US)
How can cardiac magnetic resonance help?
– S. Plein (Leeds, GB)
4070
4071
4072
4073
11:00–12:30 | London - Village 10
2012 GREAT DEBATE: CURRENT ROLE OF INTERVENTIONAL RENAL
DENERVATION IN THE TREATMENT OF SEVERE HYPERTENSION
In collaboration with EAPCI - EuroPCR
Focus Imaging Intervention
Chairperson(s): W. Wijns (Aalst, BE); I. Durand-Zaleski (Créteil, FR)
Panel.
– F. Mahfoud (Homburg/Saar, DE), W. McKane (Sheffield, GB), P.F. Plouin (Paris, FR), J.R. Renkin
(Sterrebeek, BE), L.M. Ruilope (Madrid, ES), T. Zeller (Bad Krozingen, DE)
242
4074
11:00–12:30 | The Hague - Village 10
HOW TO DEAL WITH HIGH-RISK PREGNANCIES?
Focus Cardiology Practice
Chairperson(s): J.W. Roos-Hesselink (Rotterdam, NL); P. Tornos Mas (Barcelona, ES)
Severe mitral stenosis.
Aortic dilatation.
Acute coronary syndrome.
Panel.
– J. De Backer (Ghent, BE), B. Iung (Paris, FR), M. Schwerzmann (Berne, CH), E. Thaulow (Oslo, NO),
S. Thorne (Birmingham, GB)
4075
11:00–12:30 | Case Corner - Village 10
CASE-BASED LEARNING FROM THE ESC CARDIOLOGISTS OF TOMORROW: LOOK FOR THE
ANSWER OUTSIDE THE HEART
Clinical Cases
Chairperson(s): S. Zuily (Vandoeuvre-lès-Nancy, FR); J. Silva-Cardoso (Porto, PT)
Introduction by the Chairpersons.
11:03
Cardiac storm: an unusual course of cardiomyopathy due to amyloidosis associated with multiple
myeloma, presenting with myocardial infarction, diastolic heart failure, and conduction defects.
– P. Gosciniak (Bezrzecze, PL)
Intracardiac leiomyomatosis complicated with pulmonary embolism.
– V. Ribeiro (Porto, PT)
Cardiac involvement in the hypereosinophilic syndrome.
– E. McAlindon (Bristol, GB)
Brugada type ECG: unmasked by a pheochromocytoma.
– A. Khan (Cork, IE)
Immunosuppression of recurrent pericardial graft versus host disease.
– A.C. Morley-Smith (London, GB)
Mediastinal Paraganglioma: a challenge to the echocardiographic diagnosis and endovascular
treatment.
– S. Raposeiras Roubin (Pontevedra, ES)
An unexpected cause of right atrial mass.
– T. Pereira-Da-Silva (Lisbon, PT)
Conclusion by the Chairpersons.
11:15
11:27
11:39
11:51
12:03
12:15
12:27
4076
4077
4078
4079
4080
4081
4082
TUESDAY – MORNING
11:00
243
TUESDAY, 28 AUGUST 2012 – MORNING POSTERS
08:30–12:30 | Posters - Village 10
POSTER SESSION 5
Poster Session
Posters must be set up between 08:00 and 08:30, removed between 12:30 and 13:00 and be on display from 08:30
to 12:30.The presenter should be present throughout the coffee break (10:00 to 11:00) in order to discuss the Poster.
GENETIC ASPECTS/VENTRICULAR ARRYTHMIAS
Outcome of screening of relatives to patients with long QT syndrome; a nationwide Danish study.
– J. Theilade, J. Kanters, F.L. Henriksen, M. Gilsaa-Hansen, J. Hastrup-Svendsen, O. Eschen,
A. Tybjaerg-Hansen, M. Christiansen, H.K. Jensen, H. Bundgaard (Copenhagen, Odense, Haderslev,
Aalborg and Aarhus, DK)
The australian national genetic heart disease registry.
– J. Ingles, T. Sarina, A. Evans, J. Kawa, R. Weintraub, J. Vohra, I. Winship, J. Mcgaughran, J. Atherton,
C. Semsarian (Sydney, Launceston, Melbourne and Brisbane, AU)
A new MOG1 transcript variant implicated in arrhythmias.
– V. Novelli, M. Cerrone, S. Crespo-Carbone, R. Bloise, C. Napolitano, S.G. Priori (New York, US; Pavia, IT)
A novel mutation affecting the transmembrane domain of the KCNJ2 protein is associated with high
prevalence of life-threatening ventricular arrhythmias in a family with andersen-tawil syndrome.
– E. Fernlund, C. Lundin, E. Hertervig, O. Kongstad, M. Alders, P.G. Platonov (Lund, SE; Amsterdam, NL)
A novel SCN5A missense gene mutation causing LQT3 syndrome in a large Canadian first nations family.
– M.J. Gardner, M.J. Gardner, C. Gray, J. Marcadier, A. Crowley, J. Hathaway, A. Warren, S. Dyack (Halifax,
CA)
Evidence for a heritable contribution to death from atrial fibrillation.
– N.F. Marrouche, B.D. Wilson, K. Damal, L. Cannon-Albright (Salt Lake City, US)
Inherited cardiovascular diseases (ICVDs) in the every day clinical practice: diagnostic yield and genetic
family screening.
– A. Anastasakis, X. Kotsaka, N. Protonotarios, A. Vouliotis, A. Antonakopoulos, C. Ritsatos, D. Kotsas,
C.H. Stefanadis (Athens and Naxos, GR)
Long QT3 mice have disrupted sympathovagal balance and in vivo ventricular stimulation does not
determine risk of sudden cardiac death, suggesting that a second perturbation may be required.
– A. Opel, C. L-H Huang, A. Grace, A. Tinker (London and Cambridge, GB)
The effect of corticosteroid, antiarrhythmic agents, and radiofrequency catheter ablation on ventricular
tachycardia associated with cardiac sarcoidosis.
– Y. Naruse, Y. Sekiguchi, H. Tada, T. Machino, K. Kuroki, H. Yamasaki, M. Igarashi, H. Okada, Y. Yamauchi,
K. Aonuma (Tsukuba and Tokyo, JP)
Outcome of patients with acute coronary syndromes complicated by ventricular tachycardia or fibrillation
in the acute coronary syndromes istraeli survey (ACSIS).
– K. Orvin, S. Gottlieb, I. Goldengerg, S. Matezki, G. Golovchiner, A. Battler, B. Strasberg, J. Kuznietz,
M. Haim (Petah Tikva and Tel Aviv, IL)
Changes in NT-proBNP level after successful PVC ablation in patients without structural heart disease:
evidence for PVC-induced chronic wall stress.
– C.F.B. Van Huls Van Taxis, D. Leong, S.R.D. Piers, A.P. Wijnmaalen, K. Dyrda, V. Delgado, A. Van Der
Laarse, D.A. Pijnappels, M.J. Schalij, K. Zeppenfeld (Leiden, NL)
The characteristics of malignant premature extrasystoles originating from right ventricular outflow tract.
– A. Kasai, S. Sakabe, K. Mori, K. Miyagawa, K. Moriwaki, M. Sugimoto, T. Takamura, M. Horiguchi,
A. Kawamura, T. Seko (Ise, JP)
Effect of vagal nerve on the monophasic action potential of ventricular outflow tract.
– D. Chang, L.J. Gao, S.L. Zhang, Y.L. Xia, Y.Z. Yang (Dalian, CN)
Electromechanical coupling interval: a new marker of PVC in LV dysfunction.
– M.E. Trucco, A. Berruezo, J. Fernandez-Armenta, D. Andreu, R. Borras, R. Evertz, J.M. Tolosana,
E. Arbelo, L. Mont, J. Brugada (Barcelona, ES)
Digitalis use and multivessel disease independently predict ventricular fibrillation at reperfusion in
PCI-treated patients with ST-elevation myocardial infarction.
– M.M. Demidova, J. Carlson, J.G. Smith, F. Holmqist, D. Erlinge, P.G. Platonov (Lund, SE)
Electroanatomical substrate mapping guidance for left ventricle aneurysmectomy in patients after
– P. Neuzil, J. Petru, S. Cerny, P. Pavel, J. Skoda, S. Kralovec, L. Plevkova, F. Holy, L. Sediva, V.Y. Reddy
(Prague, CZ; New York, US)
Increased spatial dispersion of the ventricular recovery time in patients with idiopathic ventricular
fibrillation.
– Y. Yazaki, Y. Goseki, Y. Saito, Y. Komatsu, A. Yamashina (Tokyo, JP)
Predictors and prognosis of ventricular fibrillation during acute coronary syndromes.
– C. Galvao Braga, V. Ramos, C. Vieira, J. Martins, S. Ribeiro, A. Gaspar, P. Azevedo, M.A. Pereira,
S. Magalhaes, A. Correia (Braga, PT)
Circulating biomarkers of extracellular matrix remodeling are associated with ventricular arrhythmia in
heart failure patients.
– K. Kelemen, J.L. Bermejo, P. Ellinghaus, T. Krahn, P. Lugenbiel, R. Becker, C. Zugck, A. Bauer, H.A. Katus,
D. Thomas (Heidelberg and Wuppertal, DE)
Efficacy of ICD therapy in high-risk children with Long QT syndrome.
– R. Ildarova, M. Shkolnikova, V. Bereznitskaya, S. Termosesov (Moscow, RU)
Takotsubo cardiomyopathy and arrhythmic risk.
– F. Rotondi, F. Manganelli, F. Candelmo, T. Lanzillo, G. Stanco, F. Alfano (Avellino, IT)
244
P4083
P4084
P4085
P4086
P4087 (W)
P4088
P4089
P4090
P4091
P4092
P4093
P4094
P4095
P4096
P4097
P4098
P4099
P4100
P4101
P4102
P4103
J waves in the early recovery phase of acute myocardial infarction and its clinical implication.
– M. Nakayama, H. Kitazawa, M. Sato, M. Okabe, A. Yamashina, Y. Aizawa (Nagaoka and Tokyo, JP)
Amyloid deposition of intramural coronary arteries and peri-coronary neurons in epicardium may be the
cause of ventricular arrhythmia in cardiac amyloidosis.
– H. Yasui, H. Ishibashi-Ueda, Y. Ikeda, T. Matsuyama (Suita, JP)
Prevalence of J wave and eraly repolarization pattern in a large population of aircrew members.
– E. Perrier, S. Bisconte, D. Permal, O. Manen, J. Deroche, D. Dubourdieu, A.P. Hornez, J.F. Oliviez,
V. Martel, P. Heno (Clamart, FR)
P4104
P4105
P4106
ELECTROPHYSIOLOGIC STUDIES/SUDDEN CARDIAC DEATH
P4107
P4108
P4109
P4110
P4111
P4112
P4113
P4114
P4115
P4116
P4117
P4118
TUESDAY – MORNING
How do female electrophysiologists deal with radiation exposure during pregnancy: Results from the
EPIC global survey.
– S. Ernst, M.K. Chung, A. Russo, E. Hoffmann, S. Eisenberg, U. Birgesdotter-Green,
C. Blomstroem-Lundquist, J. Poole (London, GB; Cleveland, Cherry Hill, Walnut Creek, San Diego and
Seattle, US; Munich, DE; Uppsala, SE)
Determinants of immediate intracardiac intervals prolongation after Percutaneous Aortic Valve
Implantation.
– J. Segura, J. Suarez De Lezo, F. Mazuelos, P. Martin, E. Caballero, M. Pan, M. Romero, S. Ojeda, J. Lopez
Aguilera, A. Medina (Cordoba and Las Palmas, ES)
Remote navigation and electroanatomical mapping with electromagnets: a validation human study.
– J.L. Merino, Y. Shachar, A. Estrada, D. Doiny, S. Castrejon, D. Filgueiras, M. Ortega, J.A. Figueroa,
E. Gang, J.L. Lopez Sendon (Madrid, ES; Inglewood and Los Angeles, US)
Management of challenging transseptal access in patients with hypermobile septum/interatrial aneurysm
or stiff septum/septal scaring.
– C.I. Park, H. Lehrmann, R. Weber, J. Schiebeling, J. Stockinger, C. Herrera, T. Arentz, A. Jadidi (Bad
Krozingen, DE)
Epicardial electrophysiolosic mapping of ganglionated plexi for concomitant atrial fibrillation.
– Y. Kondo, M. Ueda, M. Watanabe, T. Ishizaka, G. Matsumiya, Y. Kobayashi (Chiba, JP)
Distribution of delayed potentials on the right ventricular endocardium in patients with late potentials on
signal-averaged electrocardiograms due to arrhythmogenic right ventricular cardiomyopathy.
– T. Kobayashi, S. Kamakura, K. Satomi, T. Noda, K. Miyamoto, Y. Yamada, H. Okamura, T. Aiba,
S. Yasuda, W. Shimizu (Suita, JP)
Radiation exposure during electrophysiology procedures: results from the EPIC global survey.
– S. Ernst, M.K. Chung, A. Russo, E. Hoffmann, S. Eisenberg, U. Birgesdotter-Green,
C. Blomstroem-Lundquist, J. Poole (London, GB; Cleveland, Cherry Hill, Walnut Creek, San Diego and
Seattle, US; Munich, DE; Uppsala, SE)
Mortality and morbidity after cavotricuspid isthmus radiofrequency catheter ablation for atrial flutter:
outcomes from a controlled nonrandomized long-term study.
– L. Fauchier, L. Desprets, N. Clementy, B. Pierre, B. Lallemand, I. Lagrenade, S. Taillandier, A. Bernard,
D. Babuty (Tours, FR)
Predictive value of programmed ventricular stimulation in ischemic cardiomyopathy and dilated
cardiomyopathy patients with preserved systolic function.
– D. Tsiachris, K.A. Gatzoulis, A. Vouliotis, P. Dilaveris, S. Sideris, P. Arsenos, I. Skiadas, I. Sotiropoulos,
I. Kallikazaros, C. Stefanadis (Athens, GR)
Use of Wearable Cardioverter Defibrillator after implantable cardioverter defibrillator explantation: clinical
experience from 151 German patients.
– C. Wan, H. Esser, S. Szymkiewicz (Pittsburgh, US)
Return of spontaneous circulation after unwitnessed out-of-hospital cardiac arrest with asystole on initial
rhythm.
– Y. Goto, T. Maeda (Kanazawa and Komatsu, JP)
Long-term follow-up and predictors of arrhythmic events in the brugada registry of the piedmont region
of Italy.
– N. Cerrato, C. Giustetto, A. Vairo, D. Giachino, L. Barbonaglia, F. Bianchi, G. Varalda, F. D’Ascenzo,
P. Dalmasso, F. Gaita (Turin, Orbassano and Vercelli, IT)
Initiative for strategic placement of AEDs in a city center increases coverage of cardiac arrest
high-incidence areas.
– C.M.H. Malta Hansen, M. Wissenberg, P. Weeke, M.H. Ruwald, F. Lippert, G.H. Gislason, S.L. Nielsen,
L. Koeber, C. Torp-Pedersen, F. Folke (Copenhagen, DK)
Electrocardiogram fails to identify high-risk individuals: analysis of a series of 50 sudden death cases.
– M. Salar Alcaraz, P. Penafiel-Verdu, C. Munoz-Esparza, J.M. Lopez Ayala, C. Gonzalez Canovas, D. Lopez
Cuenca, F. Escudero, F. Pastor Quirante, J.R. Gimeno Blanes, M. Valdes Chavarri (Murcia, ES)
Association between an invasive strategy involving electrophysiologic study with prophylactic pacing and
survival outcomes among adults with myotonic dystrophy type 1 and conduction system disease.
– K. Wahbi, C. Meune, R. Porcher, H.M. Becane, A. Lazarus, P. Laforet, T. Stojkovic, A. Behin, B. Eymard,
D. Duboc (Paris, FR)
Cardiac conduction system involvement in patients with steinert’s myotonic dystrophy.
– P.-G. Golzio, E. Pistone, T. Mongini, M. Morello, W. Grosso Marra, F. Gaita (Turin, IT)
Significant incidence of sudden cardiac arrest under 55 with no better survival than older age groups.
– R. Havmoller, K. Reinier, C. Teodorescu, A. Uy-Evanado, E. Stecker, H. Chugh, R. Mariani, K. Gunson,
J. Jui, S.S. Chugh (Los Angeles and Portland, US)
PCI during prolonged CPR: only patients with ventricular fibrillation benefit.
– G. Simonis, J. Steglich, R.H. Strasser (Dresden, DE)
P4119
P4120
P4121
P4122
P4123
P4124
245
Circulating microRNAs after cardiac arrest.
– Y. Devaux, E. Goretti, M. Vausort, L. Zhang, D.R. Wagner, P. Stammet (Luxembourg, LU)
Impacts of rewarming speed differences on outcomes of therapeutic hypothermia in out-of-hospital
cardiac arrest: is rapid rewarming efficient?
– N. Kokubu, M. Hase, K. Tsuchihashi, J. Nishida, Y. Asai, N. Yonemoto, H. Yokoyama, K. Nagao, T. Miura,
H. Nonogi (Sapporo, Tokyo, Suita, Osaka and Shizuoka, JP)
Circadian variation in shockable heart rhythm and survival in out-of-hospital cardiac arrests.
– F. Folke, C.M. Hansen, M.W. Joergensen, F.K. Lippert, S.L. Nielsen, G.H. Gislason, M.H. Ruwald,
L. Koeber, C. Torp-Pedersen, P. Weeke (Copenhagen, DK)
Cardiac screening of first-degree relatives after sudden cardiac death in young population.
– B. Munoz-Calero, A. Recio Mayoral, F. Trujillo, M. Chaparro, L. Gonzalez-Torres, M.J. Valle-Caballero,
M.J. Iglesias, R. Hidalgo, J.M. Cruz (Seville, ES)
Risk factors for sudden cardiac death: Results from the Nordic arrhythmogenic right ventricular
cardiomyopathy registry.
– A.G. Holst, K.H. Haugaa, P.G. Platonov, T. Edvardsen, C. Lundin, T. Gilljam, O. Eschen, J. Hansen,
H. Bundgaard, J.H. Svendsen (Copenhagen, Aalborg and Gentofte, DK; Oslo, NO; Lund and Gothenburg,
SE)
Survival from inpatient cardiac arrest in a referral hospital for cardiology and cardiac surgery.
– P. Cokkinos, E. Papadopoulou, A. Gkouziouta, K. Farsalinos, V. Voudris, D.V. Cokkinos (Athens, GR)
Long term prognosis and predictors of sudden cardiac death in patient with coronary spasm: single
center cohort study.
– J.S. Ko, N. Kim (Gwangju and Iksan, KR)
Does adding up ventilation to chest compression modify memory retention when training general
population to cardiopulmonary resuscitation?
– P. Cassan, D. Zitouni, D. Meyran, E. Aliot, H. Hubert, J. Mansourati (Paris, Lille, Nancy and Brest, FR)
ECG changes during hypothermia as potential markers of mortality of successfully resuscitated patients.
– G. Apponyi, D. Pilecky, Z.S. Szelenyi, A. Horvath, S.Z. Szilagyi, K. Heltai, L. Geller, D. Becker, B. Merkely,
E. Zima (Budapest, HU)
Copeptin predicts neurological outcomes in out-of-hospital cardiac arrest survivors.
– P. Ostadal, M. Prucha, A. Kruger, D. Vondrakova, M. Janotka (Prague, CZ)
Survivors of sudden cardiac death with depression are not at significantly greater risk of recurrent
arrhythmias and death.
– M. Turagam, P. Velagapudi, A. Szabo, A. Visotcky, A. Kocheril (Madison, Milwaukee and Urbana, US)
Detection of pulseless electrical activity by a public access defibrillator using ECG and ICG.
– C. Navarro, N. Cromie, O. Escalona, R. Di Maio, A. Howe, A.I. Thompson, J. Anderson (Belfast,
Jordanstown and Craigavon, GB)
Analysis of the relation between T-wave alternans and myocardial ischemia diagnosed by gated-SPECT:
results of the SPECTACLE study.
– C. Radig Lambert, C. Cohen, C. Goetz, W. Kaiser, M.C. Perier, F. Zores, G. Roul (Colmar, Strasbourg and
Paris, FR; Freiburg, DE)
Improved prognosis after implementation of chest compression device in out-of-hospital cardiac arrest.
– S.N. Morozov, S.N. Abdusalamov, A.Y. Fedorov (Moscow and Yakutsk, RU)
Normal limits of the adult electrocardiogram for ages 16-90 years.
– P.R. Rijnbeek, G. Van Herpen, M.L. Bots, C.A. Swenne, N. Verweij, J.C.M. Witteman, J.A. Kors (Rotterdam,
Utrecht, Leiden and Groningen, NL)
First validation of esophageal long-term electrocardiography as an alternative technique for long-term
heart rhythm monitoring.
– A. Haeberlin, T. Niederhauser, T. Marisa, J. Goette, M. Jacomet, H. Tanner, J. Fuhrer, R. Vogel (Bern and
Solothurn, CH)
Relationship of fragmented QRS and delayed contrast enhanced cardiovascular magnetic resonance
(DE-CMR) imaging in patients with myocardial infarction.
– M.-S. Ahn, Y.B.S. Yoo, L.J.W. Lee, L.J.H. Lee, Y.Y.J. Youn, A.J.G. Ahn, K.J.Y. Kim, L.S.H. Lee,
Y.J.H. Yoon, C.K.H. Choe (Wonju, KR)
Frontal plane ST-segment and QRS complex abnormalities as predictors of extent of necrosis and left
ventricular dysfunction assessed by 3 Tesla cardiac MR.
– C.A. Ingino, G.A. Rodriguez-Granillo, F. Lopez, R. Borracci, J. Pulido, M. Archer, L. Celano, P. Lylyk
(Buenos Aires, AR)
A left-to-right interatrial frequency gradient during atrial fibrillation can be detected using standard
12-lead ECG.
– F. Holmqvist, I. Nault, J. Carlson, M. Hocini, M. Haissaguerre, P.G. Platonov (Lund, SE; Bordeaux-Pessac,
FR)
Epicardial cooling increases opportunity of spiral wave termination: a simulation study.
– S. Inada, T. Ashihara, R. Haraguchi, T. Arafune, I. Sakuma, M. Yamazaki, H. Honjo, I. Kodama,
K. Nakazawa (Suita, Osaka, Otsu, Tokyo and Nagoya, JP)
Role of new task force ECG criteria in the diagnosis of arrhythmogenic right ventricular
dysplasia/cardiomyopathy.
– J.M. Rubio Campal, J. Benezet-Mazuecos, P. Sanchez-Borque, M.A. Quinones, S. Del Castillo, E. Macia,
H.P. Gaebelt, J. Hernandez, A. Lopez, J. Farre (Madrid, ES)
Role of home monitoring in effective device management of patients with implantable
cardioverter-defibrillators: a prospective randomized trial.
– O. Osmera, A. Bulava (Ceske Budejovice, CZ)
246
P4125
P4126
P4127
P4128
P4129
P4130
P4131 (W)
P4132
P4133
P4134
P4135
P4136
P4137
P4138
P4139
P4140
P4141
P4142
P4143
P4144
P4145
P4146
IN-STENT-RESTENOSIS AND INVASIVE CORONARY IMAGING
P4147
P4148
P4149
P4150
P4151
P4152
P4153
P4154
P4155
P4156
P4157
P4158
P4159
P4160
P4161
P4162
TUESDAY – MORNING
Higher stroke rate in patients undergoing elective PCI for in-stent-stenosis in clinical practice in Europe:
results of the EHS PCI registry.
– A.K. Gitt, T.I.M.M. Bauer, R. Zahn, M. Hochadel, U. Zeymer, C. Hamm (Ludwigshafen and Bad Nauheim,
DE)
The optimal strategy for restenosis with stent fracture after drug-eluting stent implantation: 1st
generation DES vs. 2nd generation DES.
– S. Otsuru, K. Kadota, D. Hasegawa, S. Habara, T. Tada, H. Tanaka, Y. Fuku, N. Oka, T. Goto, K. Mitsudo
(Kurashiki, JP)
Coronary flow velocity and fluid shear stress predict late catch-up after sirolimus-eluting stent
implantation.
– H. Hikita, S. Kuroda, Y. Oosaka, N. Kawaguchi, D. Akiyama, T. Sugiyama, T. Kamiishi, S. Kimura,
A. Takahashi, M. Isobe (Yokosuka and Tokyo, JP)
Virtual histology intravasucular ultrasound comparison of neointimal morphology of in-stent restenosis
with drug eluting stents versus bare metal stents.
– S. Fujita, S. Sakuragi (Iwakuni, JP)
Predictors of neointima hyperplasia in in-stent restenosis.
– M. Popovici, I. Popovici, S. Kostin, V. Cobet, V. Ivanov, N. Ciobanu, L. Ciobanu (Chisinau, MD)
Difference in clinical restenosis rates between silicon carbide and uncoated bare metal stents.
– S. Haine, B. Cornez, J. Jacobs, H. Miljoen, M. Claeys, T. Vandendriessche, J. Bosmans, C. Vrints (Antwerp,
BE)
Changes in early cardiac gene transcript levels in peripheral blood mononuclear cells after percutaneous
coronary intervention and their relationship to restenosis.
– J.E. Kontaraki, G.E. Kochiadakis, M.E. Marketou, N.E. Igoumenidis, P.E. Vardas (Heraklion, GR)
No harmful effect of stem cell mobilization by granulocyte-colony stimulating factor on restenosis or late
luminal loss after sirolimus-eluting stent implantation.
– Y. Iwata, Y. Fujimoto, T. Kadohira, T. Morino, K. Ohkubo, K. Sugimoto, E. Ichimoto, K. Kubo, T. Miyayama,
Y. Kobayashi (Chiba, JP)
Comparison of mid-term angiographical outcomes of drug-eluting stents in hemodialysis patients.
– Y. Fuku, K. Mitsudo, K. Kadota, T. Goto, N. Oka, H. Tanaka, T. Tada, S. Habara, Y. Shigemoto,
D. Hasegawa (Kurashiki, JP)
Severe insulin resistance is a predictor of restenosis after drug-eluting stent implantation.
– T. Yufu (Koshigaya, JP)
Mobilization of CD34+KDR+ cells among circulating progenitors predicts bare-metal stent restenosis.
– L. Bonello, K.H. Harhouri, K.B. Baumstarck, L.A. Arnaud, N.L. Lesavre, C.P. Piot, F.P. Paganelli,
F.D.G. Dignat-George, F. Sabatier (Marseille and Montpellier, FR)
Correlation between hs-CRP and genetic polymorphism in in-stent-restenosis after bare metal stenting.
– M. Chinikar, P. Sadeghipour, S. Javadi, S. Rafati, A. Heidarzadeh, S. Hoda, Y. Taslimi, H. Esmaili (Rasht
and Tehran, IR)
Impaired production of anti-atherosclerotic interleukin-10 by macrophage within culprit coronary plaque
in diabetic patients with restenosis after primary PCI.
– T. Kameyama, T. Sato, T. Noto, T. Nakadate, H. Ueno, K. Yamada, H. Inoue (Toyama, Takaoka, Imizu and
Uodu, JP)
Reseeding of a decellularized arterial matrix for restenosis research.
– D. Haase, S. Otto, B.F.M. Romeike, H.-R. Figulla, T.C. Poerner (Jena, DE)
Tissue characteristics in in-stent restenosis lesions after various drug-eluting stents and bare-metal stent
assessing with optical coherence tomography.
– T. Tada, K. Kadota, S. Habara, H. Tanaka, Y. Fuku, N. Oka, H. Katoh, H. Yamamoto, T. Goto, K. Mitsudo
(Kurashiki, JP)
Comparison of neointimal tissue characteristics among bare-metal stent, paclitaxel-eluting stents and
zotarolims-eluting stents using integrated-backscatter intravascular ultrasound.
– K. Kashiyama, S. Sonoda, R. Anai, Y. Muraoka, F. Kamezaki, Y. Tsuda, M. Araki, M. Okazaki, Y. Otsuji
(Kitakyushu, JP)
Spatial distribution of culprit lesion thin cap fibroatheromas and culprit ruptured plaques in acute
coronary syndrome. An optical coherence tomography study.
– A. Karanasos, K. Toutouzas, M. Riga, E. Tsiamis, A. Synetos, K. Stathogiannis, A. Papanikolaou,
G. Triantafyllou, D. Tousoulis, C. Stefanadis (Athens, GR)
Optical coherence tomography guided angioplasty during acute coronary syndrome: the OTOCLAV study.
– P. Motreff, N. Amabile, G. Souteyrand, N. Combaret, R. Hamdan, S. Ghostine, C. Caussin
(Clermont-Ferrand and Le Plessis-Robinson, FR)
Relationship between optical coherence tomography (OCT), intravascular ultrasound tomography (IVUS)
and pressure-derived fractional flow reserve.
– T. Osue, J. Shite, T. Shinke, H. Otake, K. Hirata (Kobe, JP)
VH-IVUS predictors for lesion specific myocardial ischemia in intermediate coronary artery stenosis.
– J.H. Doh, B.K. Koo, C.W. Nam, S.Y. Lee, H. Choe, J.H. Kim, H.S. Kim, S.W. Hong (Goyang, Seoul and
Daegu, KR)
Intravascular ultrasound-guided treatment for intermediate left main coronary lesions.
– S. Golebiewski, A.I. Gziut, T. Kulawik, P. Kwiatkowski, Z. Sliwinski, J. Rzezak, T. Pawlowski, D. Vassilev,
R.J. Gil (Warsaw, PL; Sofia, BG)
P4163
P4164
P4165
P4166
P4167
247
NON CORONARY AND TAVI INTERVENTIONS
Percutaneous occlusion of left atrial appendage with the amplatzer cardiac plug: results from clinical,
echocardiographic and CT follow-up in 100 implanted patients.
– G. Santoro, S. Berti, F. Meucci, C. Palmieri, U. Paradossi, G. Squillantini, G. Rosso, F. Mori, A. Oddo
(Florence and Massa, IT)
Comparative analysis of percutaneous left atrial appendage (LAA) closure systems: a single center
experience.
– M. Kulikoglu, S. Bordignon, V. Urban, M. Gunawardene, B. Schulte-Hahn, B. Nowak, B. Schmidt,
K.R.J. Chun (Frankfurt, DE)
Refining transcatheter left atrial appendage closure: eliminating the anaesthestist and reducing the cost.
– D.F. Waterhouse, S.D. Asgedom, A. Neylon, M. Alqaseer, B. Mcadam, D.P. Foley (Dublin, IE)
The role of intracardiac echocardiography in the management of left atrial appendage occlusion: three
years experience.
– S. Berti, G. Santoro, G. Rosso, F. Meucci, A. Viggiano, U. Paradossi, C. Palmieri (Massa and Florence, IT)
Left atrial appendage occlusion: the link between imaging techniques and clinical events.
– A. Viggiano, U. Paradossi, C. Palmieri, A. De Caterina, A. Clemente, E. Cerone, S. Berti (Massa, IT)
Atrial arrhythmias after implantation of atrial septal defect devises. Is there an inflammatory component?
– M. Vavouranakis, C. Kavouras, I. Vlaseros, K. Aggeli, I. Felekos, D. Vrachatis, K. Kalogeras, S. Georgiou,
I. Kalikazaros, C. Stefanadis (Athens, GR)
“Migraine side effect” after PFO closure as secondary prevention of stroke or TIA.
– M. Kumor, E.K. Biernacka, M. Jagodzinska, A. Platek, M. Demkow, W. Ruzyllo, M. Konka, P. Hoffman
(Warsaw, PL)
Transthoracic echocardiography guidance during percutaneous closure of patent foramen ovale.
– U. Canpolat, K. Aytemir, H. Yorgun, H. Sunman, M. Dural, L. Sahiner, E.B. Kaya, G. Kabakci,
L. Tokgozoglu, A. Oto (Ankara and Kayseri, TR)
Simultaneous measurement of left ventricular volume and pressure during percutaneous mitral valve
repair with the evalve mitraclipTM system.
– O. Gaemperli, P. Biaggi, M. Osranek, C. Felix, D. Bettex, J. Grunenfelder, V. Falk, T.F. Luscher, R. Corti
(Zurich, CH)
Impact of mitral annulus dimensions assessed by 3D echocardiography on procedural results of
percutaneous edge-to-edge mitral valve repair and left atrial and left ventricular reversed remodeling.
– E. Altiok, S. Hamada, K. Brehmer, S. Reith, M. Becker, J. Schroeder, M. Almalla, N. Marx, R. Hoffmann
(Aachen, DE)
Mitral Valvuloplasty long-term follow-up of single balloon (Balt) versus Inoue balloon techniques.
– I.P. Borges, E.C.S. Peixoto, R.T.S. Peixoto, R.T.S. Peixoto (Rio de Janeiro, BR)
Percutaneous mitral balloon valvuloplasty beyond 65 years of age.
– Z. Chmielak, M. Klopotowski, M. Demkow, M. Konka, P. Hoffman, K. Kukula, M. Kruk, A. Witkowski,
W. Ruzyllo (Warsaw, PL)
Clinical and echocardiographic outcomes of patients undergoing percutaneous closure of mitral
paravalvular leak:.
– S. Valbuena Lopez, J. Ruiz Garcia, P. Salinas Sanguino, R. Moreno, S. Jimenez-Valero, G. Galeote,
A. Sanchez-Recalde, L. Calvo Orbe, M. Moreno, J. Lopez-Sendon (Madrid, ES)
Percutaneous balloon mitral commissurotomy during pregnancy: Our Experience.
– A. Tounsi, L. Abid, D. Abid, S. Mallek, M. Akrout, F. Triki, M. Hentati, S. Kammoun (Sfax, TN)
Endovascular stenting for palliation in malignant superior vena cava syndrome.
– K. Lang, M. Ulrich, S. Braeunlich, A. Schmidt, S. Guetz, S. Botsios, D. Scheinert (Eggenfelden and Leipzig,
DE)
Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced acute kidney injury in
unselected patients undergoing transcatheter aortic valve implantation.
– K.C. Chatani, A.M. Abdel-Wahab, R.T. Toelg, V.G. Geist, M.M. Marwan, A.M. Mostafa, G.R. Richardt
(BadSegeberg, DE)
Impact of percutaneous treatment of acute pulmonary embolism in intermediate and high risk patients.
– N. Farre, F. Miranda, M. Orozco-Levi, N. Salvatella, H. Tizon, L. Molina, J. Gea, J. Bruguera (Barcelona, ES)
Three dimensional rotational angiography fused with multimodal imaging modalities offers a novel,
accurate, fast and safe way to guide endomyocardial injections.
– D. Dauwe, D. Nuyens, S. De Buck, P. Claus, L. Janssens, W. Coudyzer, O. Gheysens, M. Koole,
H. Heidbuchel, S. Janssens (Leuven, BE)
Transcatheter closure of ruptured sinus of valsalva aneurysm with nitinol mesh occluders.
– J. Bialkowski, M. Szkutnik (Zabrze, PL)
Arrhythmia device lead extraction using evolution mechanical dilator sheath.
– U. Canpolat, K. Aytemir, H. Yorgun, H. Sunman, L. Sahiner, K.M. Gurses, E.B. Kaya, G. Kabakci,
L. Tokgozoglu, A. Oto (Ankara and Kayseri, TR)
Comparison of knowledge-based weaning (KBW) and physician-driven weaning of mechanically
ventilated patients in the coronary care unit.
– E.T.S. Lim, N. Hamid, N.C. Beh, G.C. Phua, J. Tan (Singapore, SG)
P4168
P4169
P4170
P4171
P4172
P4173
P4174
P4175
P4176
P4177
P4178
P4179
P4180
P4181
P4182
P4183 (W)
P4184
P4185
P4186
P4187
P4188
TAVI EXPERIENCE
Predictors and clinical outcome of significant paravalvular aortic regurgitation following transcatheter
aortic valve implantation.
– E.M.A. Wiegerinck, Z.Y. Yong, K. Boerlage-Van Dijk, K.T. Koch, M.M. Vis, B.J. Bouma, R. Cocchieri,
J.J. Piek, B.A.J.M. De Mol, J. Baan (Amsterdam, NL)
248
P4189
P4190
P4191
P4192
P4193
P4194
P4195
P4196
P4197
P4198
P4199
P4200
P4201
P4202
P4203
P4204
P4205
TUESDAY – MORNING
Incidence and intraprocedural management of aortic regurgitation in interventional aortic valve
replacement.
– M. Fueller, G. Bodman, E. Kilger, R. Sodian, M. Block (Munich, DE)
Under-deployment and asymmetrical expansion in transcatheter aortic valves.
– R. Cadenas Chamorro, P. Salinas, R. Moreno, L. Calvo, S. Jimenez-Valero, A. Sanchez-Recalde,
G. Galeote, A.M. Iniesta, I. Plaza, J.L. Lopez-Sendon (Madrid, ES)
Prosthesis/annulus discongruence by three-dimensional transesophageal echocardiography: predictor of
significant aortic regurgitation after transcatheter aortic valve implantation.
– N. Santos, C. Olmos, J.A. De Agustin Loeches, P. Marcos-Alberca, C. Fernandez-Golfin, C. Almeria,
J.L. Rodrigo, J. Zamorano, C. Macaya, L. Perez De Isla (Madrid, ES)
Clinical and hemodynamic outcomes in patients with prosthesis-patient mismatch after TAVI with both
core valve and edwards sapien XT valves.
– K. Stathogiannis, K. Toutouzas, K. Spargias, G. Latsios, A. Synetos, A. Karanasos, M. Chrissoheris,
A. Antoniadis, G. Pavlides, C. Stefanadis (Athens, GR)
Predictors of prosthesis-patient mismatch in patients undergoing TAVI with CoreValve and Sapien XT.
Impact of valve type and annular size on post TAVI aortic valve regurgitation.
Relation of Aortic Regurgitation (AR) to Plasma Brain Natriuretic Peptide (BNP) evolution after
Transfemoral Aortic Valve Implantation (TAVI) for Severe Aortic Stenosis (AS).
– K. El Chilali, T. Konorza, F. Al Rashid, P. Patsalis, B. Plicht, D. Wendt, M. Thielmann, H. Jakob, R. Erbel,
P. Kahlert (Essen, DE)
Optimazing vascular access during TAVI by using inferior epigastric artery as a landmark.
– M. Vavuranakis, K. Kalogeras, D. Vrachatis, M. Kariori, K. Aznaouridis, C. Moldovan, K. Masoura,
G. Lazaros, E. Gravia, C. Stefanadis (Athens, GR)
Effect of transfemoral aortic valve implantaion (TF-AVI) for severe aortic stenosis on plasma brain
natriuretic peptide (BNP) levels: predictive value for 30-days and 1-year survival.
– K. El Chilali, T. Konorza, F. Al Rashid, P. Patsalis, B. Plicht, D. Wendt, M. Thielmann, H. Jakob, R. Erbel,
P. Kahlert (Essen, DE)
Incidence and prognostic implications of the subclavian approach for Transcatheter aortic valve
implantation with the CoreValve prosthesis.
– A.J. Munoz Garcia, M.J. Molina Mora, E. Munoz Garcia, M.F. Jimenez Navarro, A.J. Dominguez Franco,
J.H. Alonso Briales, M. Such Martinez, J.M. Hernandez Garcia, E. De Teresa Galvan (Malaga, ES)
Decrease in sheath size for transfemoral Aortic Valve Implantation: what are the consequences?
– C. Tron, B. Borz, M. Godin, A. Canville, C. Hauville, P.-Y. Litzler, J.-P. Bessou, A. Cribier, H. Eltchaninoff
(Rouen, FR)
Lower pacing rate with CoreValve TAVI: high implantation or Accutrak catheter, or both?
– M. Drury-Smith, S. Lakshmanan, R. Giri, M. Fayaz, J. Cotton, M. Bhabra, S. Khogali (Wolverhampton, GB)
Hybrid endovascular repair for aortic arch pathology: intermediate outcomes and complications.
– W.C. Kang, E.K. Shin, C.H. Park, J.M. Kang, Y.G. Ko, D.H. Choi, Y.N. Youn, W.H. Shim (Incheon, Seoul
and Bucheon, KR)
Incidence, predictive factors and prognostic value of inflammatory reaction following tanscatheter aortic
valve implantation (TAVI).
– Y. Maazoun, C. Martinez, M. Radermecker, J. Magne, R. Durieux, O. Gach, L. Davin, J. Defraigne,
V. Legrand (Liège, BE)
Early changes of left ventricle deformation indices after transcatheter aortic valve implantation. A speckle
tracking echocardiographic study.
– M. Vavuranakis, I. Vlasseros, K. Kalogeras, M. Kariori, D. Vrachatis, C. Moldovan, V. Katsi, R. Katsarou,
I. Kallikazaros, C. Stefanadis (Athens, GR)
Mitral regurgitation after transcatheter aortic valve implantation with the Medtronic-CoreValve prosthesis
impairs survival.
– K. Boerlage-Van Dijk, E.M.A. Wiegerinck, Z.Y. Yong, B.J. Bouma, M.M. Vis, K.T. Koch, R. Cocchieri,
J.J. Piek, J. Baan (Amsterdam, NL)
Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation.
– B. Borz, E. Durand, M. Godin, C. Tron, P.-Y. Litzler, J.-P. Bessou, A. Canville, A. Cribier, H. Eltchaninoff
(Rouen and Paris, FR)
Renal outcome after transcatheter aortic valve implantation.
– R. Schnabel, M. Seiffert, S. Wilde, P. Diemert, J. Schirmer, L. Conradi, H. Reichenspurner, S. Blankenberg,
H. Treede, S. Baldus (Hamburg, DE)
Predictors of mortality post balloon aortic valvulplasty, results from the BRAVO registry.
– J. Yu, A. Kini, M.G. Cohen, U. Baber, S. Sartori, R. Mehran, G. Vlachojannis, B. O’Neill, S. Sharma,
G.D. Dangas (New York and Miami, US)
Off-label indications for trans-catheter aortic valve implantation.
– A. Segev, D. Spiegelstein, P. Fefer, A. Shinfeld, I. Hay, E. Raanani, V. Guetta (Tel Aviv, IL)
Incidence and predictors of combined safety endpoints occurrence after transcatheter Sapien XT and
CoreValve implantation. A single Centre experience.
– S. Cassese, A.M. Kasel, A.W. Leber, D. Antoni, G. Riess, A. Hutter, J. Vogel, A. Kastrati, W. Eichinger,
E. Hoffmann (Munich, DE)
P4206
P4207
P4208
P4209
P4210
249
MYOCARDIAL FUNCTION LEFT VENTRICULAR DEFORMATION
Impact of acute normobaric hypoxia on regional and global myocardial function: a speckle tracking
echocardiography study.
– B. Goebel, V. Handrick, A. Lauten, M. Fritzenwanger, J. Schuetze, S. Otto, H.R. Figulla, T. Edvardsen,
T.C. Poerner, C. Jung (Jena, DE; Oslo, NO)
Inhibition of Interleukin-1 activity by anakinra improves left ventricular myocardial deformation and
torsion in patients with CAD and coexistent rheumatoid arthritis: a randomized trial.
– I. Ikonomidis, S. Tzortzis, I. Andreadou, P. Dasou, C. Katseli, P. Katsimbri, I. Paraskevaidis, J. Parissis,
J. Lekakis, M. Anastasiou-Nana (Athens, GR)
Prognostic significance of speckle tracking-derived myocardial function in multivesel coronary disease.
– P. Zycinski, K. Wierzbowska-Drabik, H. Qawoq, P. Szczesniak, L. Chrzanowski, J.D. Kasprzak (Lodz, PL)
Left ventricular rotation and torsion and its relation to functional capacity in hypertensive patients.
– A. Majstorovic, V. Celic, B. Pencic-Popovic, A. Sljivic, B. Stojcevski, A. Andric, I. Ilic-Djordjevic, S. Backovic,
M. Pavlovic-Kleut (Belgrade, RS)
Correlation of area strain by three-dimensional speckle tracking echocardiography with exercise capacity
in subjects undergoing treadmill exercise test.
– W.-C. Tsai, Y.-W. Liu, J.-Y. Shih, Y.-S. Huang, W.-H. Li, L.-M. Tsai (Tainan and Douliou City, TW)
Chronic and acute smoking-induced impairment in longitudinal myocardial function: a strain-imaging
study in healthy young smokers.
– K. Farsalinos, D. Tsiapras, S. Kyrzopoulos, E. Avramidou, D. Vassilopoulou, V. Voudris (Athens, GR)
Two-dimensional Speckle-tracking Echocardiography to Identify reversible myocardial dysfunction.
– M. Orii, K. Hirata, K. Ishibashi, T. Yamano, T. Tanimoto, Y. Ino, T. Yamaguchi, T. Kubo, T. Imanishi,
T. Akasaka (Wakayama, JP)
Soluble angiotensin converting enzyme is linked with impaired myocardial deformation and torsion in
untreated hypertensives.
– I. Ikonomidis, A. Tsantes, H. Triantafyllidi, S. Tzortzis, P. Trivilou, I. Paraskevaidis, C. Papadopoulos,
A. Travlou, J. Lekakis, M. Anastasiou-Nana (Athens, GR)
Evaluation of left ventricular segmental strain by three-dimensional echocardiography.
– A. Muranaka, S. Yuda, M. Kawamukai, H. Kouzu, H. Akasaka, H. Ohnishi, A. Hashimoto, S. Saitoh,
K. Tsuchihashi, T. Miura (Sapporo, JP)
Impaired LV systolic function in asymptomatic lean individuals with obstructive sleep apnoea evidenced
by speckle-tracking echocardiography.
– H.Q. Pham, S.K. Namtvedt, H. Rosjo, T. Omland, K. Steine, T.G. Von Lueder (Lørenskog, NO)
Assessment of left ventricular myocardial deformation and mechanical dyssynchrony in patients with
heart failure: insights from three-dimensional wall motion analysis.
– X.X. Luo, F. Fang, A.P. Lee, Y.Y. Lam, J.E. Sanderson, J.S.W. Kwong, C.M. Yu (Hong Kong, CN)
Normal area strain values by three dimensional speckle tracking echocardiography in the first year
post-heart transplantation in the absence of acute cellular rejection.
– M. Ruiz Ortiz, D. Mesa, M. Delgado, E. Romo, F. Castillo, M.C. Morenate, C. Leon, A. Lopez Granados,
J.M. Arizon Del Prado, J. Suarez De Lezo (Cordoba, ES)
Area strain for the assessment of regional left ventricular wall thickening using 3D Speckle Tracking.
– S.F. De Marchi, S. Urheim, E.W. Remme, R. Massey, S. Aakhus (Oslo, NO)
Diabetic retinopathy is associated with the occurrence of subclinical diabetic cardiomyopathy in patients
with type II diabetes.
– C.T. Zhao, M. Wang, K.H. Yiu, H.F. Tse (Hong Kong, HK)
Ejection fraction and deformation in response to three different chemotoxic regimens.
– T. Negishi, K. Negishi, D. Agler, B. Haluska, J.C. Plana, T. Marwick (Cleveland, US; Brisbane, AU)
Left ventricular dyssynchrony in patients with microvascular obstruction after primary percutaneus
coronary intervention evaluated with Real-time 3D speckle tracking echocardiography.
– G. Pinnacchio, L. Barone, A. Stazi, I. Battipaglia, L. Marinaccio, M. Laurito, I. Coviello, A. Sestito,
G.A. Lanza, F. Crea (Rome, IT)
The dangerous liaison between left ventricular systolic function and mitral annulus calcification in
patients with type 2 diabetes without myocardial ischemia. Data from SHORTWAVE study.
– G. Faganello, S. De Feo, N. Berlinghieri, P. Faggiano, R. Candido, C. Mazzone, A. Di Lenarda,
B. Pinamonti, L. Tarantini, G. Cioffi (Trieste, Trento, Peschiera del Garda and Belluno, IT)
Effects of radiotherapy on right and left heart function in patients with left-sided breast and lung cancer
detected by strain and strain rate imaging.
– B. Cakal, S. Cakal, A. Mayadagli, K. Ekici, Z. Bayram, M.O. Gursoy, R.D. Acar, N.E. Duran, M. Yildiz,
M. Ozkan (Istanbul, TR)
Reduced left ventricular contractility with electrical dyssynchrony increases the dyscoordination by
speckle tracking strain rate analysis.
– T. Omuro, T. Maruo, S. Eguchi, Y. Yamanouchi, A. Kurihara, H. Chikuji, S. Fujii, K. Kadota, K. Mitsudo
(Kurashiki, JP)
Effect of left ventricular twisting for the accuracy of two-dimensional longitudinal strain analysis.
– M. Takeuchi, K. Otani, M. Iwataki, H. Kuwaki, K. Kaku, N. Haruki, H. Yoshitani, Y. Otsuji (Kitakyushu, JP)
Assessment of left ventricular dyssynchrony with real time 4D ultrasound system: comparison with
Doppler Myocardial Imaging.
– A.R. Martiniello, P. Caso, M. Cavallaro, C. Cioppa, I. Caso, G. Tonti, R. Calabro’ (Naples and Campobasso,
IT)
250
P4211
P4212
P4213
P4214
P4215
P4216
P4217
P4218
P4219
P4220
P4221
P4222
P4223
P4224
P4225
P4226
P4227
P4228
P4229
P4230
P4231
MYOCARDIAL FUNCTION “DIASTOLOGY”
Brain natriuretic peptide is independently associated with indices of left ventricular filling pressure but
not with left ventricular mass in asymptomatic individuals.
– N.S. Chahal, T.K. Lim, P. Jain, D. Gaze, J. Chambers, J. Kooner, P. Collinson, R. Senior (London and
Harrow, GB)
Decreased velocity propagation of the left ventricle is associated with increased arterial stiffness.
– E. Chatzistamatiou, G. Trantalis, G. Moustakas, I. Skiadas, I. Babatseva-Vagena, N. Kalovidouris, C. Liakos,
A. Avgeropoulou, C. Stefanadis, I. Kallikazaros (Athens, GR)
The E-wave deceleration rate E/DT but not the tissue-Doppler derived index E/Ea reliably characterizes
pressure-overload induced diastolic dysfunction.
– T.D. Nguyen, Y. Shingu, M. Schwarzer, A. Schrepper, T. Doenst (Jena and Leipzig, DE)
3D echocardiography facing the challenge of diastolic function evaluation.
– A. Goncalves, C. Sousa, I. Rangel, A.S. Correia, F. Macedo, J.L. Zamorano, M.J. Maciel (Porto, PT; Madrid,
ES)
Diagnostic value of exercise E/E’ ratio for the early detection of diastolic heart failure in non-obstructive
HCM patients.
– D. Zhu, G.D. Ma, X.H. Feng, Y.Z. Zhang, Z.P. Li, W. Gao (Beijing, CN)
Presence of preoperative diastolic dysfunction predicts postoperative pulmonary edema in patients
undergoing major noncardiac surgery.
– D. Cho, S.A. Kim, M.N. Kim, Y.H. Kim, S.M. Park, H.J. Lim, W.J. Shim (Seoul, KR)
Diastolic tissue doppler velocities predicts adverse outcome after st-elevation myocardial infarction
treated with primary percutaneous coronary intervention.
– T. Biering-Sorensen, P. Sogaard, R. Mogelvang, S.H. Pedersen, S. Lindberg, S. Galatius, S. Hoffmann,
J.S. Jensen (Copenhagen, DK)
Myocardial performance index determined by tissue doppler imaging m-mode predicts outcome in
patients with st-elevation myocardial infarction treated with primary percutaneous coronary intervention.
– T. Biering-Sorensen, R. Mogelvang, S.H. Pedersen, P. Sogaard, S. Galatius, J.S. Jensen (Copenhagen, DK)
Exercise left ventricular filling pressure: prognostic implications in patients after acute myocardial
infarction.
– M. Deljanin Ilic, S. Ilic, V. Stoickov, D. Kalimanovska Ostric, V. Ilic (Niska Banja and Belgrade, RS)
Diastolic but not systolic function is associated with coronary flow reserve in chronic heart failure
patents.
– M. Snoer, T. Monk-Hansen, R. Olsen, L. Pedersen, H. Rasmusen, F. Dela, E. Prescott (Copenhagen, DK)
Association between Eas index by tissue Doppler imaging and ventricular stiffness index or
ventriculoarterial interaction in patients with preserved left ventricular ejection fraction.
– H. Sako, S. Miura, S. Furuyama, A. Matsunaga, K. Saku (Fukuoka, JP)
P4232
P4233
P4234
P4235
P4236
P4237
P4238
P4239
P4240
P4241
P4242
MYOCARDIAL FUNCTION “ISCHEMIC CARDIOMYOPATHY”
P4243
P4244
P4245
P4246
P4247
TUESDAY – MORNING
The prognostic role of dobutamine stress contrast echo in patients with known or suspected coronary
artery disease in different age groups.
– C. Aggeli, I. Felekos, P. Stergiou, E. Poulidakis, A. Katsaros, E. Sfendouraki, G. Roussakis, C. Stefanadis
(Athens, GR)
Stress-echocardiography to identify restenosis in drug eluting stent patients.
– S. Calcagno, M. Pagliaro, L. Lucisano, M. Pennacchi, N. Bruno, A. D’Ambrosi, M. Mancone, G. Sardella,
F. Fedele (Rome, IT)
End-systolic pressure-volume relation and ventricular-arterial coupling predict cardiac events in patients
with negative stress echocardiography.
– T. Bombardini, R. Sicari, Q. Ciampi, S. Gherardi, L. Pratali, E. Picano (Pisa, Benevento and Cesena, IT)
Feasibility, symptoms, adverse effects and complications associated with non invasive assessment of
coronary flow velocity in women with suspected or known coronary artery disease. Experience in 1455.
– R. Montisci, M. Ruscazio, N. Zedda, C. Soro, L. Sau, F. Tuveri, L. Meloni (Cagliari, IT)
Gender difference of diagnostic utility of dobutamine stress echocardiography with early atropine
administration in detection of coronary artery disease.
– K. Wierzbowska-Drabik, N. Roszczyk, M. Sobczak, P. Lipiec, L. Chrzanowski, J.Z. Peruga, R. Krecki,
M. Plewka, J.D. Kasprzak (Lodz, PL)
Coronary flow velocity reserve in 3 major coronary arteries can be a promising alternative for fractional
flow reserve in determining hemodynamic significance of coronary artery disease.
– T. Wada, K.H. Hirata, K. Ishibashi, T. Yamano, T. Tanimoto, Y. Ino, T. Yamaguchi, T. Kubo, T. Imanishi,
Higher prevalence of carotid disease compared to myocardial ischaemia in patients undergoing
simultaneous stress echocardiography for suspected coronary artery disease.
– S. Ahmadvazir, C. Kinsey, K. Zacharias, J. Pabla, B. Shah, R. Senior (Harrow and London, GB)
Left ventricular torsion during exercise in patients with and without ischemia in the left anterior
descending coronary artery territory.
– J. Peteiro, A. Bouzas-Mosquera, A. Lopez-Sainz, M. Lopez-Perez, G. Barge-Caballero, O. Prada,
A. Castro-Beiras (A Coruña, ES)
Abnormal stress electrocardiography in the presence of normal stress echocardiography.
– M. Patchett, R. Wilkof, A. Vodonos, N. Liel-Cohen, V. Novack, S. Kobal (Beer Sheva, IL)
Ranolazine improves coronary flow reserve in patients with angina but no obstructive coronary artery
disease.
– E. Tagliamonte, T. Cirillo, U. Marinelli, C. Astarita, R. Citro, G. Riccio, C. Romano, S. Baldi (Nocera Inferiore,
Sorrento and Salerno, IT)
P4248
P4249
P4250
P4251
P4252
251
Dipyridamole coronary flow reserve stratifies prognosis in patients without left anterior descending
disease following an acute coronary syndrome.
– G. Carlomagno, L. Ascione, P. Caso, R. Iengo, C. Sordelli, M. Cavallaro, A. D’Andrea, S. Severino,
F. Arenga, R. Calabro (Naples, IT)
Incorporation of myocardial contrast echocardiography into a clinical stress echocardiography service is
feasible and provides additional diagnostic information.
– B.N. Shah, N.S. Chahal, S. Bhattacharyya, R.S. Khattar, W. Li, I. Roussin, R. Senior (London, GB)
Left ventricular torsion at rest, peak and post-exercise echocardiography.
– M. Lopez-Perez, J. Peteiro, A. Lopez-Sainz, A. Bouzas-Mosquera, G. Barge-Caballero, A. Castro-Beiras (A
Coruña, ES)
Estimation of infarct size using transthoracic measurement of coronary flow reserve in infarct related and
reference coronary artery.
– V. Giga, M. Dobric, M. Tesic, D. Sobic-Saranovic, B. Beleslin, A. Djordjevic-Dikic, J. Stepanovic,
I. Nedeljkovic, M.C. Ostojic, P.M. Seferovic (Belgrade, RS)
Prediction of left ventricular function recovery with the use of 2D speckle tracking echocardiography in
patients 12 months after acute ST-elevation myocardial infarction.
– E. Szymczyk, P. Lipiec, B. Michalski, K. Szymczyk, L. Stefanczyk, B. Wozniakowski, A. Rotkiewicz,
J.D. Kasprzak (Lodz, PL)
The additive diagnostic role of coronary flow reserve determined by transthoracic doppler
echocardiography in assessment of real significance of stenosis on right coronary artery.
– Z. Mladenovic, A. Djordjevic Dikic, D. Tavciovski, A. Angelkov Ristic, Z. Jovic, P. Djuric (Belgrade, RS)
P4253
P4254
P4255
P4256
P4257
P4258
CARDIOMYOPATHIES: PROGNOSIS
QRS fragmentation in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and
complete right bundle branch block.
– S. Peters (Gronau, DE)
The impact of sleep apnea on the occurrence of heart failure in the patients with hypertrophyic
cardiomyopathy.
– Y. Ajiro, K. Iwade, R. Tomita, N. Otsuki, H. Hattori, I. Ishida, H. Arashi, Y. Uchida, Y. Kobayashi, N. Tanaka
(Yokohama, JP)
Predictors of survival in patients with restrictive cardiomyopathy.
– J.Y. Jang, D.-H. Kang, B.J. Sun, M.S. Kim, D.H. Kim, J.M. Song, J.-H. Zo, K.-J. Choi, J.-K. Song, J.-J. Kim
(Seoul, KR)
Characterization of predictors of in-hospital cardiac complications of takotsubo cardiomyopathy:
multi-center registry from Tokyo CCU network.
– T. Murakami, T. Yoshikawa, Y. Maekawa, T. Ueda, T. Isogai, Y. Konishi, K. Sakata, K. Nagao,
T. Yamamoto, M. Takayama (Tokyo, JP)
Prognostic role of clinical presentation in patients with hypertrophic cardiomyopathy. A single center
experience.
– G. Finocchiaro, M. Merlo, B. Pinamonti, G. Barbati, A. Cocciolo, G. Sinagra (Trieste, IT)
Left ventricular reverse remodeling in idiopathic dilated cardiomyopathy: a subgroup analysis of the
population enrolled at the Florence referral center for cardiomyopathies.
– A. Fornaro, G. Castelli, M. Ciaccheri, I. Olivotto, C. Pigozzi, B. Tomberli, G.F. Gensini (Florence, IT)
Influence of triggering events on the clinical course of tako-tsubo cardiomyopathy.
– B. Schneider, A. Athanasiadis, W. Pistner, J. Schwab, U. Gottwald, W. Toepel, T. Mueller-Honold,
R. Schoeller, C. Wegner, U. Sechtem (Lübeck, Stuttgart, Aschaffenburg, Nuremberg, Celle, Idar-Oberstein,
Augsburg and Berlin, DE; Vienna, AT)
Impact of serum cardiac troponin T and I on cardiac molecular changes and dysfunction in patients with
hypertrophic cardiomyopathy.
– A. Hirashiki, R. Okamoto, T. Okumura, S. Shimazu, T. Yamada, Y. Bando, X.W. Cheng, T. Kondo,
T. Murohara (Nagoya, JP)
Assessing prognosis in idiopathic dilated cardiomyopathy: the experience of the Florence referral center
for cardiomyopathies.
– G. Castelli, A. Fornaro, M. Ciaccheri, I. Olivotto, C. Pigozzi, B. Tomberli, G.F. Gensini (Florence, IT)
Fragmented QRS complexes on 12-lead ECG predict myocardial fibrosis in hypertrophic cardiomyopathy.
– N. Sheikh, M. Papadakis, R. Bastiaenen, L. Millar, N. Emmanuel, S. Ghani, A. Zaidi, S. Gati, E. Behr,
S. Sharma (London, GB)
Tissue Doppler imaging and prognosis in asymptomatic or mildly symptomatic patients with hypertrophic
cardiomyopathy.
– H. Kitaoka, T. Kubo, K. Hayashi, Y. Baba, N. Yamasaki, Y. Matsumura, T. Furuno, Y. Doi (Kochi, JP)
Importance of hypertrophy pattern in sudden death risk stratification among patients suffering from
hypertrophic cardiomyopathy.
– E. Pagourelias, G.K. Efthimiadis, D.G. Parcharidou, T.D. Gossios, H. Karvounis, I.H. Styliadis (Thessaloniki,
GR)
Prognostic role of a high-sensitivity cardiac troponin T marker in patients with dilated cardiomyopathy.
– Y. Baba, T. Kubo, S. Yamanaka, Y. Nakashima, Y. Ochi, N. Yamasaki, Y. Matsumura, T. Furuno,
H. Kitaoka, Y. Doi (Kochi, JP)
Number of morphological kinds of ventricular premature beats with fragmented QRS waves on 12-lead
holter ECG predicted left ventricular fibrosis and fatty change on CT in hypertrophic cardiomyopathy.
252
P4259
P4260
P4261
P4262
P4263
P4264
P4265
P4266
P4267
P4268
P4269
P4270
P4271
P4272
Impact of regional left ventricular function on diagnosis, staging and prognosis in patients with cardiac
amyloidosis.
– D. Liu, K. Hu, M. Niemann, S. Herrmann, M. Cikes, S. Stoerk, S. Knop, G. Ertl, B. Bijnens, F. Weidemann
(Wurzburg, DE; Zagreb, HR; Barcelona, ES)
Severe myocardial fibrosis detected by cardiac MRI in patients with hypertrophic cardiomyopathy is
associated with high risk for future arrhythmic events.
– M. Schwarz, R. Lehmann, I. Ilic, E.M. Prinz, T. Bitter, J. Vogt, D. Horstkotte, L. Faber, C. Prinz (Bad
Oeynhausen, DE; Belgrade, RS)
Are different ballooning patterns in stress-induced (Takotsubo) cardiomyopathy associated with different
clinical backgrounds and outomes?
– J. Nishida, K. Tsuchihashi, H. Kouzu, A. Muranaka, N. Kokubu, N. Fujii, S. Yuda, M. Hase, A. Hashimoto,
T. Miura (Sapporo, JP)
Prognostic value of the admission ECG for predicting complications in patients with tako-tsubo
cardiomyopathy.
– B. Schneider, U. Desch, J. Stein (Lübeck, DE)
P4273
P4274
P4275
P4276
CARDIOMYOPATHIES: TREATMENT
Long-term follow-up of 99 patients after transcoronary ablation of septal hypertrophy (TASH) for HOCM:
No evidence for the induction of an arrhythmogenic substrate.
– T. Lawrenz, M. Schloesser, S. Gottschalk, C. Leuner, H. Kuhn, C. Stellbrink (Witten-Herdecke and Bielefeld,
DE)
Identification of patients with idiopathic dilated cardiomyopathy and SCD-HeFT inclusion criteria who
could be considered for early ICD implantation.
– M. Zecchin, A. Pivetta, M. Merlo, C. Lutman, A. Di Lenarda, D. Gregori, G. Barbati, L. Vitali Serdoz,
A. Buiatti, G. Sinagra (Trieste and Padua, IT)
Surgical correction of HOCM in patients with severe hypertrophy and septal myocardial fibrosis.
– K.V. Borisov (Moscow, RU)
Long-term recovery of atrioventricular conduction after percutaneous transluminal septal myocardial
ablation in patients with hypertrophic obstructive cardiomyopathy.
– A. Axelsson, K. Weibring, O. Havndrup, H. Kelbak, E. Jorgensen, S. Helqvist, L. Kober, H. Bundgaard,
M.K. Jensen (Copenhagen and Roskilde, DK)
Long-term outcomes after heart transplantation for Emery-Dreifuss muscular dystrophy.
– J.M. Kracht, A.J. Gay, C. Nafeh-Bizet, M. Redonnet, F. Bouchart, P.Y. Litzler, F. Doguet, A. Tabley,
F. Anselme, J.P. Bessou (Rouen, FR)
P4277
P4278
P4279
P4280
P4281
CARDIOMYOPATHIES: IMAGING
P4282
P4283
P4284
P4285
P4286
TUESDAY – MORNING
Distinguishing 320-slice CT-detected focal fibrotic lesions and non-fibrotic lesions in hypertrophic
cardiomyopathy by assessment of regional-myocardial-strain using two-dimensional Speckle-Tracking.
– A. Kataoka, N. Funabashi, S. Horie, M. Takahashi, K. Ozawa, M. Uehara, H. Takaoka, Y. Kobayashi (Chiba,
JP)
Hidden right ventricular dysfunction in asymptomatic first-degree relatives of arrhythmogenic right
ventricular cardiomyopathy assessed by speckle tracking, compared with strain Doppler.
– R. Ancona, S. Comenale Pinto, P. Caso, O. Rapisarda, C. Cavallaro, F. Vecchione, A. D’Onofrio,
M. Cavallaro, R. Calabro’ (Naples, IT)
Cardiac sarcoidosis has characteristic distribution of late gadolinium enhancement in magnetic
resonance imaging in comparison with idiopathic dilated cardiomyopathy.
– M. Sano, H. Satoh, K. Shiraki, M. Saotome, T. Urushida, H. Katoh, H. Hayashi (Hamamatsu, JP)
Traditional and innovative echocardiographic parameters for the analysis of right ventricular performance
in comparison to cardiac magnetic resonance.
– M. Cameli, M. Focardi, S.F. Carbone, A. Massoni, R. De Vito, M. Lisi, F.M. Righini, P.C. Ballo, M. Galderisi,
S. Mondillo (Siena, Florence and Naples, IT)
Speckle tracking and 3D echocardiography in arrhythmogenic right ventricular cardiomyopathy allows to
assess new findings about ventricular and atrial function.
– R. Ancona, S. Comenale Pinto, P. Caso, C. Cavallaro, F. Vecchione, A. D’Onofrio, O. Rapisarda,
M. Cavallaro, R. Calabro’ (Naples, IT)
Myocardial fibrosis in apical hypertrophic cardyomiopathy: a study by MRI.
– G. Todiere, G.D. Aquaro, P. Piaggi, F. Formisano, A. Barison, P.G. Masci, L. Bacigalupo, E. Strata,
A. Pingitore, M. Lombardi (Pisa, Genoa and Florence, IT)
Diabetes mellitus and cardiac complications in thalassemia major patients.
– A. Pepe, A. Meloni, G. Rossi, V. Caruso, L. Cuccia, A. Spasiano, E. Chiodi, V. Positano, M. Lombardi,
M.R. Gamberini (Pisa, Catania, Palermo, Naples and Ferrara, IT)
Left ventricular hypertrabeculation in individuals with sickle cell anaemia: physiology or pathology?
– S. Gati, N. Von Niekerk, M. Reed, A. Cox, A. Zaidi, S. Ghani, M. Papadakis, M. Ahmed, T. Yeghen,
S. Sharma (London, GB)
T1 mapping in differentiation of diffuse myocardial disease in hypertrophic and dilative cardiomyopathy.
– V. Puntmann, A. Pastor, Z. Chen, T. Voigt, R. Razavi, T. Schaeffter, E. Nagel (London, GB)
P4287
P4288
P4289
P4290
CARDIOMYOPATHIES: PATHOPHYSIOLOGY
Effect of physical exercise on cardiac remodeling and oxidative stress in diabetic rats.
– C. Gimenes, R. Gimenes, C.M. Rosa, G.N. Guirado, M.D.M. Cezar, D.H.S. Campos, A.A.H. Fernandes,
A.H.R. Takamoto, M.P. Okoshi, K. Okoshi (Botucatu, BR)
P4291
253
Dual assessment of coronary flow reserve in non obstructive hypertrophic cardiomyopathy:
patophysiological characteristics.
– M. Tesic, A. Djordjevic-Dikic, D. Trifunovic, O. Petrovic, I. Nedeljkovic, M. Petrovic, V. Giga, G. Stankovic,
B. Beleslin, B. Vujisic-Tesic (Belgrade, RS)
Cyclophilin A expression in endomyocardial biopsies predicts clinical outcome of patients with
congestive heart failure.
– C.S. Zuern, K.A.L. Mueller, P. Seizer, K. Klingel, R. Kandolf, A. Bauer, M. Gawaz, A.E. May (Tübingen, DE)
Impaired copper homeostasis in patients with hypertrophic cardiomyopathy.
– R. Potluri, N. Roberts, C. Miller, N. Brooks, S. Ray, G. Cooper, M. Schmitt (Manchester and Liverpool, GB)
Tyrosyl-tRNA synthetase: peculiarities of myocardial expression and autoimmune reactions at dilated
cardiomyopathy.
– D.V. Riabenko, I.U.I.U. Kondratiuk, V.I. Bobyk, L.L. Sidorik, A.I. Kornelyuk (Kyiv, UA)
Cardiotoxic anticancer agents induce an increase in myocardial weight: a pathophysiologic study of
altered cardiac mechanics.
– M. Arao, M. Sekine, K. Setsuta, K. Mizuno (Tokyo, JP)
P4292
P4293
P4294
P4295
P4296
CARDIOMYOPATHIES: DIAGNOSIS
A French registry of takotsubo syndrome in non-academic hospitals (OFSETT).
– L. Belle, J.J. Dujardin, M. Hanssen, S. Cattan, F. Albert, J.L. Georges, X. Marcaggi, D. Logeart, J.F. Aupetit,
G. Mulak (Annecy, Douai, Haguenau, Montfermeil, Chartres, Versailles, Vichy, Paris and Lyon, FR)
Syncope in hypertrophic cardiomyopathy: the diagnostic role of flow mediated dilalation.
– R. Morgagni, A. Capria, S. Verbena, M. Macrini, L. Zerillo, I. Cazzoli, F. Romeo (Rome, IT)
The extent and consequences of diagnostic uncertainty in individuals assessed for arrhythmogenic right
ventricular cardiomyopathy.
– D. Lee, P. Brennan, S. Lord (Newcastle-upon-Tyne, GB)
In dilated cardiomyopathy the stimulating potential of anti-beta1-receptor autoantibodies is positively
correlated with the depression of left ventricular function.
– A. Schlipp, V. Boivin, J. Ullrich, M. Bauer, D. Leyh, N. Deubner, M.J. Lohse, G. Ertl, R. Jahns (Wurzburg, DE)
Performance of task force diagnostic criteria for identification of symptomatic patients in the nordic
arrhythmogenic right ventricular cardiomyopathy registry.
– P.G. Platonov, A.G. Holst, K. Haugaa, T. Edvardsen, T. Gillijam, C. Lundin, O. Eschen, J. Hansen,
H. Bundgaard, J.H. Svendsen (Lund and Gothenburg, SE; Copenhagen and Aalborg, DK; Oslo, NO)
The impact of dynamic intraventricular obstruction on left ventricular mechanics in hypertrophic
cardiomyopathy.
– M. Rosca, B.A. Popescu, M. Gurzun, A. Calin, C.C. Beladan, R. Enache, I.M. Coman, C. Ginghina
(Bucharest, RO)
Cardiomyopathy in mitral valve prolapse.
– E. Malev, E. Zemtsovsky, L. Vasina, A. Pshepiy, A. Korshunova (St. Petersburg, RU)
Prevalence of psychiatric disorders in Tako-Tsubo cardiomyopathy.
– D. Doyen, S. Moschietto, P. Moceri, F. Bernasconi, T. Tibi, P. Cerboni, E. Ferrari (Nice, Antibes and
Cannes, FR)
Left ventricular non compaction: prevalence in various types of congenital heart disease.
– B.E. Staehli, C. Gebhard, P. Biaggi, S. Klaassen, E. Buechel Valsangiacomo, C.H. Attenhofer Jost,
R. Jenni, F.C. Tanner, M. Greutmann (Zurich, CH; Berlin, DE)
Clinical characteristics and short-term outcome of patients with Tako-tsubo syndrome and critical
coronary stenosis: comparison with patients with Tako-tsubo with normal coronary arteries.
– M. Previtali, G. Crimi, A. Valbusa, A. Bartolini, A. Repetto, M. Rossi, P. Rubartelli, F. Chiarella, L. Oltrona
Visconti (Pavia and Genoa, IT)
P4297
P4298
P4299
P4300
P4301
P4302
P4303
P4304
P4305 (W)
P4306
VASCULAR BIOLOGY I
Completely autologous biotube vascular grafts: eosin Y significantly promoted in vivo formation of
functional biotubes in a short term.
– Y. Nakayama, T. Tujinaka, T. Watanabe, M. Yamanami, K. Kanda, H. Yaku (Osaka and Kyoto, JP)
Angiotensin II inhibits ecSOD and ATP7A and upregulates oxidative stress via toll-like receptor 4.
– T. Nakashima, S. Umemoto, T. Okamoto, S. Matsuda, T. Murata, K. Yoshimura, T. Fukai, M. Matsuzaki
(Ube and Yamaguchi, JP; Chicago, US)
The temporal and spatial distribution of macrophage subpopulations during arteriogenesis.
– C. Troidl, G. Jung, K. Troidl, J. Hoffmann, S. Voss, H. Nef, W. Schaper, C.W. Hamm, T. Schmitz-Rixen,
H. Moellmann (Bad Nauheim, Giessen and Frankfurt am Main, DE)
Insulin induced vasoreactivity is impaired after short-term high fat feeding and is dependent on
perivascular adipose tissue as well as resistance artery properties.
– R.I. Meijer, E.C. Serne, J.S. Yudkin, C.A.F. Alta, E.J. Barrett, V.W. Van Hinsbergh, Y.M. Smulders,
E.C. Eringa (Amsterdam, NL; London, GB; Charlottesville, US)
Saphenous vein aorto-coronary bypass graft atherosclerosis in patients with chronic kidney disease:
more clacification, but less vasoconstrictor potential.
– T. Baars, P. Kleinbongard, T. Konorza, S. Moehlenkamp, D. Boese, H. Degen, J. Hippler, M. Haude,
R. Erbel, G. Heusch (Essen, Moers and Neuss, DE)
Comparison of circulating microparticles counts in patients with acute coronary syndrome with two
methodologies.
– S. Montoro-Garcia, A. Lopez-Cuenca, A.I. Romero, F. Marin, M. Valdes, E. Shantsila,
S. Manzano-Fernandez, D. Hernandez-Romero, E. Orenes-Pinero, G.Y.H. Lip (Birmingham, GB; Murcia,
ES)
254
P4307
P4308
P4309
P4310
P4311
P4312
The effect of treatment with drospirenone/ethinyl estradiol alone or in combination with metformin on
elastic properties of aorta in women with polycystic ovary syndrome.
– M.G. Kaya, B. Calapkorur, A. Celik, M. Akpek, Z. Karaca, S. Yildirim, K. Unluhizarci, F. Kelestimur (Kayseri,
TR)
Fibrin-related thrombosis risk in type 2 diabetes: relationship with vascular pathology and drug therapy.
– K.A. Hess, S.H. Alzahrani, J.F. Price, M. Strachan, P.D. Baxter, R. Cubbon, F. Phoenix, N. Marx,
P.J. Grant, R.A. Ajjan (Aachen, DE; Leeds and Edinburgh, GB)
Molecular mechanism of tissue factor regulation through RAGE-MT1-MMP axis in HMGB-1
stimulated-endothelial cells.
– K. Sugimoto, T. Ishibashi, Y. Takuwa, Y. Takeishi (Fukushima and Kanazawa, JP)
Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on vascular protection in
subjects with coronary heart disease.
– L.F.M. Pinheiro, M.C. Izar, C.N. Franca, S.P. Barbosa, H.T. Bianco, S.M. Kasmas, R.M.S. Povoa,
F.A.H. Fonseca (São Paulo, BR)
Endothelial progenitor cells in relation to endothelin-1 and endothelin receptor blockade: a randomized
controlled trial.
– C. Jung, A. Rafnsson, J. Pernow (Stockholm, SE)
Soluble adenylyl cyclase controls oxidative stress-induced apoptosis of smooth muscle cells.
– S. Kumar, A. Appukuttan, H.P. Reusch, Y. Ladilov (Bochum, DE)
The p110alpha subunit of PI 3-kinase is crucially involved in neointima formation by mediating smooth
muscle cell proliferation, migration and survival.
– J. Jesus, M. Vantler, E. Berghausen, E. Caglayan, H. Ten Freyhaus, O. Leppaenen, J. Zhao, S. Rosenkranz
(Cologne, DE; Uppsala, SE; Boston, US)
Chronic signaling of the survival factor PDGF leads to smooth muscle cell death in atherosclerotic
plaques.
– M. Vantler, L. Zhou, M. Schwab, M. Zierden, W.H. Zimmermann, J. Herz, S. Rosenkranz (Cologne and
Göttingen, DE; New York and Dallas, US)
P4313
P4314
P4315
P4316
P4317
P4318
P4319
P4320
VASCULAR BIOLOGY II
P4321
P4322
P4323
P4324
P4325
P4326
P4327
TUESDAY – MORNING
Neutrophils contribute to DVT formation by forming procoagulant and prothrombotic neutrophil
extracellular traps.
– K. Stark, M.L. Von Bruehl, A. Steinhart, S. Chandraratne, M. Lorenz, R. Coletti, S. Pfeiler, D. Manukyan,
B. Engelmann, S. Massberg (Munich, DE)
Small-size circulating microparticles in post myocardial infarction patients: changes over 30 days and
relationship to the fibrinolytic status.
– S. Montoro-Garcia, E. Shantsila, L. Tapp, B.J. Wrigley, F. Marin, G.Y.H. Lip (Birmingham, GB; Murcia, ES)
Leptin is expressed in human carotid atherosclerotic plaques and plays an active role in plaque stability
via its effects on human vascular smooth muscle cells phenotype.
– A. Dupont, A. Elkalioubie, C. Zawadzki, M. Tagzirt, C. Lavisse, B. Staels, S. Haulon, B. Jude, S. Susen,
E. Van Belle (Lille, FR)
Endothelial Microparticles (EMP) are taken up in an Annexin I/PSR dependent pathway by target cells and
promote endothelial regeneration.
– F. Jansen, X. Yang, F.F. Hoyer, K. Paul, U.M. Becher, M. Kebschull, J. Bedorf, G. Nickenig, N. Werner
(Bonn, DE)
Lack of junD promotes oxidative stress-induced vascular aging.
– E. Osto, F. Paneni, B. Mateescu, P. Mocharla, S. Briand, E. Perna, A. Akhmedov, C. Matter, T. Luscher,
F. Cosentino (Zurich, CH; Paris, FR)
Impaired periaortic adipocyte differentiation in angiotensin AT1 receptor deficient mice: Possible role in
pro-inflammatory phenotypic modulation of perivascular adipose tissue.
– H. Yamada, D. Irie, T. Kato, H. Kawahito, S. Kishida, K. Ikeda, M. Okigaki, H. Matsubara (Kyoto, JP)
Krueppel-like factor 4 is downregulated in circulating monocyte subsets of patients with Coronary Artery
Disease.
– F.S. Czepluch, H. Kuschicke, M. Schlegel, M. Mueller, M. Bernhardt, F. Bremmer, J. Riggert, G. Hasenfuss,
K. Schaefer (Göttingen, DE)
Is NGAL assessment in patients referred to renal artery stenting for atherosclerotic renal artery occlusive
disease of clinical value?
– D. Rzeznik, T. Przewlocki, A. Kablak-Ziembicka, A. Roslawiecka, A. Kozanecki, M. Kostkiewicz, K. Zmudka,
P. Podolec (Krakow, PL)
Decrease in circulating myeloid and plasmacytoid Dendritic Cell Precursors (dcps) in patients with
Chronic Kidney Disease stage 3.
– D. Kretzschmar, K.P. Paul, H.R.F. Figulla, G.W. Wolf, M.B. Busch, A.Y. Yilmaz (Jena, DE)
Quantification of new structural features of coronary plaque components by post-hoc computational
analysis of Virtual-Histology IVUS images.
– T. Papaioannou, D. Schizas, M. Vavuranakis, O. Katsarou, D. Soulis, C. Stefanadis (Athens, GR)
Hypoxia reoxygenation-induced endothelial barrier failure: Role of RhoA, Rac1, and MLCK.
– M. Aslam, S. Rohrbach, K.-D. Schluter, D. Sedding, C. Hamm, T. Noll, D. Guenduez (Giessen and Dresden,
DE)
Uric acid levels are associated with asymmetric dimethylarginine, L-arginine and arterial stiffness in
essential hypertensive patients.
– K. Dimitriadis, C. Tsioufis, A. Kasiakogias, M. Giakoumis, I. Bafakis, K. Kintis, I. Andirikou, D. Tousoulis,
C. Stefanadis (Athens, GR)
P4328
P4329
P4330
P4331
P4332
255
The paraoxonase 55 L/M polymorphism influences the onset of acute coronary syndrome but not stable
angina.
– S. Gomes, A. Pereira, A.C. Sousa, B. Silva, S. Freitas, G. Guerra, A. Brehm, J.J. Araujo, M. Mendonca,
R. Palma Dos Reis (Funchal and Lisbon, PT)
Angiotensin II induces early mechanical heterogeneity along the abdominal aorta, preceding murine
aneurysm formation.
– U. Raaz, L. Maegdefessel, R. Toh, A. Deng, J.M. Spin, P.S. Tsao (Stanford, US)
Phenotypic characterization of leukocytes at the culprit lesion site in acute coronary syndrome patients.
– A. Mangold, S. Puthenkalam, K. Distelmaier, C. Adlbrecht, K.T. Preissner, I.M. Lang (Vienna, AT; Giessen,
DE)
Circulating apoptotic endothelial cells and apoptotic endothelial microparticles independently predict the
presence of cardiac allograft vasculopathy.
– N. Singh, E. Van Craeyveld, M. Tjwa, A. Ciarka, W. Droogne, S. Gordts, F. Jacobs, J. Vanhaecke, J. Van
Cleemput, B. De Geest (Leuven, BE)
The experimental study of a new kind absorbable magnesium alloy stent.
– Y. Shuixiang, L.L. Wang, Y.X. Cui, E.D. Wang, J.P. Yang, J.W. Zhu, P. Wang, L.C. Lei (Beijing, CN)
Angiotensin-(1-7) suppresses the number and function of the circulating fibrocytes by upregulating
endothelial nitric oxide synthase expression.
– K. Wang, X.S. Hu, C.Q. Du, S.K. Tu, F.R. Zhang, X.D. Xie (Hangzhou, CN)
P4333
P4334
P4335
P4336
P4337
P4338
VASCULAR REMODELLING
Wnt4 contributes to intimal thickening by promoting VSMC proliferation via up-regulation of RCAN1.
– A. Tsaousi, H. Williams, G.M. Connolly, S.J. George (Bristol, GB)
A non-polymeric ciglitazone-eluting stent inhibits neointimal proliferation stronger than sirolimus-eluting
stents: an experimental study using optical coherence tomography in rabbit iliacal arteries.
– T.C. Poerner, S. Otto, H. Schubert, B. Romeike, D. Haase, H.R. Figulla (Jena, DE)
Functional inhibition of microRNA-92a increases endothelial regeneration and reduce neointimal
formation after vascular injury by targeting kruppel-like factor-4.
– C. Iaconetti, A. Polimeni, S. Sorrentino, J. Sabatino, G. Pironti, G. Esposito, A. Curcio, C. Indolfi (Catanzaro
and Naples, IT)
The PI 3-kinase isoform p110alpha promotes vascular remodelling in pulmonary arterial hypertension.
– E.M. Berghausen, M. Vantler, W. Janssen, H. Ten Freyhaus, J.J. Zhao, R.T. Schermuly, S. Rosenkranz
(Cologne, Bad Nauheim and Giessen, DE; Boston, US)
Two-chain High Molecular Weight Kininogen (HKa) inhibits neointimal lesion formation by preventing
leukocyte recruitment.
– J.-M. Daniel, F. Reich, J. Dutzmann, K.T. Preissner, C.W. Hamm, D.G. Sedding (Giessen, DE)
Hyaluronic acid metabolism is increased in human abdominal aortic aneurysm.
– T. Miyoshi, T. Yonezawa, M. Doi, A. Aoki, K. Nakamura, S. Hirohata, S. Kusachi, Y. Ninomiya, K. Kusano,
H. Ito (Okayama and Takamatsu, JP)
Valsartan inhibits aortic remodeling by blocking transforming growth factor-beta 1-Smads pathway in
diabetic rats.
– H. Sun, Y. Zhao, W. Zhang, M. Zhong, G. Su (Jinan, CN)
A novel adipocytokine, CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal
formation after vascular injury.
– Y. Uemura, R. Shibata, K. Ohashi, T. Enomoto, T. Kambara, T. Murohara, N. Ouchi (Nagoya, JP)
Furin-dependent maturation of proNGF induces migration of vascular smooth muscle cells by
TrkA-mediated recruitment of paxillin to focal adhesion sites.
– D. Urban, J. Lorenz, H. Meyborg, S. Gosh, J. Kaufmann, K. Kappert, E. Fleck, P. Stawowy (Berlin, DE)
MicroRNA-146a and its role in endothelial cells during vascular remodeling processes.
– R. Widmer-Teske, W. Bielenberg, J.-M. Daniel, H. Nef, C. Troidl, S. Achenbach, C. Hamm, D. Sedding
(Giessen, DE)
MicroRNA-146a and its role in vascular smooth muscle cells during vascular remodeling processes.
– D. Sedding, W. Bielenberg, J.-M. Daniel, H. Nef, C. Troidl, S. Achenbach, C. Hamm, R. Widmer-Teske
(Giessen, DE)
Ablation of PDGF receptor signaling reduces neointima formation after balloon angioplasty and does not
affect the proliferation and migration of endothelial cells.
– T. Kramer, M. Vantler, E. Caglayan, M. Scherner, O. Leppaenen, S. Rosenkranz (Cologne, DE; Uppsala, SE)
Changes of elastic properties of large arteries in systemic sclerosis are related to endothelial activation
and matrix tissue remodelling.
– K. Irzyk, M. Ciurzynski, P. Bienias, Z. Rymarczyk, M. Kostrubiec, Z. Bartoszewicz, U. Demkow,
A. Szewczyk, M. Siwicka, P. Pruszczyk (Warsaw, PL)
Border zone coronary collateral network detected with an imaging cryomicrotome in the infarcted human
heart.
– P.H.M. Van Den Wijngaard, P. Van Horssen, A.C. Van Der Wal, M.G.J.T.B. Van Lier, M. Brandt,
J.A.E. Spaan, M. Siebes (Amsterdam, NL)
Angiotensin II (AngII)-induced arterial remodeling is associated with upregulation of miR-21 and
downregulation of miR-29b.
– U. Raaz, L. Maegdefessel, R. Toh, A. Deng, J.M. Spin, P.S. Tsao (Stanford, US)
Changes of vascular walls in different levels of arterial system in patients with stable coronary artery
disease and type 2 diabetes mellitus.
– A.A. Shchendrygina, Y.N. Belenkov, E.V. Privalova, Y.A. Danilogorskaya, E.A. Zheleznykh (Moscow, RU)
256
P4339
P4340
P4341
P4342
P4343
P4344
P4345
P4346
P4347
P4348
P4349
P4350
P4351
P4352
P4353
P4354
ASSESSMENT & INTERVENTION TO IMPROVE
P4355
P4356
P4357
P4358 (W)
P4359
P4360
P4361
P4362
P4363
P4364
P4365
P4366
P4367
P4368
P4369
P4370
P4371
TUESDAY – MORNING
Relationship between red cell distribution width (RDW) and clinical outcomes in non-ST elevation
myocardial infarction and unstable angina pectoris: 3-years follow-up.
– M. Gul, H. Uyarel, M. Ergelen, D. Karacimen, M. Ugur, M. Bozbey, A. Turer, E. Ayhan, O. Akgul, N. Uslu
(Istanbul and Balikesir, TR)
Echocardiographic epicardial fat thickness is associated with arterial stiffness.
– B.J. Kim, B.S. Kim, J.H. Kang (Seoul, KR)
Plasma BNP versus cardiac risk scores for risk stratification after major orthopedic surgery.
– S. Katsanos, N. Kafkas, D. Leong, A. Mavrogenis, C. Varounis, D. Babalis, J. Parissis, M. Anastasiou-Nana,
G. Filippatos (Athens, GR; Leiden, NL)
Multiple biomarkers improve the prediction of cardiovascular mortality in patients on chronic
hemodialysis.
– H. Takahashi, H. Ishii, Y. Kumada, T. Aoyama, D. Kamoi, J. Ishii, T. Murohara, M. Tanaka (Nagoya and
Toyoake, JP)
Causality of inflammation related to blood leucocyte count for the progression of arterial stiffness and
pressure wave reflection.
– H. Tomiyama, M. Odaira, M. Yoshida, C. Matsumoto, K. Shiina, A. Yamashina (Tokyo, JP)
Prognostic relevance of epicaridal adipose tissue in patients with coronary artery disease assessed by
cardiovascular magnetic resonance.
– C. Doesch, D. Haghi, T. Suselbeck, R. Lany, S.O. Schoenberg, M. Borggrefe, T. Papavassiliu (Mannheim,
DE)
Mild/moderate renal dysfunction: its role in the preoperative evaluation.
– L.W. Ramos, L. Nicoletti, F. Ignacio, E. Castilho, E. Elly, B. Cristina, M. Wolf, M. Calil, J.C.S. Goes (São
Paulo, BR)
Systematic review of risk factors for upper gastrointestinal bleeding in patients using low-dose
acetylsalicylic acid.
– V.E. Valkhoff, E.J. Kuipers, R. Pearce, A. Lanas (Rotterdam, NL; Oxford, GB; Zaragoza, ES)
Contrast-induced nephropathy (CIN) after primary percutaneous coronary intervension (PCI); the role of
heat shock proteins.
– A.K. Jaroszynska, A. Glowniak, A. Wysokinski, A. Jaroszynski (Lublin, PL)
Incidence, risk factors, and outcomes of perioperative Acute Kidney Injury in noncardiac and nonvascular
surgery.
– M. Biteker, A. Dayan, A.I. Tekkesin, M.M. Can, E. Ilhan (Istanbul, Malatya and Van, TR)
The radial artery amplification index is an integrator of cardiovascular risk and general atherosclerotic
burden.
– D. Rosenbaum, F. Rached, E. Bruckert, P. Giral, X. Girerd (Paris, FR)
The association between brachial-ankle pulse wave velocity and the extent of coronary artery disease in
patients with angina.
– I.H. Jung, S.Y. Lee, M.J. Choi, D.S. Lim, S.J. Lee, J.H. Kim, Y.M. Rho, W.H. Shim (Bucheon and Seoul, KR)
The existence of non-obstructive plaque in carotid artery predicts cardiovascular death in patients of
end-stage renal disease on maintenance hemodialysis.
– H.T. Hsin, S.R. Ke, Y.S. Peng (Taipei and New Taipei City, TW)
Impact of type 2 diabetes and coronary heart disease on cardiovascular risk in high-risk hypertensive
patients: a subanalysis of the CASE-J Ex.
– S. Yasuno, K. Ueshima, S. Tanaka, A. Fujimoto, M. Kasahara, Y.M. Nakao, T. Ogihara, T. Saruta, K. Nakao
(Kyoto, Osaka and Tokyo, JP)
Fasting serum apolipoprotein B-48 levels were correlated with the prevalence of coronary artery disease.
– D. Masuda, T. Sugimoto, T. Ohama, M. Nishida, M. Ishigami, T. Kawamoto, A. Matsuyama, N. Sakai,
I. Komuro, S. Yamashita (Osaka, Hiroshima and Kobe, JP)
Development and psychometric properties of the Heart Failure Knowledge Scale in Japan.
– N. Kato, K. Kinugawa, E. Nakayama, T. Tsuji, Y. Kumagai, C. Miura, M. Nagayama, T. Sumiyoshi,
H. Tomoike, R. Nagai (Tokyo, JP)
Short duration holter monitoring is equally as good as daily monitoring in heart rate and pause
assessment.
– S. Fall, T. O’Hora, O. Macavaney, V. Maher (Dublin, IE)
Diagnostic angiography with 5F catheters supports early ambulation and discharge.
– V. Gatt, M. Borg, J. Agius, A. Fenech, R.G. Xuereb, V. Grech (Msida, MT)
The evolving role of the angina specialist nurse in a district general hospital in the UK.
– J. Caton, C. Dereszkiewicz, N. Naqvi (Wigan, GB)
Groin dressing post cardiac catheterization: traditional pressure versus transparent film.
– R. Al-Shualah (Jubail, SA)
PCI in very elderly patients suffering an ACS.
– M. Gusai, P. Merella, G. Peddis, G. Casu (Nuoro, IT)
Preoperative statin use and postoperative atrial fibrillation after major noncardiac, nonvascular surgery.
– M. Biteker, A. Dayan, M.M. Can, E. Ilhan, A. Tekkesin (Istanbul, Malatya and Van, TR)
Carperitide can protect against acute kidney injury in patients with chronic kidney disease undergoing
coronary angiography.
– T. Senoo, K. Manabe, S. Umemura, M. Motohiro, H. Kamihata, T. Iwasaka (Hirakata, JP)
Effects of community-based general practitioners-led care for 12,864 patients with hypertension: study of
cardiovascular risk intervention - hypertension (SCRI-HTN) in China.
– H.H.X. Wang, J.J. Wang (Shatin, HK; Guangzhou, CN)
P4372
P4373
P4374
P4375
P4376
P4377
P4378
257
The ability of N-terminal B-type natriuretic peptide and microalbuminuria for identifying high risk patient
of cardiovascular disease in a large community cohort.
– J.W. Lee, B.S. Yoo, J.H. Lee, Y.J. Youn, M.S. Ahn, S.G. Ahn, J.Y. Kim, S.H. Lee, J. Yoon, K.H. Choe
(Wonju, KR)
Pravastatin combined with valsartan shows additive beneficial vascular effects in patients with
hypercholesterolemia.
– K. Koh, H. Choi (Incheon, KR)
P4379 (W)
P4380 (W)
MIND, BODY & BEHAVIOUR: IMPLICATIONS IN CARDIOVASCULAR RISK AND DISEASE
Anxiety in patients with chronic heart failure: impact of perception of control and acceptance coping.
– C. Nahlen, G. Bjorling, M. Elfstrom, H. Persson, F. Saboonchi (Stockholm and Västerås, SE)
Depressed chronic heart failure patients have impaired autonomic function.
– S.J. Lonie, A. Stewart, D. Toia, D. Hare (Melbourne, AU)
Adherence to beta-blocker therapy in heart failure patients.
– H.D. Duengen, D.O. Obradovic, S. Inkrot, E. Tahirovic, N. Opacic, L. Stark, T. Trippel, V. Tscholl,
J. Mueller-Nordhorn, N. Rieckmann (Berlin, DE; Krusevac, RS)
Illness behaviour and gender in cardio-surgical patients.
– M. Ferratini, M. Modica, R. Spezzaferri, P. Castiglioni (Milan, IT)
Effects of lifestyle factors, disease history and awareness on health-related quality of life in a Thai
population.
– P. Vathesatogkit, M. Woodward, M. Kimman, E.S. Tai, W. Aekplakorn, B. Hengprasith, H.L. Wee, P. Sritara
(Sydney, AU; Singapore, SG; Bangkok and Nonthaburi, TH)
The sicker refuse getting healthier: cardiac rehabilitation acceptance paradox.
– M. Krawczyk, M. Dominiak, M. Kurpesa, T. Rechcinski, J.D. Kasprzak (Lodz, PL)
Dementia as an independent predictor of mortality for one year after hospital discharging of elderly
subjects with cardiovascular diseases.
– L.N. Matos, A. Frisoli Jr, E.R. Alves, L.F. Guimaraes, A.R. Diniz, E.T. Pinto, A. Greco, I. Helber,
A.C. Carvalho (São Paulo, BR)
The difference of QOL between older and younger patients with atrial fibrillation in Japan.
– Y. Tanimoto, S. Kohsaka, I. Ueda, T. Kimura, N. Nishiyama, K. Fukumoto, Y. Aizawa, K. Tanimoto,
S. Takatsuki, K. Fukuda (Tokyo, JP)
Anxiety, obesity and cortisol levels in patients with acute coronary syndrome.
– A.L. Arrebola Moreno, R. Marfil-Alvarez, R. Garcia-Retamero, V. Alcalde, F. Ruiz-Cabello, R. Melgares,
A. Catena, J.A. Ramirez-Hernandez (Granada, ES)
Clinical correlations of cognitive impairment in chronic heart failure.
– M. Nikolaou, J. Parissis, T. Katsoulas, M. Thodi, I. Behlivanoglou, G. Zisis, V. Gaitani, E. Rentoukas,
G. Filippatos, M. Anastasiou Nana (Athens, GR)
Symptom profile of hypertensive primary care patients with undiagnosed obstructive sleep apnea - a
structural equation model analysis.
– A. Brostrom, O. Sunnergren, P. Johansson, E. Svensson, M. Ulander, P. Nilsen, E. Svanborg (Linköping
and Jönköping, SE)
Differences in cardiovascular signs and risk factors among hypertensive middle aged men and women
with high vs. low risk on the Berlin sleep apnea questionnaire.
– A. Brostrom, P. Johansson, B. Riegel, P. Nilsen, B. Fridlund, E. Svanborg (Linköping and Jönköping, SE;
Philadelphia, US)
Is increased high-sensitive troponin T associated with severity of sleep apnoea syndrome?
– N. Troester, M. Palfner, M. Dominco, A. Avian, H. Olschewski (Graz, AT)
Nutritional assessment in a Universitary Department of Cardiology.
– A.I. Romero, C. Fernandez-Redondo, M. Quintana-Giner, S. Manzano-Fernandez, M.R. Gracia-Rodenas,
E. Jover, D. Hernandez-Romero, E. Orenes-Pinero, M. Valdes, F. Marin (Murcia, ES)
Frequency of returning to work after ST segment elevation myocardial infarction.
– E. Trzos, B.-U. Uznanska-Loch, R.-B. Bugielska, T.-R. Rechcinski, J.-K. Kasprzak, U.C.-G. Cieslik-Guerra,
Z.B. Bednarkiewicz, M. K.-P. Krzeminska-Pakula, M.K. Kurpesa (Lodz, PL)
Adherence to the Mediterranean diet reduces the likelihood of acute coronary syndromes, even among
people with high anxiety rates: a case-control study.
– C.M. Kastorini, H.J. Milionis, E. Georgousopoulou, M. Symeopoulou, S. Bitsi, A. Vemmou, V. Nikolaou,
K.N. Vemmos, J.A. Goudevenos, D.B. Panagiotakos (Ioannina and Athens, GR)
Evaluation of cardiovascular disease patients and healthy subjects as regards risk factors’ knowledge
and beliefs.
– C.M. Kastorini, H.J. Milionis, E. Bika, E. Ntziou, M.S. Kostapanos, E. Georgousopoulou, V. Nikolaou,
K.N. Vemmos, J.A. Goudevenos, D.B. Panagiotakos (Ioannina and Athens, GR)
Hip fracture and risk of acute myocardial infarction: a nationwide study.
– C.H. Chiang, H.B. Leu, Z.Y. Chen (Taipei, TW)
Secular trends in women with acute coronary syndrome (ACS) referred to coronary artery angiography: a
15-year observation of the University Hospital Bern.
– H. Saner, J. Mollet, S. Cook, S. Windecker, P. Eser, P. Stute, B. Meier (Bern and Fribourg, CH)
Physical activity attenuates subclinical atherosclerosis in subjects with chronic spinal cord injury.
– W. Nadruz Junior, J.R. Matos-Souza, A.A. Costa E Silva, L.F. Campos, D. Goulart, M. Etchebehere,
J.I. Gorla, A. Cliquet Jr (Campinas, BR)
Vitamin D deficiency in relation to circulating inflammatory cells and inflammatory markers among
apparently healthy individuals.
– V. Bountziouka, T. Akalestos, N. Vallianou, A. Evangelopoulos, M. Bonou, P. Avgerinos, E. Vogiatzakis,
J. Barbetseas, D.B. Panagiotakos (Athens, GR)
258
P4381
P4382
P4383
P4384 (W)
P4385
P4386
P4387
P4388
P4389
P4390
P4391
P4392
P4393
P4394
P4395
P4396
P4397
P4398
P4399
P4400
P4401
Genetic predisposition to higher blood pressure increases coronary artery disease risk.
– W. Lieb, H. Jansen, C. Loley, M.P. Reilly, R. Mcpherson, I.R. Koenig, J. Erdmann, N.J. Samani, R.S. Vasan,
H. Schunkert (Greifswald and Lübeck, DE; Philadelphia and Boston, US; Ottawa, CA; Leicester, GB)
Mitochondrial haplogroups H and J: risk and protective factors for ischemic cardiomyopathy.
– M. Fernandez-Caggiano, J. Barallobre-Barreiro, I. Rego-Perez, M.G. Crespo-Leiro, Z. Grille, F.J. Blanco,
N. Domenech Garcia (Corunna, ES)
Prediction of ischemic events based on transcriptomic and genomic profiling in patients undergoing
carotid endarterectomy.
– J. Persson, L. Folkersen, J. Ekstrand, H.E. Agaradh, G.K. Hansson, A. Gabrielsen, U. Hedin,
G. Paulsson-Berne (Stockholm, SE)
Genetic variants primarily associated with type 2 diabetes also affect coronary artery disease risk.
– H. Jansen, W. Lieb, C. Loley, M.P. Reilly, R. Mcpherson, I.R. Koenig, J. Erdmann, N.J. Samani, R.S. Vasan,
H. Schunkert (Lübeck and Greifswald, DE; Philadelphia and Boston, US; Ottawa, CA; Leicester, GB)
Impact of arterial stiffness on adverse cardiovascular outcomes and mortality in peritoneal dialysis
patients.
– M.G. Kaya, M. Sipahioglu, H. Kucuk, A. Unal, F. Oguz, B. Tokgoz, O. Oymak, C. Utas (Kayseri, TR)
Cardiovascular disease incidence and compliance on treatment stategy in patients with familial
hypercholesterolemia.
– V. Metaxa, I. Skoumas, C. Pitsavos, E. Oikonomou, C. Masoura, E. Tsetsekou, C. Stefanadis (Athens, GR)
Association of male pattern baldness with angiographic coronary artery disease severity and collateral
development.
– I. Sari, K. Aykent, V. Davutoglu, M. Yuce, O. Ozer, M. Kaplan, H. Alici, S. Ercan, M. Aksoy (Gaziantep, TR)
Risk factors for coronary plaque progression in patients with far east Aasians - A serial volumetric IVUS
analysis.
– A. Hirohata, K. Yamamoto, E. Hirose, Y. Kobayashi, F. Sano, H. Takafuji, M. Ohara, R. Yoshioka, Y. Iino,
T. Ohe (Okayama, JP)
Acute coronary syndrome: a serious threat even at age 40.
– F. Saraiva, H. Martins, S. Monteiro, F. Goncalves, P. Monteiro, L. Goncalves, L.A. Providencia (Coimbra, PT)
P4402
P4403
P4404
P4405
P4406
P4407
P4408
P4409
P4410
RENAL DENERVATION THERAPY IN HYPERTENSION
P4411
P4412
P4413
P4414
P4415
P4416
P4417
TUESDAY – MORNING
One year pooled outcomes following renal sympathetic denervation in patients with resistant
hypertension: From the Symplicity HTN-2 trial.
– M. Böhm, M.P. Schlaich, H. Krum, R.E. Schmieder, P. Sobotka, M.D. Esler (Homburg and Erlangen, DE;
Melbourne, AU; Mountain View, US)
Percutaneous renal sympathetic denervation exerts a chronic effect on renal hemodynamics using a
novel catheter for radiofrequency ablation: data from an animal study.
– K. Dimitriadis, C. Tsioufis, V. Papademetriou, D. Tsiachris, C. Thomopoulos, A. Kasiakogias, E. Park,
C. Hata, C. Stefanadis (Athens, GR; Washington and Irvine, US)
Renal sympathetic denervation - inducing an immediate and persisting blood pressure lowering effect.
– A. Plehn, S. Dietz, M. Leuthold, T. Schubert, A. Vogt, D. Holzapfel, M. Buerke, S. Markau, M. Girndt,
K. Werdan (Halle, DE)
Renal denervation for resistant hypertension: real world outcomes.
– D.M. Mylotte, M.C. Morice, T. Unterseeh, Y. Louvard, T. Lefevre, P. Garot, H. Benamer (Massy, FR)
Renal sympathetic denervation with brachytherapy using beta-radiation catheter. Results from a
feasibility and safety preclinical study.
– R. Waksman, I. Barbash, R. Chan, R. Torguson, D. Hellinga, R. Baffour, R. Seabron, F. Kelodgie, R. Virmani
(Washington and Gaithersburg, US)
Effect of renal sympathetic denervation on blood pressure and renal perfusion in a pig model for
obstructive sleep apnea.
– D. Linz, M. Loehn, F. Mahfoud, C. Ukena, W. Linz, K. Wirth, M. Böhm (Homburg and Frankfurt/Main, DE)
Percutaneous renal denervation (PRD) improves central hemodynamics and arterial stiffness - a pilot
study.
– K.F. Franzen, K. Mortensen, F. Himmel, J. Stritzke, J. Koester, J. Bock, H. Schunkert, J. Weil, M. Reppel
(Lübeck, DE)
Age-dependent effects of renal denervation therapy on diastolic blood pressure and pulse pressure.
– C. Fatum, K. Mortensen, F. Himmel, M. Reppel, C. Gisbertz, F. Bode, H. Schunkert, J. Weil (Lübeck, DE)
P4418
RENIN–ANGIOTENSIN–ALDOSTERONE SYSTEM IN HYPERTENSION
Pleiotropic role of angiotensin-converting-enzyme inhibitors on bone remodeling biomarkers in
hypertensive subjects.
– E.L. Stepien, T. Wilkosz, E. Wypasek, M. Tlalka, M. Pasowicz (Krakow, PL)
The Effect of sRAGE in inhibiting Angiotensin II-mediated Atherosclerosis in Apolipoprotein E deficient
mice.
– S. Park, D. Lee, J.H. Chung, K.H. Lee, S.H. Kim, T.W. Jin (Seoul, KR)
Effect of valsartan or ramipril addition to amlodipine/hydrochlorotiazide combination on left ventricular
hypertrophy in hypertensive patients with type 2 diabetes.
– R. Fogari, A. Mugellini, A. Zoppi, P. Preti, G. Derosa (Pavia, IT)
Cardiorenal protection by BAY 94-8862, a novel non-steroidal mineralocorticoid receptor antagonist in a
preclinical model of hypertension and diastolic heart failure.
– M. Delbeck, A. Kretschmer, R. Kast, L. Baerfacker, E. Hartmann, S. Schaefer, P. Kolkhof (Wuppertal, DE)
Predictors of adequate response in spironolactone-treated resistant hypertension.
– A.D. Javier, M.C. Acelajado, M.C. Acelajado-Valdenor (Manila, PH)
P4419
P4420
P4421
P4422
P4423
259
The effect life-style education programme together with the telmisartan treatment in patients with
essential hypertension.
– P. Solik, E. Demesova, P. Lesny, M. Luknar, I. Varga, E. Goncalvesova (Bratislava, SK)
Effects of telmisartan on adiponectin and Retinol-Binding Protein 4 in patients with type 2 diabetes.
– V. Shishkova, A. Remennik (Moscow, RU)
Blood pressure reduction with aliskiren in outpatients with hypertension in real life during 2-year
follow-up. Results of the prospective 3A Registry.
– U. Zeymer, R. Dechend, E. Deeg, I. Hagedorn, R. Schmieder (Ludwigshafen, Berlin, Nuremberg and
Erlangen, DE)
P4424
P4425
P4426
PHARMACOLOGY OF HYPERTENSION: MISCELLANEOUS
Phytochemical drugs are the new progress in the genetically determined arterial hypertension treatment.
– V.I. Zabela, V.V. Shylau, V.Y.U. Afonin (Minsk, BY)
Haemodynamic effects of dapagliflozin versus hydrochlorothiazide in subjects with type 2 diabetes
mellitus.
– H.L. Heerspink, D. De Zeeuw, L. Wei, B.R. Leslie, J.F. List (Groningen, NL; Hopewell and Princeton, US)
Coronary artery calcification and ECG pattern of left ventricular hypertrophy or myocardial ischemia
identify different healthy subjects at risk.
– S.Z. Diederichsen, O. Gerke, M.H. Olsen, J. Lambrechtsen, N.P.R. Sand, B.L. Norgaard, H. Mickley,
A.C. Diederichsen (Odense, Svendborg, Esbjerg and Vejle, DK)
Five-year target systolic blood pressure less than 120 mmHg for more than 65 aged hypertension patients
with chronic renal disease.
– X.H. Zeng, Z.H. Liu, Y.Y. Li, X.J. Zeng (Chengdu, CN)
Cholesterol control and incident antihypertensive treatment in hypercholesterolemic subjects treated or
not with statins: a pharmacoepidemiological report.
– A. Cicero, L. Degli Esposti, S. Saragoni, S. Buda, S. Radici, P. Lilli, C. Borghi (Bologna, Ravenna, Piacenza
and Foligno, IT)
Long-term, open-label treatment with triple olmesartan (O)/amlodipine (A)/hydrochlorothiazide (H)
combination therapy in moderate-to-severe hypertension patients (pts).
– M. Volpe, B. Ammentorp, P. Laeis (Rome and Pozzilli, IT; Munich, DE)
Renoprotective effect of cilnidipine via the antioxidant activity in hypertensive patients.
– T. Soeki, M. Kitani, H. Yamada, T. Wakatsuki, T. Kawano, S. Orino, K. Kawano, A. Kakutani, S. Bando,
M. Sata (Tokushima, Higashikagawa and Yoshinogawa, JP)
Does obstructive sleep apnea affect the right heart in patients with resistant hypertension?
Echocardiographic study.
– P.P. Dobrowolski, E. Florczak, A. Klisiewicz, A. Prejbisz, P. Bielen, E. Warchol, H. Janaszek-Sitkowska,
A. Januszewicz, P. Sliwinski, P. Hoffman (Warsaw, PL)
P4427
P4428
P4429
P4430
P4431
P4432
P4433
P4434
NOVEL DIAGNOSTIC AND THERAPEUTIC APPROACHES IN STABLE CORONARY ARTERY DISEASE
Utility of high-sensitivity cardiac troponin T in patients undergoing elective coronary angiography.
– W. Hochholzer, C.M. Valina, C. Stratz, D. Schlittenhardt, D. Trenk, F.J. Neumann (Bad Krozingen, DE)
Evidence of a synergistic impact of polymorphisms on C-reactive protein and interleukin-6 gene in
patients with stable angina pectoris: Effect on inflammatory process.
– G. Hatzis, D. Tousoulis, A. Miliou, N. Papageorgiou, G. Bouras, G. Latsios, G. Siasos, K. Tsioufis,
K. Toutouzas, C. Stefanadis (Athens, GR)
Association between increased levels of cardiac troponin before elective stenting and optical coherence
tomography findings in stable angina pectoris.
– T. Lee, T. Kakuta, T. Murai, T. Iwai, T. Takagi, K. Hishikari, Y. Iesaka (Tsuchiura, JP)
Diagnostic performance of cardiac hybrid imaging of single photon emission computed tomography and
coronary computed tomography.
– M. Nishio, T. Nemoto, M. Asai, K. Kashiwase, K. Matsuo, A. Hirata, Y. Ueda (Osaka, JP)
Ivabradine in combination with beta-blocker is more effective than up-titration of beta-blockers in
patients with stable angina.
– Y.A. Karpov, M.G. Glezer, Y.A. Vasyuk, R.T. Saygitov, E. Shkolnik (Moscow, RU)
Influence of coronary plaque compositions on fractional flow reserve and epicardial stenosis resistance.
– C. Akdeniz, S. Umman, Y. Nisanci, B. Umman, Z. Bugra, M. Sezer (Istanbul, TR)
Plasma cyclophilin A level is a novel biomarker of coronary artery disease.
– K. Satoh, Y. Fukumoto, K. Sugimura, Y. Miura, K. Nochioka, T. Aoki, S. Tatebe, Y. Takagi, J. Takahashi,
H. Shimokawa (Sendai, JP)
Increased rho-kinase activity in patients with vasospastic angina after the great east japan earthquake
disaster.
– T. Nihei, J. Takahashi, Y. Kikuchi, Y. Ito, R. Tsuburaya, Y. Takagi, M. Nakayama, K. Ito, S. Yasuda,
H. Shimokawa (Sendai and Suita, JP)
“Heart team” decision making in the management of patients with Coronary Artery Disease; structure,
outcomes and reproducibility.
– L. Tapp, J. Thekkudan, E. Morris, H. Luckraz, M.S. Norell (Wolverhampton, GB)
The appropriate time of intravenous hydration to prevent contrast-induced nephropathy.
– S. Namiuchi, T. Sugie, T. Takii, T. Kawaguchi, K. Yamaya, A. Kato (Sendai, JP)
Effective radiation dose to obtain coronary morphology and function: comparison of a non-invasive and
an invasive strategy.
– G. Toth, A. Ntalianis, M. De Booj, S. Pyxaras, L. Di Serafino, F. De Vroey, P. Vanhoenacker, P. De Bondt,
W. Wijns, B. De Bruyne (Aalst, BE)
260
P4435
P4436
P4437
P4438
P4439
P4440
P4441
P4442
P4443
P4444
P4445
P4446
P4447
P4448
P4449
P4450
P4451
P4452
P4453
P4454
P4455
P4456
P4457
P4458
P4459
P4460
P4461
TUESDAY – MORNING
Nearly doubled 5-year-mortality in patients with stable coronary artery disease and prior stroke in clinical
practice: results of the Star-Registry.
– A.K. Gitt, F. Towae, C. Juenger, A. Papp, R. Zahn, U. Zeymer, J. Senges (Ludwigshafen, DE)
Prognostic impact of uric acid in patients with stable coronary artery disease.
– G. Ndrepepa, S. Braun, M. Hadamitzky, M. Fusaro, H.U. Haase, K.A. Birkmeier, A. Schomig, A. Kastrati
(Munich, DE)
Serum vitamin D levels are independently associated with severity of coronary artery disease.
– F. Akin, N. Kose, M. Sari, M. Duran, O. Uysal, D. Goldsmith, M. Kanbay (Mugla, Istanbul and Kayseri, TR;
London, GB)
Lack of concordance between image stress tests and invasive functional evaluation with pressure wire in
patients with stable angina.
– S.B. Baptista, P. Magno, J.R. Loureiro, M. Nedio, C. Monteiro, E. Lourenco, P. Leal, P.F. Abreu, V. Gil
(Amadora, PT)
A novel method for the detection of coronary artery disease using an ultrasensitive microphone on the
chest wall.
– S.E. Schmidt, J.J. Struijk, L.H. Madsen, J. Hansen, H. Zimmermann, H. Moller, D. Hammershoi, E. Toft,
H. Kelbaek, P. Clemmensen (Aalborg and Copenhagen, DK)
Effects of ranolazine and ivabradine on exercise stress test and on coronary and peripheral vascular
function in patients with refractory microvascular angina.
– A. Villano, A. Di Franco, R. Nerla, G. Russo, A. Sestito, P. Tarzia, P. Lamendola, F.M. Sarullo, G.A. Lanza,
F. Crea (Rome and Palermo, IT)
Impact of metabolic syndrome on the outcome of patients with stable coronary artery disease submitted
to different types of treatment: 10-year follow-up of the MASS II study.
– E.G. Lima, W. Hueb, R. Rahmi, R.D.O. Vieira, C.L. Garzillo, A.C. Pereira, A.C. Hueb, P.C. Rezende,
J.A.F. Ramires, R. Kalil Filho (São Paulo, BR)
YKL-40 is associated with long-term mortality in patients with stable coronary artery disease.
– M. Harutyunyan, P. Winkel, J. Hilden, J.P. Goetze, J.S. Johansen, J.F. Hansen, G.B. Jensen, E. Kjoeller,
H.J. Kolmos, J. Kastrup (Copenhagen, Herlev, Hvidovre and Odense, DK)
Coronary plaque characteristics that indicate distal embolization during percutaneous coronary
intervention in patients with stable angina-virtual histology intravascular ultrasound study.
– F. Inoue, T. Fujimoto, H. Oka, K. Ueshima, T. Nakano, K. Fujiki, N. Maruyama, S. Yoshimoto (Nara, JP)
Effects of ranolazine and ivabradine on angina status and quality of life in patients with microvascular
angina.
– A. Villano, A. Di Franco, R. Nerla, G. Russo, A. Sestito, P. Lamendola, A. Di Monaco, F.M. Sarullo,
G.A. Lanza, F. Crea (Rome and Palermo, IT)
Low testosterone levels correlate with the angiographic extent of coronary artery disease in patients with
stable angina and/or abnormal stress test.
– N. Ioakeimidis, C. Vlachopoulos, A. Aggelis, D. Terentes-Printzios, A. Synodinos, A. Samentzas,
A. Aggelakas, K. Rokkas, K. Aznaouridis, C. Stefanadis (Athens, GR)
Markers of prognosis, incidence of sudden cardiac death and heart failure in coronary artery disease.
– E. Bobescu, D. Dobreanu, N. Aldulea, A. Covaciu (Brasov and Targu Mures, RO)
Extracorporeal shockwave myocardial revascularization therapy (ESMR): an alternative for patients with
end-stage coronary artery disease and chronic refractory angina pectoris?
– J. Vainer, J. Habets, C. De Pont, A. Lousberg, S. Schalla, B. Brans, J. Waltenberger (Maastricht, NL;
Münster, DE)
The prevalence of refractory angina in patients undergoing coronary angiography for stable ischemic
heart disease.
– I.S. Lubchenko, A.A. Doletsky, D.A. Andreev, A.V. Svet, A.L. Syrkin (Moscow, RU)
Prognostic value of “tight” blood pressure control in patients with coronary artery disease: evidence from
the Action database.
– P. Meredith, S. Lloyd, I. Ford, H.L. Elliott (Glasgow, GB)
Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with
coronary artery disease.
– G. Ndrepepa, T. Tada, M. Fusaro, L. King, M. Hadamitzky, H.U. Haase, A. Schomig, J. Pache, A. Kastrati
(Munich, DE)
Non-invasive therapy for management of patients with advanced Coronary Artery Disease.
– S.Z. Rasheed, W. Kazmi (Karachi, PK)
P4462
UPDATE ON INNATE AND ADAPTIVE IMMUNITY IN CORONARY ARTERY DISEASE
Interleukin-6 promoter genetic polymorphism is associated with the presence and the severity of
– G. Hatzis, D. Tousoulis, N. Papageorgiou, A. Miliou, E. Androulakis, G. Latsios, G. Siasos, A.M. Kampoli,
C. Tentolouris, C. Stefanadis (Athens, GR)
Lipoprotein-associated phospholipase A2 (Lp-PLA2) bound on high density lipoprotein is associated with
lower risk of cardiac death in stable coronary artery disease patients: a three year follow-up.
– L. Rallidis, J. Lekakis, I. Rizos, C. Tellis, C. Varounis, D. Barmperis, A. Charalampopoulos, M. Zolindaki,
M. Anastasiou-Nana, A. Tselepis (Athens, Ioannina and Piraeus, GR)
Peripheral blood monocyte sirt1 expression is reduced in patients with coronary artery disease.
– A. Breitenstein, C.A. Wyss, R.S. Spescha, D. Hof, M. Hasun, A. Akhmedov, A. Von Eckardstein, W. Maier,
T.F. Luscher, G.G. Camici (Zurich, CH)
Memory T cells are related with microvascular obstruction in ST segment acute myocardial infarction.
– M.J. Forteza, V. Bodi, I. Trapero, F.J. Chaustre, C. Gomez, I. Benet, J. Sanchis, J.V. Monmeneu,
F.J. Chorro (Valencia, ES)
P4463
P4464
P4465
P4466
261
Patients with acute myocardial infarction and severe obstructive coronary atherosclerosis display distinct
peripheral blood gene expression profiles.
– D. Aronson, Y. Drier, M. Shmoish, E. Domani, E. Sprecher, S. Nahum (Haifa, Rehovot and Tel Aviv, IL)
Role of cd31 and cd38 in innate and adaptive immunity in patients with chronic stable angina and acute
coronary syndromes.
– D. Flego, A. Severino, A. Giglio, V. Galiffa, F. Trotta, D. Pedicino, M. Previtero, G. Liuzzo, F. Crea (Rome, IT)
Erythrocyte aggregation portends worse outcomes in unstable angina patients undergoing Percutaneous
Coronary Interventions.
– A. Steinvil, B. Shmuel, A. Halkin, G. Keren, A. Finkelstein, N. Mashav, M. Zuzut, S. Berliner, G. Aviram,
Y. Arbel (Tel Aviv, IL)
Admission white blood cell count predicts acute kidney injury in patients with acute myocardial infarction.
– G. Lazaros, D. Tsiachris, A. Patialiakas, A. Kordalis, C. Tsioufis, C. Vlachopoulos, D. Tousoulis,
Elevated plasma high sensitivity C-reactive protein and endothelin are associated with decreased
flicker-light induced retinal arteriolar dilatation.
– A. Alfiadh, N. Uddin, S.K. Patel, E. Glatz, A.M. Wilson, D.J. Clark, R. Kawasaki, T.Y. Wong, L.M. Burrel,
O. Farouque (Melbourne, AU)
Myocardial injury induces AIM2 inflammasome expression in neutrophil granulocytes in patients with
acute coronary syndrome.
– J. Hoffmann, H.M. Nef, L.P. Pyttel, P. Thiele, C. Troidl, C. Liebetrau, S. Szardien, S. Voss, C.W. Hamm,
H. Moellmann (Bad Nauheim and Giessen, DE)
Monocyte chemoattractant protein-1 release does not respond to acute variations of background
inflammation and lipid peroxidation, but it is subjected to circadian variations.
– A.S. Antonopoulos, C. Antoniades, M. Demosthenous, D. Tousoulis, K. Marinou, A. Miliou, C. Bakogiannis,
C. Psarros, C. Vlachopoulos, C. Stefanadis (Athens, GR)
Increased YKL-40 levels in patients with isolated coronary artery ectasia.
– T. Erdogan, S.A. Kocaman, M. Cetin, A. Kirbas, M.E. Durakoglugil, A. Canga, A. Yilmaz, Y. Cicek,
S. Dogan, M. Bostan (Rize, TR)
Functional characteristics of monocytes subsets in the acute and healing phases of ST elevation
myocardial infarction and their effect on ejection fraction.
– A. Ghattas, G. Lip, H. Griffiths, E. Shantsila (Birmingham, GB)
Inflammatory capacity of peri-coronary adipose tissue may affect plaque destabilization in patients with
non ST segment myocardial infarction.
– T. Mazurek, M. Kobylecka, J. Kochman, K. Filipiak, L. Krolicki, G. Opolski (Warsaw, PL)
Infection with human immunodeficiency virus is an independent predictor of increased aortic stiffness.
– M. Asaad, O.J. Rider, N. Ntusi, E. Wainwright, A. Pitcher, J. Suttie, K. Clarke, L. Dorrell, S. Neubauer,
C. Holloway (Oxford, GB)
Low-grade inflammation and post-operative clinical outcome in elective coronary artery bypass surgery:
the emerging role of monocyte chemoattractant protein 1.
– M. Demosthenous, C. Antoniades, D. Tousoulis, A.S. Antonopoulos, A. Miliou, C. Bakogiannis, C. Psarros,
N. Koumallos, N. Sfyras, C. Stefanadis (Athens, GR)
Monocyte-derived angiogenic/reparative cells in myocardial infarction: focus on monocyte
subpopulations.
– E. Shantsila, A.D. Tapp, B.J. Wrigley, A. Shantsila, G.Y.H. Lip (Birmingham, GB)
The association of neutrophil/lymphocyte ratio with coronary flow and in-hospital mace in patients with
STEMI undergoing primary PCI.
– M. Akpek, O. Sahin, D. Elcik, M.G. Kaya (Kayseri, TR)
Higher plasma levels of platelet derived growth factor and matrix metalloproteinase-9 in coronary artery
in patients with acute myocardial infarction.
– T. Koizumi, K. Sugi, J. Tanno, J. Sato, T. Kikutani, S. Nakano, T. Muramatsu, N. Komiyama, S. Nishimura
(Hidaka, JP)
The impact of hsCRP on acetylcholine induced coronary artery spasm in female patients.
– J.Y. Park, Y.S. Chun, S.K. Ryu, J.W. Choi, S.W. Rha, A. Elnagar, S.I. Im, S.W. Kim, C.U. Choi, D.J. Oh
(Seoul, KR)
Suppression of iron metabolism pathway and improvement of cardiac function by erythropoietin
administration in patients with acute myocardial infarction.
– M. Oda, K. Toba, K. Kato, T. Ozawa, T. Suzuki, H. Suzuki, N. Tomosugi, Y. Aizawa (Niigata, Yokohama,
Kanazawa and Nagaoka, JP)
Low T3 syndrome and inflammation in patients with ST-elevation myocardial infarction.
– E. Galli, N. Botto, U. Paradossi, A. Mazzone, M. Baroni, C. Palmieri, M. Ravani, A. Clerico, G. Iervasi,
S. Berti (Pisa and Massa, IT)
High C-reactive protein is a better predictor of occult coronary artery disease than low testosterone in
asymptomatic men less than 60 years with erectile dysfunction.
– D. Terentes-Printzios, C. Vlachopoulos, N. Ioakeimidis, A. Aggelis, A. Synodinos, P. Xaplanteris, K. Rokkas,
A. Samentzas, K. Aznaouridis, C. Stefanadis (Athens, GR)
Does the gene expression of transforming growth factor beta1 (TGFbeta1) contributes to the occurrence
of acute coronary syndrome (ACS)?
– J. Dabek (Katowice, PL)
Early cardiac gene transcript levels in peripheral blood mononuclear cells reflect severity in stable
– J.E. Kontaraki, G.E. Kochiadakis, M.E. Marketou, G. Chlouverakis, N.E. Igoumenidis, I.G. Saloustros,
P.E. Vardas (Heraklion, GR)
262
P4467
P4468
P4469
P4470
P4471
P4472
P4473
P4474
P4475
P4476
P4477
P4478
P4479
P4480
P4481
P4482
P4483
P4484
P4485
P4486
P4487
Gamma-glutamyltransferase levels are associated with inflammatory activation, myocardial dysfunction
and in-hospital mortality in patients with ST-elevation myocardial infarction.
– E. Galli, M. Mariani, N. Botto, U. Paradossi, C. Palmieri, A. Taddei, A. Clerico, M. Emdin, G. Iervasi, S. Berti
(Pisa and Massa, IT)
Predictive incremental value of combination of inflammatory cytokines (IL6-IL10-MIG) on impaired
ventricular function at discharge and on 6-month mortality after ST-elevation myocardial infarction.
– E. Ammirati, C.V. Cannistraci, N. Cristell, A. Palini, V. Guida, A. Monello, A. Durante, A.A. Manfredi,
D. Cianflone, A. Maseri (Milan and Florence, IT; Thuwal, SA)
P4488
P4489
UPDATE ON CORONARY SPASM AND MICROVASCULAR DYSFUNCTION
P4490
P4491
P4492
P4493
P4494
P4495
P4496
P4497
P4498
P4499
P4500
TUESDAY – MORNING
The area of microvascular obstruction after acute myocardial infarction is determined mainly by infarct
size and reduced clot permeability.
– J. Zalewski, P. Lech, M. Durak, J. Nessler, A. Undas, K. Zmudka (Krakow, PL)
Prevalence of microvascular obstruction after primary percutaneous coronary intervention is higher in
male patients with hypogonadism.
– G. Niccoli, D. D’Amario, D. Milardi, G. Grande, F. Fracassi, C. Carrozza, G. Canu, C. Zuppi, A. Pontecorvi,
F. Crea (Rome, IT)
Correlation between coronary microvascular function and angina status in patients with stable
microvascular angina.
– A. Di Franco, A. Di Monaco, P. Lamendola, A. Sestito, A. Villano, G. Russo, F. Infusino, P. Tarzia,
G.A. Lanza, F. Crea (Rome, IT)
Effect of short-acting nitrates on exercise stress test and coronary microcirculation in patients with
microvascular angina.
– G. Russo, A. Di Franco, P. Lamendola, A. Di Monaco, R. Nerla, A. Villano, P. Tarzia, A. Sestito, G.A. Lanza,
F. Crea (Rome, IT)
The index of microcirculatory resistance was strongly associated with infarct size only in anterior
ST-segment elevation myocardial infarction, but not in non-anterior STEMI.
– H. Shibata, N. Ito, A. Tsuruoka, Y. Kurozumi, N. Yamada, T. Natsukawa, K. Okada, H. Sawano, Y. Doi,
T. Hayashi (Suita, JP)
Quantitative analysis of microvascular obstruction is bestly related to clinical prognosis than clinical
markers at a 1 year follow-up: a contrast-enhanced MRI study.
– L. Biere, M. Le Nezet, G. Clerfond, V. Mateus, S. Grall, J. Jeanneteau, F. Prunier, S. Willoteaux, A. Furber
(Angers, FR)
Coronary microvascular function is impaired in diabetic patients with normal coronary arteries and
correlates to renal function.
– C. Marciano, M. Galderisi, C. D’Amore, R. Esposito, P. Gargiulo, L. Casaretti, R. Formisano, F. Lo Iudice,
M. Cecere, P. Perrone Filardi (Naples, IT)
The Impact of ECG Change during Intracoronary Acetylcholine Provocation test on the 12 months Clinical
Outcomes in Korean patients.
– S.W. Rha, J.Y. Park, S.K. Ryu, J.W. Choi, B.G. Choi, A. Elnagar, S.I. Im, S.W. Kim, C.U. Choi, D.J. Oh
(Seoul, KR)
Association of myocardial bridge and acetylcholine induced coroanry artery spasm and 12-months
clinical outcomes.
(Seoul, KR)
Twelve months clinical outcomes of diffuse coronary artery spasm as compared with focal coronary
artery spasm.
– S.Y. Choi, S.W. Rha, A. Elnagar, S.I. Im, S.W. Kim, S.W. Han, C.U. Choi, C.G. Park, H.S. Seo, D.J. Oh
(Seoul, KR)
Impact of alcohol on coronary artery spasm as assessed with intracoronary acetylcholine provocation
test.
– S.W. Rha, B.G. Choi, A. Elnagar, S.I. Im, S.W. Kim, C.U. Choi, J.W. Kim, C.G. Pak, H.S. Seo, D.J. Oh
(Seoul, KR)
CONDITIONING AND OXYDATIVE STRESS: FROM BENCH TO PRACTICE
Exendin-4 postconditioning is not effective in hearts isolated from hypertensive SHR-SP rats with left
ventricular hypertrophy.
– B. Faricelli, M. Salomonsson, A. Consoli, T. Engstroem, M. Treiman (Copenhagen, DK; Chieti, IT)
Impact of ischemic postconditioning in acute myocardial infarction patients with preconditioning.
– T. Takeuchi, H. Ota, Y. Ishii, N. Hasebe (Asahikawa, JP)
Second window and chronic remote ischemic conditioning prevent endothelial injury by
ischemia-reperfusion in humans.
– K. Pryds, S. Rasalingam, H. Contractor, M.R. Schmidt, R.K. Kharbanda, H.E. Botker (Aarhus, DK; Oxford,
GB)
Effect of hydrogen gas inhalation on lipid metabolism and left ventricular remodeling induced by
intermittent hypoxia in mice.
– S. Nishioka, T. Yoshioka, M. Ohkita, Y. Matsumura, N. Ishizaka, Y. Okada, T. Hayashi (Takatsuki, JP)
APE1/Ref-1 decreases ROS generation and myocardial infarction in a mouse model of acute myocardial
infarction.
– J.O. Jeong, S.A. Jin, S.J. Park, J.H. Park, J.Y. Yoon, S.K. Kim, S.W. Choi, J.H. Kim, B.H. Jeon, I.W. Seong
(Daejeon, KR)
P4501
P4502
P4503
P4504
P4505
263
Effect of sildenafil on mitochodria in rat myocardial infarction model - morphological and property
changes utilizing atomic force microscopy.
– W. Kim, K.H. Lee, S.R. Lee, H.H. Jang, H.S. Kim, J.S. Woo, G.J. Lee, H.K. Park (Seoul, KR)
P4506
DIASTOLIC DYSFUNCTION: EPIDEMIOLOGY AND MECHANISM
Prevalence and incidence of myocardial dysfunction and chronic heart failure in the patients with type 1
diabetes: a 7-year prospective cohort study.
– E. Parnicka-Konduracka, M. Malecki, D. Galicka-Latala, G. Gajos, P. Rostoff, A. Pietrucha, J. Nessler
(Krakow, PL)
Prevalence, correlates and prognostic significance of QRS prolongation in heart failure with reduced and
preserved ejection fraction.
– L.H. Lund, J. Jurga, M. Edner, L. Benson, U. Dahlstrom, C. Linde, U. Alehagen (Stockholm and Linköping,
SE)
Prevalence of increased heart rate, links with clinical status and therapy in outpatients with heart failure
with preserved ejection fraction in modern Poland: results of preserved-DATA-HELP study.
– E.A. Jankowska, B. Kurian, W. Banasiak, P. Ponikowski (Wroclaw and Warsaw, PL)
Old tools in new combination: combined stress echocardiography cardiopulmonary exercise testing in
early detection of diastolic dysfunction.
– I. Nedeljkovic, M. Ostojic, V. Giga, J. Stepanovic, A. Djordjevic-Dikic, V. Stojanov, B. Parapid, S. Mazic,
M. Petrovic, M. Beleslin (Belgrade, RS)
Anthracycline cardiotoxicity: incidence at present time.
– J.M. Serrano, C. Cristobal, C. Graupner, R.M. Jimenez, A. Curcio, L. Morales, M. Luaces, P. Talavera,
J. Guerra, J. Alonso (Fuenlabrada, ES)
Relation between diastolic function in rest and during stress and peak exercise capacity among heart
transplant recipients.
– T. Monk-Hansen, C. Have Dall, S. Bisgaard Christensen, M. Snoer, H. Rasmusen, F. Gustafsson,
E. Prescott (Copenhagen and Gentofte, DK)
Diastolic dysfunction is associated with reduced exercise capacity in non-obese subjects. Results from a
population-based study sample.
– M. Dorr, A. Hummel, T. Reffelmann, S. Glaeser, C. Schaeper, B. Koch, H. Volzke, R. Ewert, S.B. Felix
(Greifswald, DE)
The association between computed tomography-derived three-dimensional pericardial adipose burden,
cardiac structural alteration and diastology.
– Y.H. Lai, C.H. Yun, C.H. Yen, Y.J. Wu, J.Y. Kuo, H.I. Yeh, C.L. Hung (Taipei and New Taipei, TW)
Strong association between cardiac fatty acid uptake using BMIPP and abnormalities in diastolic left
ventricular function in diabetic patients with heart failure.
– T. Hashizume, S. Shioji, T. Akasaka (Tanabe and Wakayama, JP)
A risk-factor based porcine model of heart failure with preserved ejection fraction (HFPEF).
– M. Schwarzl, S. Seiler, P. Steendijk, B. Pieske, H. Post (Graz, AT; Leiden, NL)
P4507
P4508
P4509
P4510
P4511
P4512
P4513
P4514
P4515
P4516
HEART FAILURE WITH PRESERVED EJECTION FRACTION-ECHO INVESTIGATION
The relation between left atrial systolic function and left ventricular performance in heart failure with
– Y.J. Lim, S. Kawano, H. Nanmori, M. Takeuchi (Higashiosaka, JP)
Radial ventricular dyssynchrony on exercise in patients with heart failure and normal ejection fraction.
– F.W.G. Wenzelburger, Y.T. Tan, F. Leyva, J.E. Sanderson (Stoke On Trent and Birmingham, GB; Hong
Kong, HK)
Prognostic significance of calibrated integrated backscatter in patients with heart failure and preserved
ejection fraction.
– B.D. Here, D. Stepowski, C. Vallet, B. Kurtz, V. Richard, J.N. Dacher, H. Eltchaninoff, F. Bauer (Rouen, FR)
Left but not right ventricular diastolic function deteriorates during follow up in patients with systemic
sclerosis.
– M. Ciurzynski, P. Bienias, K. Irzyk, K. Kurnicka, B. Lichodziejewska, M. Kostrubiec, Z. Rymarczyk,
A. Szewczyk, M. Siwicka, P. Pruszczyk (Warsaw, PL)
Left ventricular torsion during exercise in patients with and without increase in left ventricular filling
pressures.
– G. Barge-Caballero, J. Peteiro, A. Bouzas-Mosquera, A. Lopez-Sainz, M. Lopez-Perez, O. Prada,
A. Castro-Beiras (A Coruña, ES)
Ventricular-arterial coupling and arterial stiffness in hypertensive subjects with diastolic heart failure.
– I. Goncharov, R. Akhmetov, L. Alexandria, Y. Kotovskaya, S. Villevalde (Moscow, RU)
Moving toward an ejection fraction paradox: the ratio between left ventricular and left atrial volume.
– P. Pellicori, A. Bennett, O. Khaleva, A. Torabi, P. Costanzo, E. Wright, K. Wong, A.L. Clark, J.G.F. Cleland
(Hull, GB)
Deceleration time of early diastolic velocity by tissue Doppler velocity image: a novel index of left
ventricular end-diastolic pressure.
– K. Takemoto, K. Hirata, K. Ishibashi, T. Yamano, T. Tanimoto, Y. Ino, T. Yamaguchi, T. Kubo, T. Imanishi,
Impact of gender difference on the relation between arterial stiffness and left ventricular diastolic
function in healthy subjects.
– M. Saito, H. Okayama, H. Higashi, H. Morioka, T. Yoshii, G. Hiasa, T. Sumimoto, K. Nishimura, K. Inoue,
J. Higaki (Ozu, Matsuyama and Toon, JP)
264
P4517
P4518
P4519
P4520
P4521
P4522
P4523
P4524
P4525
Increased prevalence of diastolic heart failure can be identified by impaired global longitudinal strain in
patients with rheumatoid arthritis.
– T. Schau, M. Zaenker, M. Schoepp, D. Rijab, M. Neuss, J. Meyhoefer, C. Butter (Bernau bei Berlin, DE)
Diagnostic of heart failure with normal ejection fraction in outpatients: usefulness of european society of
cardiology guideline.
– A.J. Lagoeiro Jorge, M.L. Ribeiro, L.C.M. Fernandes, M.C. Freire, E.T. Mesquita (Niterói, BR)
Diastolic filling pressures, a valuable tool in the detection of acute allograft rejection in heart
transplantation.
– M. Sanchez Garcia, S. Mingo Santos, V. Monivas Palomero, I. Garcia Lunar, E. Gonzalez Lopez, P. Beltran
Correas, C. Mitroi, M. Gomez Bueno, J. Segovia Cubero, L.A. Alonso Pulpon (Madrid, ES)
P4526
P4527
P4528
DISTAOLIC DYSFUNCTION AND TREATMENT
Differing relations of the clinical responder rate to the left ventricular reverse remodelling and changes in
left ventricular filling pattern in patients receiving cardiac resynchronization therapy.
– M. Dekany, G. Zoltan, B. Szabo, B. Muk, B. Ancsin, T. Borsanyi, G.Z. Duray, R.G. Kiss, N. Nyolczas
(Budapest, HU)
Creatine Phosphate Sodium combining with fractose diphosphate for injection on severe diastolic heart
failure.
– X. Zeng, Y.Y. Li, X.J. Zeng, A.Y. Tu, Z.H. Liu (Chengdu, CN)
Diastolic function improves after resolution of takotsubo cardiomyopathy.
– S. Kumar, M. Waldenborg, P. Bhumireddy, K. Ramkissoon, A.L. Innasimuthu, K. Loiske, K. Emilsson,
J.M. Lazar (New York and Brooklyn, US; Örebro, SE)
A low glycemic and insulinemic diet improves diastolic cardiac function and metabolic syndrome more
than the traditional low-fat diet in overweight patients with type 2 diabetes.
– H. Von Bibra, G. Wulf, T. Schuster, A. Pfuetzner, P. Heilmeyer (Munich, Isny and Mainz, DE)
Adaptive servo ventilation improves long-term prognosis in heart failure patients with preserved left
ventricular ejection fraction and sleep disordered breathing.
– S. Suzuki, A. Yoshihisa, M. Miyata, T. Yamaki, K. Sugimoto, H. Kunii, K. Nakazato, H. Suzuki, S. Saitoh,
Y. Takeishi (Fukushima, JP)
P4529
P4530
P4531
P4532
P4533
HEART FAILURE WITH PRESERVED EJECTION FRACTION: BIOMARKERS
Serum cystatin C as a biomaker of cardiac diastolic dysfunction in patients with cardiac disease and
– K. Nosaka, K. Nakamura, K.F. Kusano, T. Tada, T. Miyoshi, M. Doi, K. Kohno, H. Morita, H. Ito (Takamatsu
and Okayama, JP)
Serum vitamin D and CRP levels are independently associated with diastolic dysfunction.
– F. Akin, N. Kose, M. Sari, M. Duran, O. Uysal, D. Goldsmith, M. Kanbay (Mugla, Istanbul and Kayseri, TR;
London, GB)
Dissecting the mechanisms of left ventricular diastolic dysfunction and inflammation in continuous
ambulatory peritoneal dialysis patients.
– C. Wu, Y.-T. Huang, J. Lee (Taipei and New Taipei City, TW)
Pulmonary hypertension and collagen metabolism in patients with heart failure and preserved ejection
fraction.
– M. Farrero Torres, E. Santiago, M. Batlle, I. Blanco, G. Kasa, M. Cardona, M.A. Castel, J.A. Barbera,
F. Perez Villa (Barcelona, ES)
Expression of connective tissue growth factor in diastolic heart failure patients and canine models.
– C. Wu, Y. Wang, J. Lee, C. Tsai, F. Chiang (Taipei, TW)
P4534
P4535
P4536
P4537
P4538
PHARMACOTHERAPY
P4539
TUESDAY – MORNING
Resveratrol, a SIRT1 activator, prevents cardiomyopathy in dystrophin-deficient mice by down-regulation
of p300.
– A. Kuno, M. Tanno, T. Miki, S. Ishikawa, Y. Horio, T. Miura (Sapporo, JP)
Continuous infusion of the novel chimeric natriuretic peptide cenderitide in the dahl salt sensitive rat
model of hypertension and renal dysfunction: evidence for renoprotection.
– M. Schiltgen, A. Walsh, D. Evans, H. Lieu, J.C. Burnett (Minneapolis, San Mateo and Rochester, US)
Reduction in hospitalization for worsening of heart failure with ivabradine in patients with chronic systolic
heart failure in the SHIFT trial.
– J.S. Borer, M. Böhm, I. Ford, M. Komajda, L. Tavazzi, J. Lopez Sendon, M. Alings, E. Lopez De Sa,
K. Swedberg, on behalf of the Shift Investigators (New York, US; Homburg, DE; Glasgow, GB; Paris, FR;
Cotignola, IT; Madrid, ES; Breda, NL; Gothenburg, SE)
Antibodies to C-ending (intracellular) fragment of the angiotensin II type 1 receptor and endothelial NO
synthase in patients with congestive heart failure: first clinical exerience.
– T.Y. Spitsina, T.H. Temirsultanova, O.V. Ilyukhin, Y.M. Lopatin (Volgograd, RU)
Systematic review of the proportion of heart failure patients reporting side effects of beta-blockers in
whom the medication is genuinely causative: ethical implications for informed consent.
– N. Zaman, A.J. Barron, G.D. Cole, R. Wensel, D.O. Okonko, D.P. Francis (London, GB)
Tranilast reduces pathological cardiac fibrosis and improves diastolic function following kidney
dysfunction: implication for cardio-renal syndrome.
– M. Watanabe, F. See, A. Kompa, B. Wang, S. Lekawanvijit, A. Boyle, R. Gilbert, K. Connelly, D. Kelly,
H. Krum (Melbourne, AU; New York and San Francisco, US; Toronto, CA)
P4540
P4541 (W)
P4542
P4543
P4544
265
Reno-protecitve and diuretic therapy with low doses of natriuretic peptide and dopamine in acute heart
failure patients.
– M. Kamiya, N. Sato, A. Nozaki, M. Akiya, H. Okazaki, Y. Takahashi, K. Mizuno (Tokyo, JP)
Decreased mortality and development of heart failure after first-time myocardial infarction between
1997-2009, a danish nationwide cohort study.
– A. Gjesing, C. Andersson, L. Kober, G. Gislason, C. Torp-Pedersen (Copenhagen, DK)
Cardiac iron and function by CMR in thalassemia major patients treated with combined deferiprone and
desferrioxamine regimen versus monotherapies: a multi-center, observational and prospective study.
– A. Pepe, A. Meloni, G. Rossi, G.B. Ruffo, D.G. D’Ascola, M. Santodirocco, C. Tudisca, L. Gulino,
M. Lombardi, P. Ricchi (Pisa, Palermo, Reggio Calabria, San Giovanni Rotondo and Naples, IT)
Evaluation of safety, tolerability, PK and hemodynamic properties of JNJ- 39588146 (stresscopin) in
healthy and HF subjects: a phase 1 ascending dose randomized multicenter trial.
– A. Olson, V. Conraads, B. Wollaert, J. Di, J. Jiang, O. Bueno, D. Polidori, P. Gengo, M. Lu, N. Shankley (La
Jolla, US; Antwerp, BE)
Should we achieve the target doses of beta-blockers in chronic heart failure patients with adequate heart
rate control?
– K. Leemasawat, A. Phrommintikul, R. Kanjanavanit, W. Wongcharoen, K. Okonogi, L. Yongsmith,
S. Yooprasert, A. Sukonthasarn (Chiang Mai, TH)
Effect of aldosterone antagonism on ejection fraction and exercise capacity is independent of NYHA
classification: a meta-analysis of 1575 patients in randomized controlled trials.
– D. Phelan, P. Thavendiranathan, P. Collier, T. Marwick (Cleveland, US)
Management of acute heart failure and adherence to guidelines in different clinical presentations.
– T. Tarvasmaki, V.P. Harjola, K. Siirila-Waris, J. Tolonen, M.S. Nieminen, J. Lassus (Helsinki, FI)
Continuous furosemide infusion versus furosemide mannitol infusion in acute congestive heart failure.
– M. Turagam, P. Velagapudi, V.S. Hanumanthu, A. Kocheril, J. Holley (Milwaukee, Madison, Boston and
Urbana, US)
Zofenopril and ramipril plus ASA in post-myocardial infarction patients with left ventricular systolic
dysfunction: a post-hoc analysis in preserved or impaired left ventricular fraction at entry.
– C. Borghi, E. Ambrosioni (Bologna, IT)
Treatment effect versus selection bias in systolic heart failure patients receiving higher target doses of
ACE inhibitors: Insights from Studies of Left Ventricular Dysfunction (SOLVD) treatment trial.
– A. Ahmed, B. Pitt, G.S. Filippatos, I.B. Aban, P. Deedwania, G.C. Fonarow, D.E. Forman, M. Gheorghiade,
W.S. Aronow, R.C. Bourge (Birmingham, Ann Arbor, Fresno, Los Angeles, Boston, Chicago and Valhalla,
US; Athens, GR)
Statin therapy and clinical outcomes in acute heart failure patients complicating acute myocardial
infarction: insights from the EPHESUS trial.
– D. Dobre, P. Rossignol, Y. Murin, A. Parkhomenko, Z. Lamiral, H. Krum, D.J. Van Veldhuisen, B. Pitt,
F. Zannad (Nancy, FR; Bratislava, SK; Kiev, UA; Melbourne, AU; Groningen, NL; Ann Arbor, US)
Efficacy of ivabradine therapy on right heart parameters and prognosis in patients with severe systolic
chronic heart failure.
– L.R. Tumasyan, K.G. Adamyan, A.L. Chilingaryan (Yerevan, AM)
Subcutaneous furosemide can prevent hospitalization in fluid overload decompensation of chronic heart
failure.
– E. Zatarain Nicolas, J. Lopez Diaz, H. Garcia Pardo, C. Ortiz Bautista, A. Recio Platero, I.J. Amat Santos,
M.G. Sandin Fuentes, L. De La Fuente Galan, A. San Roman Calvar (Valladolid, ES)
Are there relationships between high resting heart rate and not optimal doses of beta-blockers in
outpatients with systolic heart failure in contemporary Poland? Results of DATA-HELP study.
– E.A. Jankowska, B. Kurian, W. Banasiak, P. Ponikowski (Wroclaw and Warsaw, PL)
Eplerenone and new-onset diabetes in patients with mild heart failure.
– D. Preiss, D.J. Van Veldhuisen, H. Krum, K. Swedberg, H. Shi, J. Vincent, S.J. Pocock, B. Pitt, F. Zannad,
J. McMurray (Glasgow and London, GB; Groningen, NL; Melbourne, AU; Gothenburg, SE; New York and
Ann Arbor, US; Nancy, FR)
Do early and late nephroprotective effects differ with different inhibitors of renin-angiotensin-aldosteron
system in chronic heart failure patients?
– O.V. Tsygankova, D. Platonov, Z.G. Bondareva, I.V. Arutyunyan (Novosibirsk and Tver, RU)
Effect of valsartan and amlodipine on heart failure and left ventricular mass in japanese hypertensive
patients with glucose intolerance: a subanalysis of the Nagoya heart study.
– T. Nagahiro, T. Kondo, K. Yamashita, T. Muramatsu, K. Matsushita, K. Maeda, S. Shintani, T. Murohara
(Nagoya, JP)
Effects of oral administration of orodispersible L-Carnosine in patients with chronic heart failure and
severe left ventricular dysfunction.
– C. Lombardi, V. Carubelli, C. Ciccarese, A. Castrini, V. Lazzarini, B. Piovanelli, E. Vizzardi, S. Nodari,
M. Metra, L. Dei Cas (Brescia, IT)
266
P4545
P4546
P4547
P4548
P4549
P4550
P4551
P4552
P4553
P4554
P4555
P4556
P4557
P4558
P4559 (W)
P4560
P4561
P4562
TUESDAY, 28 AUGUST 2012 – LUNCH TIME SESSIONS
MEET THE GUIDELINES TASK FORCE III
Special Session
Chairperson(s): J.J. Bax (Leiden, NL); U. Sechtem (Stuttgart, DE)
12:45
13:07
Valvular heart disease: questions and answers to the panellists.
– A. Vahanian (Paris, FR), O. Alfieri (Brescia, IT), M.A. Borger (Leipzig, DE), P. Lancellotti (Liège, BE)
Atrial fibrillation focused update: questions and answers to the panellists.
– A.J. Camm (London, GB), G. Hindricks (Leipzig, DE), S.H. Hohnloser (Frankfurt, DE), G.Y.H. Lip
(Birmingham, GB)
4563
4564
MEET THE TRIALIST V: THE GREAT EAST JAPAN EARTHQUAKE DISASTER AND
CARDIOVASCULAR DISEASES
Meet the Trialists
Chairperson(s): G. Steinbeck (Munich, DE)
12:45
The Great East Japan Earthquake Disaster and Cardiovascular Diseases.
– H. Shimokawa (Sendai, JP)
4565
ESC GENERAL ASSEMBLY
Special Event
THE HEART OF THE MATTER: ARRHYTHMIAS IN WOMEN AND MINIMIZING RADIATION
RISKS
Sponsored by EPIC Alliance
Satellite Symposium
Chairperson(s): J. Poole (Seattle, US); C. Blomstrom-Lundqvist (Uppsala, SE)
13:00
13:10
13:25
13:40
13:55
Introduction.
– J. Poole (Seattle, US)
Gender differences in heritable disorders.
– S.G. Priori (Pavia, IT)
Working on in the electrophysiology lab: radiation risks to you and your patients.
– S. Ernst (London, GB)
Incidence of ventricular arrhythmias in women and cardiovascular implantable electronic devices
benefit.
– A. Russo (Moorestown, US)
Research applications - A gender related difference in approvals?
– C. Blomstrom-Lundqvist (Uppsala, SE)
4566
4567
4568
4569
4570
CHANGING PARADIGMS IN THE MANAGEMENT OF RECENT ONSET ATRIAL
FIBRILLATION
Sponsored by MSD
Satellite Symposium
13:05
13:25
13:50
14:15
14:25
Welcome and opening remarks.
Unmet needs in the pharmacological cardioversion of atrial fibrillation: the perspective of an
electrophysiologist.
– J.R. Ehrlich (Frankfurt, DE)
Vernakalant: conversion of atrial fibrillation in patients with ischemic heart disease.
– C. Torp-Pedersen (Hellerup, DK)
Real-life experience with vernakalant: a swedish cohort.
– S. Juul-Moller (Malmo, SE)
Panel discussion and Q&A session.
Closing remarks.
– C. Torp-Pedersen (Hellerup, DK)
TUESDAY – LUNCH TIME
Chairperson(s): P. Kirchhof (Birmingham, GB); C. Torp-Pedersen (Hellerup, DK)
13:00
4571
4572
4573
4574
4575
4576
267
EV-077: A NOVEL APPROACH TO VASCULAR INFLAMMATION
Sponsored by Evolva
Satellite Symposium
Chairperson(s): L.C. Wallentin (Uppsala, SE); J. Weitz (Ontario, CA)
13:00
13:10
13:25
13:35
13:45
14:00
Unmet medical need: the overlooked therapeutic potential of thromboxane receptor antagonism.
– J. Weitz (Ontario, CA)
Vascular inflammation drives atherothrombosis.
– K. Sakariassen (Biella, IT)
Effects of thromboxane receptor antagonism on platelet reactivity in type 2 diabetics on
treatment with aspirin or clopidogrel.
– M. Cattaneo (Milan, IT)
Antagonism of thromboxane receptor inhibits vascular inflammation: effects on endothelial cells &
vascular smooth muscle cells.
– M. Back (Stockholm, SE)
First clinical results with EV-077: proof of concept study in type 2 diabetics & epidemiological
background.
– N. Bender (Bad Duerkheim, DE)
Roundtable discussion. Potential role of thromboxane receptor antagonism in reduction of
vascular inflammation and its medical consequences. Stand alone treatment or adjunct to
existing therapy?
– L.C. Wallentin (Uppsala, SE), J. Weitz (Ontario, CA), K. Sakariassen (Biella, IT), M. Cattaneo (Milan, IT),
M. Back (Stockholm, SE), N. Bender (Bad Duerkheim, DE), P. Fontana (Geneva, CH), J.-M. Dogne (Namur,
BE)
4577
4578
4579
4580
4581
4582
FROM EARLY DIAGNOSIS TO LONG TERM MANAGEMENT OF PULMONARY ARTERIAL
HYPERTENSION PATIENTS: LEARNING FROM EXPERIENCE
Sponsored by GSK
Satellite Symposium
Chairperson(s): J.S.R. Gibbs (London, GB); J.L. Vachiery (Brussels, BE)
13:00
13:20
13:35
Academic lecture: Management of functional class II patients: what is the evidence.
Clinical case: Management of functional class II patient through a real life case.
– J.L. Vachiery (Brussels, BE)
Panel discussion.
– J.S.R. Gibbs (London, GB), J.L. Vachiery (Brussels, BE)
4583
4584
4585
IMPACT OF GLUCOSE-LOWERING DRUGS ON CARDIOVASCULAR
ENDPOINTS - BENEFIT, NEUTRALITY OR HARM?
Organised by the Sahlgrenska Academy - Gothenburg University
Course Director: Prof. Karl Swedberg (Gothenburg, SE)
EBAC Accredited Educational Programme
Chairperson(s): L. Ryden (Stockholm, SE); I. Raz (Jerusalem, IL)
13:00
13:05
13:22
13:39
13:56
Welcome and introduction.
– I. Raz (Jerusalem, IL)
Effects of established glucose lowering drugs on cardiovascular risk.
– L. Ryden (Stockholm, SE)
Cardiovascular profile of incretin modulators and sodium-glucose cotransporter 2 inhibitors.
– J. Wilding (Liverpool, GB)
Outcomes trials with newer glucose-lowering drugs.
– I. Raz (Jerusalem, IL)
Concluding remarks.
– L. Ryden (Stockholm, SE)
4586
4587
4588
4589
4590
“This educational programme is accredited by the European Board for Accreditation in Cardiology (EBAC) for one
hour of External CME credits. Each participant should claim only those hours of credit that have actually been spent
in the educational activity. EBAC works in cooperation with the European Accreditation Council for Continuing
Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).”
Programme supported by an unrestricted educational grant from AstraZeneca and Bristol-Myers Squibb
268
THE EVOLVING ROLE OF HIGH-DENSITY LIPOPROTEIN IN THE SECONDARY
PREVENTION OF HIGH RISK PATIENTS WITH CARDIOVASCULAR DISEASE
Sponsored by Cleveland Clinic
Satellite Symposium
Chairperson(s): S.J. Nicholls (Adelaide, AU); A.M. Lincoff (Cleveland, US)
13:00
13:15
13:30
13:45
14:00
14:25
Rationale for targeting high-density lipoprotein: setting the stage.
– S.E. Nissen (Cleveland, US)
Apolipoprotein 1 induction: genetic regulation of atherosclerosis.
– J.J.P. Kastelein (Amsterdam, NL)
Cholesterylester transfer protein inhibition: finding the sweet spot.
– B. Brewer (Potomac, US)
Potent cholesterylester transfer protein inhibition: is bigger better.
– S.J. Nicholls (Adelaide, AU)
Question and answer.
– All Speakers
Final thoughts.
– A.M. Lincoff (Cleveland, US)
4591
4592
4593
4594
4595
BENEFITS OF HIGHLY PURIFIED EPA/DHA ETHYL ESTERS ON CARDIOVASCULAR
HEALTH IN HIGH RISK PATIENTS
Sponsored by Abbott EPD
Satellite Symposium
Chairperson(s): D. Vinereanu (Bucharest, RO); G. Kolovou (Athens, GR)
13:00
13:05
13:30
13:55
14:20
Cardiovascular health.
– D. Vinereanu (Bucharest, RO)
Cardiovascular health in high risk patient groups- how highly purified EPA/DHA ethyl esters can
help to manage it.
– D. Vinereanu (Bucharest, RO)
Treatment options for dyslipidemia in high risk patients.
– G. Kolovou (Athens, GR)
Differences in EPA/DHA formulations and their importance for the treatment of cardiovascular
risk.
– H. Rupp (Marburg, DE)
Closing remarks.
– All Speakers
4596
4597
4598
4599
LEFT ATRIAL APPENDAGE CLOSURE (LAAC) FOR STROKE PREVENTION: REASONS TO
CONSIDER A DEVICE ALTERNATIVE
Sponsored by Boston Scientific
Satellite Symposium
Chairperson(s): H. Sievert (Frankfurt, DE)
13:03
13:18
13:30
13:42
Introduction.
– H. Sievert (Frankfurt, DE)
LAAC with WATCHMAN device: latest clinical evidence.
– V.Y. Reddy (New York, US)
Patient selection considerations.
2012 ESC guidelines perspective.
– M. Glikson (Ramat Gan, IL)
Program closing and final thoughts.
4600
4601
4602
TUESDAY – LUNCH TIME
13:00
4603
4604
13:00–14:00 | Cairo - Village 6
OPTIMAL MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION PATIENTS: ARE
WE THERE YET? A CASE-BASED APPROACH
Sponsored by Pfizer Ltd
Satellite Symposium
Chairperson(s): N. Galie (Bologna, IT); M. Delcroix (Leuven, BE)
13:00
13:05
13:20
13:40
13:55
– M. Delcroix (Leuven, BE)
What is the best way to assess the quality of life of pulmonary arterial hypertension patients?
– M. Delcroix (Leuven, BE)
Putting theory into practice: a case-based discussion.
– M. Humbert (Clamart, FR)
Goal-oriented treatment strategies: which goal for which patient?
Closing summary.
4605
4606
4607
4608
4609
269
MAXIMIZE THE RESPONSE OF CARDIAC RESYNCHRONIZATION THERAPY
Sponsored by Medtronic
Satellite Symposium
Chairperson(s): J.G.F. Cleland (Kingston-upon-Hull, GB); S. Favale (Bari, IT)
13:00
13:05
13:20
13:35
13:50
Introduction.
– J.G.F. Cleland (Kingston-upon-Hull, GB)
Which patients benefit from cardiac resynchonization therapy?
– P. Mabo (Rennes, FR)
Automatic therapy adaptation to individual patient needs.
– S. Faerestrand (Bergen, NO)
Innovative tools to improve cardiac resynchronization therapy response at follow-up.
– M.G. Scheffer (Rotterdam, NL)
Conclusion.
– S. Favale (Bari, IT)
4610
4611
4612
4613
4614
13:00–14:00 | Paris - Village 9
DRUG ELUTING STENTS (DES); LATE STENT THROMBOSIS; PROTECT RANDOMIZED
TRIAL
Sponsored by Medtronic
Satellite Symposium
Chairperson(s): E. Camenzind (Geneva, CH); P.G. Steg (Paris, FR)
13:00
13:05
13:15
13:25
13:35
13:45
Introduction.
– P.G. Steg (Paris, FR)
Stent thrombosis; the landscape.
– E. Camenzind (Geneva, CH)
“PROTECT” results.
“PROTECT” in perspective.
– L. Mauri (Boston, US)
Lessons learned.
– S. Windecker (Berne, CH)
Discussion.
4615
4616
4617
4618
4619
4620
13:00–14:30 | London & The Hague - Village 10
OPTIMIZING HEART FAILURE MANAGEMENT
Organised by the Universitätsklinikum Des Saarlandes
Course Director: Prof. Michael Böhm (Homburg/Saar, DE)
EBAC Accredited Educational Programme
Chairperson(s): K. Swedberg (Gothenburg, SE); J.S. Borer (New York, US)
13:00
13:05
13:20
13:35
13:50
14:20
Introduction.
– K. Swedberg (Gothenburg, SE)
New clinical perspective derived from SHIFT.
– J.S. Borer (New York, US)
New heart failure Guidelines: therapeutic role of ivabradine.
– J.J.V. McMurray (Glasgow, GB)
Benefits of Ivabradine in heart failure: how and why.
– M. Böhm (Homburg/Saar, DE)
Panel discussion: the role of ivabradine in the medical therapy of coronary artery disease and
heart failure.
– M. Böhm (Homburg/Saar, DE), J.S. Borer (New York, US), M.R. Cowie (London, GB), V. Mareev (Moscow,
RU), M. Pfeffer (Boston, US), K. Swedberg (Gothenburg, SE)
Conclusion.
– J.S. Borer (New York, US)
4621
4622
4623
4624
4625
4626
“This educational programme is accredited by the European Board for Accreditation in Cardiology (EBAC) for one
hour of External CME credits. Each participant should claim only those hours of credit that have actually been spent
in the educational activity. EBAC works in cooperation with the European Accreditation Council for Continuing
Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).”
Programme supported by an unrestricted educational grant from SERVIER
270
TUESDAY, 28 AUGUST 2012 – AFTERNOON SESSIONS
CLINICAL CONSIDERATIONS AND PRACTICAL APPROACHES TO MANAGING PATIENTS
WITH DYSLIPIDEMIA
Sponsored by MSD
Satellite Symposium
Chairperson(s): J.E. Deanfield (London, GB); J.J.P. Kastelein (Amsterdam, NL)
14:45
14:50
15:10
15:30
15:50
16:10
Chair welcome and opening remarks.
– J.E. Deanfield (London, GB)
Unmet medical need in the treatment of high-risk populations.
– P.J. Barter (Sydney, AU)
Effective treatment options with add-on or combination therapy.
– C. Ballantyne (Houston, US)
Comprehensive lipid management: a treatment paradigm for optimal cardiovascular risk
reduction.
– J.J.P. Kastelein (Amsterdam, NL)
Panel discussion.
– All Speakers
Closing remarks.
– J.E. Deanfield (London, GB), J.J.P. Kastelein (Amsterdam, NL)
4627
4628
4629
4630
4631
THE NEW ERA OF ORAL ANTICOAGULATION – ACHIEVEMENTS AND CHALLENGES
Sponsored by Daiichi Sankyo Europe GmbH
Satellite Symposium
Chairperson(s): J. Weitz (Ontario, CA); A.J. Camm (London, GB)
14:45
14:50
15:05
15:20
15:35
15:50
16:10
– J. Weitz (Ontario, CA)
Novel oral anticoagulants in atrial fibrillation - A first inventory.
Challenges of new oral anticoagulants in clinical practice.
– H. Heidbuchel (Leuven, BE)
The pharmacological basis of edoxaban development: once daily dosing.
– R. De Caterina (Chieti, IT)
ENGAGE AF-TIMI 48 - Edoxaban in atrial fibrillation. What can we expect?
– R.P. Giugliano (Boston, US)
Panel discussion.
– All Speakers
Closing.
4632
4633
4634
4635
4636
4637
MAKING SENSE OF THE DATA: WHY STILL USE GP IIB/IIIA INHIBITORS IN HIGH-RISK
ACUTE CORONARY SYNDROME PERCUTANEOUS CORONARY INTERVENTION?
Sponsored by Janssen and Eli Lilly and Company
Satellite Symposium
Chairperson(s): H. Schuehlen (Berlin, DE); L. Bolognese (Arezzo, IT)
14:50
15:10
15:30
15:50
16:10
Introduction.
– H. Schuehlen (Berlin, DE)
Recent trial data – Revealing the death of GP IIb/IIIa inhibitors?
– S.D. Kristensen (Aarhus, DK)
Recent registry data – Flying in the face of the evidence?
– U. Zeymer (Ludwigshafen, DE)
Decoding the data – Applying the evidence, not reacting.
– H. Ince (Rostock, DE)
Discussion.
– All Speakers
Closing remarks.
– L. Bolognese (Arezzo, IT)
4638
4639
TUESDAY – AFTERNOON
14:45
4640
4641
4642
271
ASSESSING AND MANAGING ON-TREATMENT CARDIOVASCULAR RISK: WHEN KEY
“QUANTITY” TARGETS ARE MET, IN WHICH PATIENTS DOES “QUALITY” MAKE THE
DIFFERENCE? PITAVASTATIN – A NEW TREATMENT OPTION IN PATIENTS WITH HIGH
CARDIOVASCULAR RISK
Sponsored by Recordati S.p.A / Kowa
Satellite Symposium
Chairperson(s): K.K. Ray (London, GB); J. Chapman (Paris, FR)
14:45
14:50
15:00
15:25
15:55
16:10
Chair’s introduction.
– K.K. Ray (London, GB)
Persistent challenges in the management of dyslipidaemia.
– J. Chapman (Paris, FR)
Pitavastatin in high risk patients: adding “quality” to “quantity”.
– T. Hiro (Ube, JP)
Pitavastatin: a new tool to address persistent challenges.
– J.R. Gonzalez Juanatey (Santiago de Compostela, ES), P. Marques da Silva (Lisbon, PT)
Audience Q&A.
– K.K. Ray (London, GB)
Chairs wrap up and close.
– J. Chapman (Paris, FR)
4643
4644
4645
4646
4647
4648
THE STEPS OF STABLE ISCHEMIC HEART DISEASE PATIENT’S MANAGEMENT
Sponsored by The Menarini Group
Satellite Symposium
Chairperson(s): C.W. Hamm (Bad Nauheim, DE); J.L. Lopez-Sendon (Madrid, ES)
14:45
14:50
15:15
15:40
16:05
Welcome & introduction.
– C.W. Hamm (Bad Nauheim, DE)
The 1st step; to identify the stable ischemic heart disease patient.
– C. Daly (Dublin, IE)
The 2nd step: to reach the hub of the stable ischemic heart disease.
– J.L. Tamargo (Madrid, ES)
The 3rd step: the succesful management for the identified ischemic patients.
– P.A. Merlini (San Donato Milanese, IT)
Conclusions & summary.
– J.L. Lopez-Sendon (Madrid, ES)
4649
4650
4651
4652
4653
SECONDARY PREVENTION: FROM AWARENESS TO ACTION
Moderated Posters
Chairperson(s): L. Ryden (Stockholm, SE); H. Voeller (Rudersdorf, DE)
15:30
15:37
15:45
15:52
16:00
16:07
16:15
16:22
272
Prevalence, co-prevalence and awareness of cardiovascular risk factors - results from the
population based Gutenberg Health Study.
– J. Prochaska, S. Goebel, A. Schulz, R.B. Schnabel, N. Khuseyinova, S. Herkenhoff, C. Espinola-Klein,
S. Blankenberg, T. Muenzel, P.S. Wild (Mainz and Hamburg, DE)
Use of lipid lowering therapy in primary care across Europe: results from the European study on
cardiovascular risk prevention in daily practice (eurika).
– J.P.J. Halcox, F. Tubach, J.R. Banegas, C. Borghi, J. Dallongeville, G. De Backer, J. Perk, P.G. Steg,
F. Rodriguez-Artalejo, E. Guallar (Cardiff, GB; Paris and Lille, FR; Madrid, ES; Bologna, IT; Ghent, BE;
Kalmar, SE)
Low levels of IgM antibodies against phosphorylcholine (anti-PC) increase the risk of ischemic
cardiovascular events among European men at high risk of cardiovascular events.
– B. Gigante, K. Leander, R. Strawbridge, B. Sennblad, F. Veglia, D. Baldassarre, E. Tremoli, S.E. Humphries,
J. Frostegard, U. De Faire (Stockholm, SE; Milan, IT; London, GB)
Fasting and postprandial triglycerides are independent cardiovascular risk markers in non-obese
coronary artery disease patients with normal glucose tolerance.
– C. Werner, S. Groenewold, M. Fritsch, A. Filmer, S. Graeber, M. Böhm, U. Laufs (Homburg, DE)
The effect of plant stanol esters on blood flow in adults.
– P. Simonen, H. Gylling, H. Lindholm, J. Konttinen, M.J. Nissinen, M. Hallikainen (Helsinki and Kuopio, FI)
Reduced blood pressure and risk of future cardiovascular disease from structured care algorithm
in primary care patients with persistent hypertension: a multicentre randomized controlled trial.
– S. Stewart, M.J. Carrington, C.H. Swemmer, N.P. Kurstjens, G.J. Jennings (Melbourne and Sydney, AU)
Successful weight loss following gastric sleeve surgery improves vascular function in obese
individuals.
– M.E. Iancu, C.A. Copaescu, C. Ginghina (Bucharest, RO)
The ferrari corporate wellness program: a new concept of cardiovascular prevention in the
companies.
– F. Fernando, A. Biffi, A. Carluccio, M.T. Carluccio, A.F.G. Cicero, C. Borghi (Rome and Bologna, IT)
P4654
P4655
P4656
P4657
P4658
P4659
P4660
P4661
CARDIAC MAGNETIC RESONANCE ACROSS THE SPECTRUM OF CARDIOMYOPATHY
Moderated Posters
Chairperson(s): A.C. Van Rossum (Amsterdam, NL); J. Schulz-Menger (Berlin, DE)
15:30
15:37
15:45
15:52
16:00
16:07
16:15
16:22
Comprehensive assessment of diastolic function from velocity-encoded cardiac magnetic
resonance in patients with hypertrophic cardiomyopathy.
– G. Ashrafpoor, N. Kachenoura, E. Bollache, L. Macron, A. Azarine, E. Bruguiere, M. Desnos, A. Hagege,
E. Mousseaux, A. Redheuil (Paris, FR)
High energy myocardial metabolism in patients with different causes of left ventricular
hypertrophy by 31P magnetic resonance spectroscopy.
– V.V. Mazaev, O.V. Stukalova, S.A. Gabrusenko, F.T. Ageev, S.K. Ternovoy, I.E. Chazova (Moscow, RU)
The left atrium build-up of amyloid in patients with cardiac amyloidosis (CA) is associated with left
atrium dysfunction: morphological and functional evaluation by cardiac magnetic resonance.
– E. Di Pietro, E. Liodakis, A. Grasso, F. Secchi, A. Rapacciuolo, M.C. De Angelis, F. Esposito, G. Maresca,
S. Bartolome Mateos, S. Prasad (Naples and Milan, IT; London, GB)
Role of cardiovascular magnetic resonance in the diagnosis and management of constrictive
pericarditis.
– A. Cagnolo, A. Barison, G.D. Aquaro, C. Ardenghi, M. Carrozzo, M. Deiana, A. Balbarini, M. Lombardi (Pisa,
IT)
Late gadolinium enhanced cardiac magnetic resonance in lamin A/C, cardiac troponin T and
myosin binding protein C gene mutation related cardiomyopathies: characteristics and clinical
associations.
– A. Santosa, J. Franke, D. Schmahl, B. Meder, R. Pribe, P. Ehlermann, G. Kopietz, H. Steen, G. Korosoglou,
H.A. Katus (Heidelberg, DE)
Diffuse myocardial fibrosis by post-contrast T1-time is closely related to the degree of heart
failure in heart failure with normal ejection fraction.
– B.A. Marzluf, D. Bonderman, S. Pfaffenberger, E. Ringelspacher, M. Huelsmann, C. Tufaro, I.M. Lang,
G. Maurer, R. Pacher, J. Mascherbauer (Vienna, AT)
Relation of myocardial fibrosis to left ventricular and mitochondrial function in nonischemic
dilated cardiomyopathy -a comparison focal and interstitial fibrosis-.
– T. Yamada, A. Hirashiki, X.W. Cheng, T. Okumura, S. Shimazu, R. Okamoto, N. Shinoda, K. Takeshita,
Uniformity of circumferential strain and strain delay index are the most relevant left
intraventricular dyssynchrony indices to identify patients with impaired left ventricular function.
– S. El Ghannudi, E. Breton, M.Y. Jeung, P. Croisille, P. Germain (Strasbourg and Saint Etienne, FR)
P4662
P4663
P4664
P4665
P4666
P4667
P4668
P4669
2ND SATELLITE SYMPOSIUM ON RARE CARDIOVASCULAR DISEASES
Satellite Symposium
Sponsored by Centre for Rare Cardiovascular Diseases in John Paul II Hospital, Krakow, Poland
Chairperson(s): P. Podolec (Krakow, PL); A. Torbicki (Otwock, PL); J.G.F. Cleland (Kingston-upon-Hull, GB)
16:32
Introduction.
– P. Podolec (Krakow, PL)
Rare diseases: a priority in public health and research.
– S. Ayme (Paris, FR)
4670
4671
16:30
Pregnancy in patient with Turner syndrome, coarctation of aorta, bicuspid aortic valve and
aneurysm of aorta
16:47
16:56
17:01
Case presentation.
– L. Tomkiewicz-Pajak (Krakow, PL)
How would I treat?
– P. Hoffman (Warsaw, PL)
Comment.
– Z. Gasior (Katowice, PL)
4672
4673
4674
Rapid clinical detoriation after first line treatment of a patients with idiopathic pulmonary arterial
hypertension
17:04
17:13
17:18
17:21
17:24
Case presentation.
– G. Kopec (Krakow, PL)
How would I treat?
Comment.
– P. Rubis (Krakow, PL)
The journal of Rare Cardiovascular Diseases - First issue.
– J. Podolec (Krakow, PL)
The end of the symposium and closing remarks.
– A. Torbicki (Otwock, PL), J.G.F. Cleland (Kingston-upon-Hull, GB)
4675
4676
4677
4678
4679
273
DUAL ANTIPLATELET THERAPY IN STEMI PATIENTS: FROM STATISTICAL SIGNIFICANCE
TO CLINICAL RELEVANCE
Sponsored by Daiichi Sankyo Europe GmbH & Eli Lilly and Company
Satellite Symposium
Chairperson(s): P.M. Clemmensen (Copenhagen, DK); G. Montalescot (Paris, FR)
16:30
16:35
17:00
17:25
17:50
– G. Montalescot (Paris, FR)
Current experience.
– U. Zeymer (Ludwigshafen, DE)
Current recommendations and corresponding data.
– P. Widimsky (Prague, CZ)
Future perspectives of treatments in STEMI patients.
– P. Goldstein (Lille, FR)
Discussion and concluding remarks.
– P.M. Clemmensen (Copenhagen, DK)
4680
4681
4682
4683
4684
INNOVATION IN HYPERTENSION: MULTI-ELECTRODE RENAL NERVE ABLATION FOR
THE TREATMENT OF HYPERTENSION
Sponsored by St. Jude Medical
Satellite Symposium
Chairperson(s): M. Caulfield (London, GB); T.F. Luescher (Zurich, CH)
16:30
16:40
16:55
17:10
17:25
274
Opening: the burden of hypertension and the role of the sympathetic nervous system in
modulating BP.
– M. Caulfield (London, GB)
Multi-electrode renal nerve ablation – Procedure walkthrough and initial clinical results.
– C. Tsioufis (P.Penteli, Athens, GR)
Resistant hypertension – Initial treatment and referrer observations.
– C. Borghi (Bologna, IT)
Patient selection – Characterizing the best responders for renal nerve ablation – Now and in the
future.
– M. Lobo (London, GB)
Conclusion and take-away message.
– T.F. Luescher (Zurich, CH)
4685
4686
4687
4688
4689
TUESDAY, 28 AUGUST 2012 – AFTERNOON POSTERS
14:00–18:00 | Posters - Village 10
POSTER SESSION 6
Poster Session
ARRHYTHMIA MECHANISMS AND ANTIARRHYTHMIC DRUGS
Ranolazine modifies the electrophysiological effects of acute myocardial stretching.
– L. Brines Ferrando, L. Such-Miquel, I. Del-Canto, C. Soler, G. Parra, N. Gallego, J. Barber, A. Alberola,
L. Such, F.J. Chorro (Valencia, ES)
Novel electrophysiological properties of dronedarone: Inhibition of human cardiac two-pore-domain
potassium (K2P) channels.
– C. Schmidt, F. Wiedmann, P.A. Schweizer, R. Becker, H.A. Katus, D. Thomas (Heidelberg, DE)
Mechanisms of antiarrhythmic activity of new class III agent Niferidile in patients with supraventricular
arrhythmias.
– N. Mironov, S.P. Golitsyn, S.F. Sokolov, E.B. Maikov, Y.U.A. Yuricheva, N.B. Shlevkov, L.V. Rosenstraukh,
E.I. Chazov (Moscow, RU)
Flecainide improves exercise testing parameters in patients with catecholaminergic polymorphic
ventricular tachycardia.
– E. Zorio Grima, D. Domingo Valero, M.A. Arnau Vives, J. Soriano Falco, P. Medina Badenes, J. Rueda
Soriano, M.J. Sancho-Tello De Carranza, A. Salvador Sanz (Valencia, ES)
Value-based pricing for dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial
fibrillation in Germany.
– M. Krejczy, S. Marx, K. Obermann, M. Wehling, J. Harenberg (Mannheim, DE)
Network meta-analysis of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with
non-valvular atrial fibrillation.
– S. Marx, H.-C. Diener, J. Harenberg, G. Lip, V. Marder, M. Wehling, C. Weiss (Mannheim and Essen, DE;
Birmingham, GB; Los Angeles, US)
Administration of vernakalant in a highly sensitive model of proarrhythmia caused prolongation of
myocardial repolarization without increased vulnerability to arrhythmias.
– S. Kaese, G. Frommeyer, C. Clauss, M. Schmidt, L. Eckardt, P. Milberg (Münster, DE)
P4690
P4691
P4692
P4693
P4694
P4695
P4696
ARRHYTHMIA MECHANISMS
P4697
P4698
P4699
P4700
P4701
P4702
F 16915 prevents heart failure induced atrial structural remodelling: a promising new drug as up-stream
therapy for atrial fibrillation.
– C. Pignier, R. Letienne, F. Lantoine-Adam, M. David-Dufilho, S. Hatem, B. Le Gand (Castres and Paris, FR)
Zooming in on the focus: flecainide inhibits atrial fibrillation maintained by aconitine.
– D. Linz, J. Eckstein, B. Maesen, A. Van Hunnick, S. Verheule, U. Schotten (Homburg, DE; Basel, CH;
Maastricht, NL)
Absence of cyclase-associated protein 2 leads to marked atrial and ventricular conduction delays and
ventricular arrhythmias.
– F. Stoeckigt, V. Peche, A.A. Noegel, G. Nickenig, M. Linhart, R. Andrie, J.W. Schrickel (Bonn and Cologne,
DE)
NRDc regulates circulatory dynamics through modulating sinus node automaticity and cardiac
sympathetic innervation.
– M. Ohno, Y. Hiraoka, T. Matsuoka, K. Nishi, S. Saijo, H. Matsuura, T. Kita, E. Nishi, T. Kimura (Kyoto, Otsu
and Kobe, JP)
Decreased connexin43/Nav1.5 expression and reduced sodium current through downregulation of
desmoplakin by small RNA interference in HL-1 cardiomyocytes.
– Q.H. Zhang, S.L. Wu, C.Y. Deng, F. Rao, J.N. Zhu, X.Y. Liu, L.P. Mai, H.H. Tan, D.Z. Xiao, X.Y. Yu
(Guangzhou, CN)
Validation of an increased Tpeak-Tend interval in a large series of Brugada syndrome patients as a highly
and independently ECG parameter related to symptoms and cardiac events.
– P. Maury, A. Rollin, V. Probst, F. Sacher, J.L. Pasquie, F. Raczka, J.B. Gouraud, A. Duparc, J.M. Davy,
M. Haissaguerre (Toulouse, Nantes, Bordeaux and Montpellier, FR)
Induction of torsades des pointes is facilitated by stimulation of extra-cardiac alpha-adrenergic
receptors.
– M.B. Thomsen, T. Mow (Copenhagen, DK)
Ranolazine suppresses atrial fibrillation in an experimental model of chronic heart failure due to
development of atrial postrepolarization refractoriness and slowing of conduction velocity.
– P. Milberg, G. Frommeyer, S. Rajamani, L. Belardinelli, L. Eckardt (Münster, DE; Palo Alto, US)
Myofibroblasts do not contribute to the substrate for atrial fibrillation. A study of human left atrial
appendages.
– S.P.J. Krul, S.C.M. Van Amersfoorth, G.S.C. Geuzenbroek, A.H.G. Driessen, A.A.M. Wilde, J.M.T. De
Bakker, J.R. De Groot (Amsterdam, Nieuwegein and Utrecht, NL)
Cervical vagal nerves contain sympathetic ganglion cells.
– H.W.P. Park, P.S.S. Chen, M.C.F. Fishbein (Gwangju, KR; Indianapolis and Los Angeles, US)
EUK-8, an antioxidant suppresses the electrical remodeling induced by hyperglycemia in
heart/muscle-specific manganese superoxide dismutase-deficient mice.
– S. Ishikawa, S. Niwano, H. Niwano, M. Murakami, A. Satoh, Y. Masaki, T. Kosukegawa, T. Shimizu,
T. Izumi (Kanagawa and Chiba, JP)
An in vitro model of early or late reperfusion-scars to explain clinical reentrant arrhythmia characteristics
and anti-arrhythmic potential of pharmacologic or electric defibrillation.
– S.F. Askar, S.R.D. Piers, K. Zeppenfeld, M.J. Schalij, D.A. Pijnappels (Leiden, NL)
P4703
P4704
P4705
P4706
P4707
P4708
275
The anatomic relationship between the right and left ventricular outflow tracts: its relevance in catheter
ablation.
– J.A. Cabrera, M. Murillo, G. Pizarro, E. Gonzalez-Caballero, B. Fuertes, S. Bayona, A. Garcia-Lopez,
A. Pastor, D. Sanchez-Quintana (Madrid and Badajoz, ES)
Acute block of Kv1.5 channels by DHA increases rabbit atrial refractory period.
– C. Pignier, R. Letienne, B. Le Grand (Castres, FR)
The change of preferential internodal pathways during sympathetic stimulation.
– H.S. Mun, J. Wee, J. Shim, J.S. Uhm, J.Y. Kim, H.N. Pak, M.H. Lee, B. Joung (Seoul, KR)
Depletion of connexin45 and connexin30.2 deteriorates AV-nodal conduction in the murine heart.
– J.W. Schrickel, M. Frank, R. Andrie, L. Lickfett, G. Nickenig, K. Willecke (Bonn, DE)
Dexmedetomidine and clonidine inhibit ventricular tachyarrhythmias in a rabbit model of acquired long
QT syndrome.
– K. Tsutsui, T. Mikamo, A. Sugiura, K. Kanamori, N. Yamagishi, S. Yamagishi, H. Watanabe, T. Kunishima,
N. Hayami, Y. Murakawa (Kanagawa, JP)
Lymphocytic cell infiltration of myocardium is associated with the episode of ventricular fibrillation in
patients with brugada syndrome.
– M. Tanaka, K. Nakamura, D. Miura, K. Nakagawa, N. Nishii, S. Nagase, H. Morita, K. Kusano, C. Yutani,
H. Ito (Okayama, JP)
P4709
P4710
P4711
P4712
P4713
P4714
ELECTROCARDIOGRAM/NON INVASIVE STUDIES/SYNCOPE
False tendons are possibly associated with genesis of J-waves: prospective study in young healthy men.
– M. Nakagawa, K. Ezaki, H. Miyazaki, Y. Teshima, K. Yufu, N. Takahashi, T. Saikawa (Yufu, JP)
Partial blockade of IK1 destabilizes the rotation center of spiral wave reentry without enhancement of
wavefront-tail interactions in the arm.
– Y. Kushiyama, H. Honjo, R. Niwa, H. Takanari, M. Yamazaki, Y. Takemoto, I. Sakuma, I. Kodama,
K. Kamiya (Nagoya and Tokyo, JP)
Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with
resistant hypertension.
– C. Ukena, F. Mahfoud, I. Kindermann, A. Spies, D. Linz, B. Cremers, U. Laufs, H.R. Neuberger, M. Böhm
(Homburg, DE)
Distribution of J waves on 87-lead body surface map in patients with inferolateral early repolarization
syndrome.
– T. Kobayashi, S. Kamakura, K. Miyamoto, Y. Yamada, H. Okamura, T. Noda, K. Satomi, T. Aiba,
S. Yasuda, W. Shimizu (Suita, JP)
QT peak prolongation predicts cardiac death following stroke.
– K. Y.-K. Wong, R.S. Macwalter, D. Douglas, H. Fraser, A.D. Struthers (Hull and Dundee, GB)
Changes in QRS duration in ECG leads with ST segment elevation differentiate acute pericarditis and
acute transmural myocardial ischemia.
– X. Rossello, R.F. Wiegerinck, J. Alguersuari, A. Bardaji, F. Worner, M. Sutil, A. Ferrero, J. Cinca (Barcelona,
Palma de Mallorca, Tarragona and Lleida, ES)
Is QRS axis pattern associated to the type of surgical repair in adults with operated tetralogy of fallot?
– Z. Jalal, N. Combes, J.B. Thambo, M. Haissaguerre, F. Sacher (Bordeaux-Pessac and Toulouse, FR)
Early repolarization patterns in young healthy individuals: prevalence, morphological characteristics and
impact of gender, ethnicity and physical activity.
– S. Ghani, S. Di Fino, A. Gravina, A. Zaidi, N. Sheikh, S. Gati, H. Raju, S. Sharma (London, GB)
The prognostic value of sinoatrial block of Wenckebach type (Mobitz I) in patients with symptoms
suggestive of paroxysmal cardiac arrhythmias.
– E. Kramarz, K. Makowski (Warsaw, PL)
Cardiac autonomic disturbances in patients with vasovagal syndrome: comparison between
123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability.
– G.E. Kochiadakis, M.E. Marketou, S. Koukouraki, F. Parthenakis, G.E. Chlouverakis, N. Karkavitsas,
P.E. Vardas (Heraklion, GR)
Screening for arrhythmogenic myocardial substrate by 12-lead ECG, high resolution ECG and T-wave
alternans in patients with low to intermediate sudden cardiac death risk.
– N. Mewton, D.G. Strauss, P. Rizzi, R.L. Verrier, L.G. Tereshchenko, B. Nearing, F.E. Marchlinski, C. Cox,
P.M. Spooner, J.A.C. Lima (Bron, FR; Siver Spring, Baltimore, Boston and Philadelphia, US)
Fragmented QRS complex in patients with Idiopathic Ventricular Fibrillation.
– S.J. Park, K.M. Byeon, S.H. Lee, Y.K. On, J.S. Kim (Seoul, KR)
Prevalence, electrocardiographic characteristics and variations of early repolarization syndrome on a
population of healthy subjects.
– P.H. Heno, A. Rossi, O. Manen, S. Bisconte, B. Azman, J. Louembe, J. Deroche, V. Kanczuga, E. Perrier
(Clamart, FR)
Various morphological ventricular premature beats with fragmented QRS waves on a 12 lead holter ECG
had a positive relationship with the left ventricular fibrosis on CT in hypertrophic cardiomyopathy.
Association of sudden cardiac death and ambient temperatures in scotland, 1995-2004.
– A. Shah, C. Yap, S. Cobbe, A. Mcconnachi, D.E. Newby, N.L.M. Mills, J. Pell (Edinburgh, Birmingham and
Glasgow, GB)
Prediction of ventricular arrythmias by QRS-fragmentation detected with magnetic field imaging (MFI)
among patients with reduced left ventricular ejection fraction.
– T. Tonnis, A. Cuneo, K. Kyriazis, A. Ujeyl, K.H. Kuck (Hamburg, DE)
276
P4715
P4716
P4717
P4718
P4719
P4720
P4721
P4722
P4723
P4724
P4725
P4726
P4727
P4728
P4729
P4730
How to differentiate patients at risk of cardiac and non-cardiac death using heart rate and its variability?
– J. Sacha, S. Barabach, G. Statkiewicz-Barabach, K. Sacha, A. Muller, J. Piskorski, G. Schmidt (Opole,
Wroclaw, Krakow and Poznan, PL; Munich, DE)
Treatment of patients with inappropriate sinus node tachycardia: If-channel inhibition or ablation?
– J. Borbola, P. Abraham, C.S. Foldesi, A. Kardos (Budapest, HU)
The role of non-invasive methods in determining the arrhythmic risk in myotonic dystrophy type 1.
– C. Calore, A. Polo, V. Romeo, F. Folino, G. Buja, C. Angelini, E. Bonifazi, E. Pegoraro, S. Iliceto, P. Melacini
(Padua and Rome, IT)
Exploring the origin of J-wave with magnetocardiography (MCG): depolarization or repolarization?
– N. Iwakami, S. Kamakura, H. Takaki, S. Hashimoto, H. Okamura, T. Noda, K. Satomi, T. Aiba, W. Shimizu,
M. Sugimachi (Suita, JP)
The importance of atrioventricular conduction and myocardial function in ventricular arrhythmogenesis in
lamin A/C mutation carriers.
– N.E. Hasselberg, T. Edvardsen, H. Petri, K.E. Berge, T.P. Leren, H. Bundgaard, K.H. Haugaa (Oslo, NO;
Copenhagen, DK)
Left atrial strain predicts postoperative atrial fibrillation in patients waiting for aortic valve replacement
for aortic stenosis.
– M. Cameli, M. Lisi, R. Reccia, E. Bigio, E. Bennati, A. Malandrino, M. Maccherini, M. Chiavarelli, M. Henein,
S. Mondillo (Siena, IT; Umeå, SE)
Clinical aspects and prognosis of type 1 ECG pattern of Brugada syndrome.
– K. Letsas, M. Efremidis, P. Korantzopoulos, N. Fragakis, K. Kappos, P. Strempelas, G. Bakosis,
C. Kavvouras, A. Sideris, T. Arentz (Athens, Ioannina and Thessaloniki, GR; Bad Krozingen, DE)
T-wave alternans is helpful for predicting recurrence of fatal arrhythmias in ventricular fibrillation
survivors.
– S. Yamada, H. Suzuki, M. Sato, S. Iwaya, M. Kamioka, Y. Kamiyama, S. Saitoh, Y. Takeishi (Fukushima, JP)
Utility of magnetocardiography for detection of delayed potentials, epsilon waves, with arrhythmogenic
right ventricular cardiomyopathy.
– Y. Ito, K. Yoshida, N. Murakoshi, H. Tada, Y. Sekiguchi, M. Igarashi, H. Yamasaki, K. Kuroki, T. Kaneshiro,
K. Aonuma (Ibaraki, JP)
P4731
P4732
P4733
P4734
P4735
P4736
P4737
P4738
P4739
SYNCOPE
P4740
P4741
P4742
P4743
P4744
P4745
P4746
Home orthostatic training is not effective in elderly patients With vasovagal syncope - a prospective
randomised controlled trial.
– S. Podd, J. Hunt, A.N. Sulke (Eastbourne, GB)
Additional diagnostic value of very prolonged observation by implantable loop recorder in patients with
unexplained syncope.
– R. Maggi, T. Furukawa, C. Bertolone, D. Fontana, M. Brignole (Lavagna, IT)
Vasovagal syncope mediated by emotional distress associated with increased risk of cardiovascular
events.
– D. Zysko (Wroclaw, PL)
Two-year diagnostic yield of implantable loop recorder in patients with neurally-mediated syncope
enrolled in the ISSUE3 trial.
– M. Tomaino, M. Brignole, V. Russo, R. Massa, C. Menozzi, M. Gulizia, T. Kus, M. Iorfida, H.H. Ebert,
R. Sutton (Bolzano, Lavagna, Taranto, Alessandria, Reggio Emilia, Catania and Turin, IT; Montreal, CA;
Riesa, DE; London, GB)
Tilt table testing in patients with suspected epilepsy.
– I. Rangel, J. Freitas, A. Sousa, A.S. Correia, A. Lebreiro, M. Paiva, C. Sousa, M.J. Maciel (Porto, PT)
Incidence, etiology and predictors of adverse outcomes in 43315 patients presenting to the emergency
department with syncope: an international meta-analysis.
– F. D’Ascenzo, G. Biondi Zoccai, M.J. Reed, F. Gaita (Turin and Rome, IT; Edinburgh, GB)
The risk of clotting induced by orthostatic stress patients with vaso-vagal syncope.
– A.Z. Pietrucha, I. Bzukala, D. Fedak, M. Wnuk, E. Konduracka, W. Piwowarska, J. Nessler (Krakow, PL)
Incidence of permanent atrioventricular block in patients with syncope and bifascicular block.
– C. Ukena, F. Mahfoud, I. Lee, H.R. Neuberger, M. Böhm, A. Buob, G. Froehlig (Homburg, DE)
Prevalence of depression syndrome in patients with vaso-vagal syncope.
– A.Z. Pietrucha, A. Borowiec, D. Mroczek-Czernecka, M. Wnuk, I. Bzukala, M. Wegrzynowska,
E. Konduracka, O. Kruszelnicka, W. Piwowarska, J. Nessler (Krakow, PL)
The CHADS2 risk score predicts long-term outcome after first admission for syncope - A nationwide
study.
– M. Ruwald, C. Jons, M. Lock Hansen, A.C.H. Ruwald, M.V. Hojgaard, L. Kober, C. Torp-Pedersen,
J. Hansen, G. Gislason (Hellerup and Copenhagen, DK)
Pictureconomics: a micro-costing analysis of diagnostic investigations for unexplained syncope.
– N. Edvardsson, S. Tsintzos, C. Garutti, G. Rieger, N. Linker (Gothenburg, SE; Maastricht, NL;
Middlesbrough, GB)
Remote monitoring of implantable loop recorders: high artefact in the early phase following implant.
– I.A. Fazal, R. Bhardwaj, M. Tynan, C.J. Plummer, J.M. Mccomb (Newcastle-upon-Tyne, GB)
In patients with vasovagal syncope the increase of adrenomedullin during the positive head-up tilt test
correlates with HRV parameters.
– J. Gajek, D. Zysko (Wroclaw, PL)
The influence of the menstrual cycle on the tilt testing result.
– D. Zysko, J. Gajek, L. Terpilowski, A.K. Agrawal, P. Wroblewski, J. Rudnicki (Wroclaw, PL)
P4747
P4748
P4749
P4750
P4751
P4752
P4753
277
PERCUTANEOUS CORONARY INTERVENTION: INVASIVE IMAGING/DEVICES AND TECHNIQUE
Head to head comparison of fully drug-free bioresorbable PLA and bare metal stents in normal porcine
coronary: a six-month angiography and OCT follow-up study.
– E. Durand, M. Vert, T. Sharkawi, A. Lafont (Paris and Montpellier, FR)
The volume of lipid-rich plaque, measured by integrated backscatter IVUS was associated with amount of
captured plaques by filter-type distal protection device during coronary intervention.
– K. Kitagawa, T. Uetani, A. Kunimura, Y. Shimbo, H. Ando, K. Harada, T. Yoshida, T. Amano, T. Matsubara,
T. Murohara (Nagoya and Nagakute-Cho, JP)
Effects of the intravascular ultrasound-guided true lumen tracking for recanalization of chronic total
occlusion.
– H. Tanaka, K. Kadota, S. Habara, Y. Fuku, T. Goto, K. Mitsudo (Kurashiki, JP)
Nine months optical coherence tomography evaluation of neointimal coverage of a strategy of
paclitaxel-eluting balloon plus bare metal stent.
– I. Porto, K. Ducci, G. Cautilli, P. Angioli, S. Grotti, G. Falsini, F. Liistro, L. Bolognese (Arezzo, IT)
Intravascular ultrasound guided everolimus eluting stent implantation resolves the disadvantage of thin
strut cobalt chromium platform in patients with diabetes.
– H. Takahashi, S. Yamada, T. Hayashi, Y. Yasaka, S. Kobayashi, T. Takaya, N. Miyoshi, S. Oishi, T. Toba,
M. Yokoyama (Himeji, JP)
Feasibility and efficacy of ex-vivo stent fracture detection by optical coherence tomography (OCT) and
microcomputed tomography (microCT).
– M. Vorpahl, V. Veulemanns, P. Horn, T. Ball, D. Zlotnik, P. Maurovic-Horvat, T. Zeus, R. Westenfeld,
M. Kelm, J. Foerst (Düsseldorf, DE; Roanoke and Lebanon, US; Budapest, HU)
Neointimal appearance of late clinical event related lesions after bare-metal stent and sirolimus-eluting
stent implantation assessed by Optical Coherence Tomography.
– Y. Ino, T. Kubo, H. Kitabata, Y. Ozaki, Y. Shiono, T. Yamaguchi, T. Tanimoto, K. Hirata, T. Imanishi,
Assessment of coronary vascular response after first in man implantation of a novel thin strut low profile
fixed wire stent.
– R. Diletti, H.M. Garcia-Garcia, V. Farooq, P. Stella, P. Agostoni, J. De Schepper, M. Pomeranz,
P.W. Serruys (Rotterdam and Utrecht, NL; New Providence, US)
Development of microporous covered stents for treating cerebral aneurysms without disturbing
branching vascular flow.
– Y. Nakayama, S. Nishi, H. Ishibashi-Ueda, M. Miyake, A. Wada (Osaka, Sapporo, Suita and Okayama, JP)
Sex-related differences in percutaneous coronary interventions for chronic total occlusions.
– G. Ferrante, P. Garot, T. Harb, T. Unterseeh, H. Benamer, M.C. Morice, T. Lefevre, Y. Louvard (Massy and
Quincy, FR)
Impact of final kissing balloon in distal left main bifurcation lesions treated with single or two stents
techniques.
– S.W. Rha, B.G. Choi, A. Elnagar, S.I. Im, S.W. Kim, S.W. Han, C.U. Choi, C.G. Park, H.S. Seo, D.J. Oh
(Seoul, KR)
Very late stent thrombosis in diabetic patients on long-term dual antiplatelet treatment after 1st
generation drug-eluting stent implantation: comparison with patients on single antiplatelet treatment.
– V. Voudris, P. Karyofyllis, C. Doulaptsis, I. Moukas, S. Thomopoulou, D.V. Cokkinos (Athens, GR)
Predilatation with drug eluting balloon followed by bare metal stent implantation versus drug eluting
stent in the treatment of simple de-novo native coronary stenosis.
– F. Liistro, I. Porto, P. Angioli, S. Grotti, K. Ducci, G. Falsini, L. Bolognese (Arezzo, IT)
Differential determinants of early stent thrombosis in drug-eluting and bare metal stents: ex vivo human
autopsy study.
– M. Nakano, F. Otsuka, S.K. Yazdani, A.V. Finn, R. Kutys, E.R. Ladich, F.D. Kolodgie, R. Virmani
(Gaithersburg and Atlanta, US)
Angiographic and clinical outcome in the treatment of restenosis of drug eluting stents with drug
coated balloons in diabetics: insights from the PEPCAD-DES: study.
– H. Rittger, A.M. Sinha, J. Brachmann, W.G. Daniel, J. Woehrle (Erlangen, Hof, Coburg and Ulm, DE)
Angiographic and clinical outcomes of paclitaxel coated balloon angioplasty versus uncoated balloon
angioplasty in drug eluting stent resenosis: insights from the PEPCAD-DES study.
– H. Rittger, A.M. Sinha, M. Waliszewski, J. Brachmann, W.G. Daniel, J. Woehrle (Erlangen, Hof, Melsungen,
Coburg and Ulm, DE)
Thin-strut stent is favorable for severe calcified lesion needed rotational atherectomy in real world
Percutaneous Coronary Intervention.
– Y. Lee, M. Nishino, M. Taniike, N. Makino, H. Kato, Y. Egami, R. Shutta, J. Tanouchi, Y. Yamada (Osaka,
JP)
Angiographic outcomes of everolimus-eluting stent as compared to sirolimus-eluting stent: a sub-study
of the RESET trial.
– K. Kozuma, N. Suzuki, K. Tanabe, S. Suwa, M. Iwabuchi, K. Igarashi, Y. Morino, K. Kimura, K. Kadota,
T. Kimura (Tokyo, Shizuoka, Kitakyushu, Sapporo, Morioka, Yokohama, Kurashiki and Kyoto, JP)
Stent maximal expansion capacity with current DES platforms: a critical factor for left main stent
selection?
– N. Foin, S. Sen, C. Di Mario, J.E. Davies (London, GB)
Is there an advantage in using second vs. first generation drug eluting stents in acute coronary
syndromes?
– C. Machado, L. Raposo, H. Dores, S. Leal, P. Goncalves, R. Teles, H. Mesquita Gabriel, M. Almeida,
M. Mendes (Ponta Delgada and Lisbon, PT)
278
P4754
P4755
P4756 (W)
P4757
P4758
P4759
P4760
P4761
P4762
P4763
P4764
P4765
P4766
P4767
P4768 (W)
P4769 (W)
P4770
P4771
P4772
P4773
The anti-proliferative effect of atorvastatin is dependent on stent surface material.
– A. Strohbach, R. Begunk, H. Meyer Zu Schwabedissen, S.A. Walz, M.C. Busch, S.B. Felix, R. Busch
(Greifswald, DE)
One-year outcome after PCI for distal left main stenosis treated with single stenting or with T-stenting.
– M. Ferenc, H.J. Buettner, M. Gick, T. Comberg, J. Rothe, C.H. Valina, R.-P. Kienzle, N. Loeffelhardt,
H.-P. Bestehorn, F.-J. Neumann (Bad Krozingen, DE)
Drug eluting stents with microporous polymeric covering as a scaffold for acquisition of extremely thin
noeintimal lying without disturbing branching vascular flow.
– Y. Nakayama, S. Nishi, H. Ishibashi-Ueda (Osaka and Sapporo, JP)
Comparison of 3-year clinical outcomes between classic crush and modified mini-crush technique in
coronary bifurcation lesions.
– H.M. Yang, S.J. Tahk, S.Y. Choi, H.S. Lim, M.H. Yoon, B.J. Choi, K.W. Seo, J.W. Kim, G.S. Hwang, X. Jie
(Suwon, KR)
Assessment of an asymmetrical coating stent with sirolimus released from ablumial matrix in porcine
model.
– L. Shen, Y. Wu, F. Zhang, A. Sun, J. Qian, W. Zhong, J. Ge (Shanghai, CN)
The ulnar puncture technique: lessons from experience.
– R.M. Valdesuso Aguilar, J.R. Gimeno, F.J. Lacunza, J. Garcia De Lara, J. Hurtado, E. Pinar, M. Valdes
(Murcia, ES)
P4774
P4775
P4776
P4777
P4778
P4779
PERCUTANEOUS CORONARY INTERVENTION OUTCOMES
P4780
P4781
P4782
P4783
P4784
P4785
P4786
P4787
The impact of circadian variations on long-term clinical outcomes in patients with acute ST-segment
elevation myocardial infarction undergoing primary percutaneous coronary intervention.
– J.B. Choi, K.S. Cha, M.J. Park, E.Y. Yun, H.W. Lee, J.H. Oh, J.H. Choi, H.C. Lee, T.J. Hong, S.G. An
(Busan, KR)
Impact of microalbuminuria on clinical cardiovascular outcomes in patients with mild renal dysfunction
who underwent elective PCI.
– A. Kunimura, T. Uetani, K. Kitagawa, Y. Shimbo, H. Ando, K. Harada, T. Yoshida, T. Matsubara, T. Amano,
High preprocedural total adiponectin levels are associated with poor long-term cardiovascular outcome
after percutaneous coronary intervention.
– N. Kpogbemabou, D.C. Delhaye, S.A. Sudre, L.G. Lemesle, M.T. Modine, M.M. Mahmoudi, S.B. Steals,
L.G. Luc, B.C. Bauters, L.J.M. Lablanche (Lille, FR; Cambridge, GB)
Prognostic significance of body mass index for in-hospital and long-term mortality in patients undergoing
primary percutaneous coronary intervention.
– C.Y. Karabay, V. Oduncu, A. Kalayci, A. Guler, S.M. Aung, R. Zehir, A. Erkol, C. Gecmen, A. Kilicgedik,
C. Kirma (Istanbul, TR)
Comparison on 1-Year MACE of everolimus-eluting stent Xience vs sirolimus-eluting stent cypher in
diabetic patients.
– F. Liistro, I. Porto, S. Grotti, P. Angioli, K. Ducci, R. Brandini, G. Falsini, L. Bolognese (Arezzo, IT)
Effects of EPC capture stent and CD34+ mobilization in acute myocardial infarction.
– P. Scacciatella, M. D’Amico, M. Pennone, F. Conrotto, T. Usmiani, E. Meliga, I. Meynet, E. Pelloni,
G. Amato, S. Marra (Turin, IT)
Developments in the last ten years - LHC and PCI German registry results of the years 2010 compared to
the year 2000.
– B. Levenson, A. Albrecht, S. Goehring, W. Haerer, N. Reifart, G. Ringwald, B. Troger (Berlin, Ulm, Bad
Soden, Bruchsal and Frankfurt am Main, DE)
Multivessel versus culprit lesion percutaneous coronary intervention in ST-elevation myocardial
infarction: is more worse?
– D. Radovanovic, B. Nallamothu, O. Bertel, F. Eberli, G. Pedrazzini, S. Windecker, R. Jeger, P. Erne (Zurich,
Lugano, Berne, Basel and Lucerne, CH; Michigan, US)
Impact of successful thrombus retrieval during primary percutaneous coronary intervention with
thrombus aspiration on the infarct size and microvascular obstruction: a magnetic resonance imaging
study.
– R. Chopard, P. Plastaras, J. Jehl, V. Descotes-Genon, M.F. Seronde, S. Janin, B. Kastler, F. Schiele,
N. Meneveau (Besançon, FR)
Real-world use of the second-generation cobalt-chromium sirolimus-eluting stents: 12-month results
from the prospective multicentre FOCUS registry.
– F. Zhang, J. Ge, J. Qian, L. Ge, J. Zhou (Shanghai, CN)
Intra-procedural stent thrombosis: a new risk factor for adverse outcome in patients undergoing
percutaneous coronary intervention for acute coronary syndrome.
– S.J. Brener, A.J. Kirtane, M.B. Mcentegart, E. Cristea, K. Xu, R. Mehran, G.W. Stone (New York, US)
Polymer-Free Sirolimus- versus Polymer-Based Paclitaxel-eluting stents. An individual patient data
analysis of randomized trials.
– S. Cassese, S. Desch, T. Tada, R.A. Byrne, L. King, J. Mehilli, A. Schomig, H. Thiele, A. Kastrati (Munich
and Leipzig, DE)
Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock
following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study.
– V. Kunadian, M. Veerasamy, A. Zaman (Newcastle-upon-Tyne, GB)
In hospital clinical outcome of patients with definite stent thrombosis.
– M. Almalla, J. Schroeder, N. Marx, R. Hoffmann (Aachen, DE)
P4788
P4789
P4790
P4791
P4792
P4793
279
Twelve-month safety and performance results of the paclitaxel-eluting bioabsorbable magnesium
scaffold in the prospective, multicenter first-in-man trial -BIOSOLVE-I.
– M. Haude, R. Erbel, S. Verheye, R. Waksman, H. Degen, D. Boese, P. Vermeersch, P. Erne, J. Koolen
(Neuss and Essen, DE; Antwerp, BE; Washington, US; Lucerne, CH; Eindhoven, NL)
Cost-effectiveness of drug-coated balloon angioplasty and drug-eluting stent implantation for treatment
of coronary in-stent restenosis.
– M. Dorenkamp, A. Leber, C. Sohns, L. Boldt, M. Roser, F. Kleber, W. Haverkamp, K. Bonaventura (Berlin,
Munich, Göttingen and Potsdam, DE)
Difference of vascular response between everolimus- and paclitaxel-eluting stents for small coronary
artery diseases: optical coherence tomography analysis.
– K. Nasu, Y. Oikawa, S. Shirai, H. Hozawa, S. Tohara, M. Kadotani, H. Abe, Y. Takeda, S. Usui, T. Serikawa
(Toyohashi, Tokyo, Kitakyushu, Adachi-ku, Kasukabe, Kakogawa, Matsumoto, Osaka and Fukuoka, JP)
Pre-procedural serum albumin and C-reactive protein levels predict clinical outcome after Drug-Eluting
Stents implantation in hemodialysis patients.
– T. Aoyama, H. Ishii, H. Takahashi, Y. Kumada, D. Kamoi, Y. Kawamura, K. Kawashima, T. Sakakibara,
M. Tanaka, T. Murohara (Nagoya, JP)
Second vs. first generation DES are associated with a better safety profile in real world coronary
percutaneous intervention: analysis of 3266 procedures from a single centre prospective registry.
– H. Dores, L. Raposo, S. Leal, C. Machado, P.A. Goncalves, R.C. Teles, H.M. Gabriel, M.S. Almeida,
M. Mendes (Lisbon, PT)
Impact of adjunctive post-dilatation after drug-eluting stent implantation on the clinical outcomes in
patients with acute myocardial infarction: Sub-study of EVER-ZOTA multicenter trial.
– S.Y. Yoo, J.K. Sung, S.H. Lee, C.K. Lee, B.K. Lee, D.H. Yoon (Gangneung, Wonju and Chuncheon, KR)
Bare-nitinol stent versus paclitaxel-coated balloon for femoro-popliteal revascularization. An adjusted
indirect comparison meta-analysis of randomized trials.
– S. Cassese, R.A. Byrne, I. Ott, T. Ibrahim, T. Tada, L. King, A. Kastrati, M. Fusaro (Munich, DE)
P4794
P4795
P4796
P4797 (W)
P4798
P4799
P4800
MANAGEMENT OF CORONARY ARTERY DISEASE AND PERCUTANEOUS CORONARY INTERVENTION
COMPLICATIONS
Bivalirudin Vs Unfractionated Heparin during Percutaneous Coronary Intervention in High Risk Patients
for Bleeding. AntiCoagulant Regimen In high risk PAtients for Bleeding - ACRIPAB Trial.
– A. Feldman, K. Suleiman, L. Bushari, E. Rozner, N.A. Freedberg, Y. Turgeman (Afula, IL)
Triple over Dual anti-Platelet therapy was not mandatory in Acute Coronary Syndrome Patients with 2nd
Generation Drug eluting Stent Implantation.
– Y.-S. Choi, J.-Y. Kim, J.-S. Yu, W.-B. Chung, C.-S. Park, P.-J. Kim, K. Chang, H.-Y. Kim, W.-S. Chung,
K.-B. Seung (Seoul, KR)
Brain natriuretic peptide during coronary intervention prevents endothelial dysfunction post PCI via
NP-cGMP activation.
– A. Peleg, D. Ghanim, D. Qarawani, Y. Hasin (Tiberias, IL)
Why is the posterior myocardial infarction the most frequent cause of acute mechanical complications?
– S. Simek, J. Horak, T. Kovarnik, J. Belohlavek, M. Aschermann, V. Mrazek, J. Humhal, A. Linhart (Prague,
CZ)
Effect of high dose statin pretreatment on endothelial progenitor cells after percutaneous coronary
intervention (Hipocrates study).
– A. Eisen, D. Leshem-Lev, K. Orvin, T. Ben Gal, O. Daddush, A. Battler, E.I. Lev (Petah Tikva, IL)
Elective percutaneous coronary intervention does not improve outcomes in patients with coronary artery
disease (a prospective cohort study).
– T.A. Ilyushchenko, A. Komarov, I. Levitskiy, A. Samko, O. Shakmatova, A. Deev, Y.U. Karpov,
E. Panchenko (Moscow, RU)
Onset-to-needle times in patients with ST-segment elevation myocardial infarction: shortest referral route
to a primary coronary intervention facility.
– H. Leleu, F. Capuano, M. Ferrua, G. Nitenberg, E. Minvielle, F. Schiele (Villejuif and Besançon, FR)
Improved prognosis of weekends/holidays admission for acute myocardial infarction and a decreasing
weekend-effect from 2005 to 2010.
– J.H. Lee, S.Y. Jang, J.K. Kang, D.H. Yang, H.S. Park, Y. Cho, S.C. Chae, J.E. Jun, M.H. Jeong, Y.J. Kim
(Daegu and Gwangju, KR)
Syntax score predicts major bleeding after drug-eluting stent implantation.
– R. Iijima, N. Nagashima, K. Yamazaki, T. Araki, M. Utsunomiya, M. Hori, H. Itaya, M. Shiba, H. Hara,
M. Nakamura (Tokyo, JP)
Clinical risk scores for the prediction of CIN before primary PCI.
– G. Ando, G. Morabito, O. Trio, F. Saporito, C. De Gregorio, G. Oreto (Messina, IT)
Comparison of the new Mayo Clinic risk scores and clinical SYNTAX Score in predicting adverse
cardiovascular outcomes following percutaneous coronary intervention at our heart center.
– H.J. Brown, J. Ho Khe Sui, C. Tan (Quezon City, PH)
Protamine usage following implantation drug-eluting stents: is it safe?
– B. Kremer Diniz Goncalves, A.L.T. Tedeschi, M.A.S. Sena, R.T.S.P. Peixoto (Niterói, BR)
Does over-aggressive stent expansion without IVUS guidance predispose to restenosis?
– Y. Chacko, K. Haladyn, R. Chan, R. Lim (Brisbane, AU)
Impact of Mehran Risk Score for the prediction of Contrast-Induced Nephropathy in the Japanese
patients who undergoing Percutaneous Coronary Intervention.
– E. Ojima, A. Sato, T. Hoshi, H. Watabe, Y. Kakefuda, D. Abe, M. Endo, K. Aonuma (Moriya, Tsukuba,
Hitachi and Kasama, JP)
280
P4801
P4802
P4803
P4804
P4805
P4806
P4807
P4808
P4809
P4810
P4811
P4812
P4813
P4814
Use of protamine fo rearly femoral sheath removal after coronary stent angioplasty.
– B. Kremer Diniz Goncalves, A.L.T. Tedeschi, M.A.S. Sena, R.T.S.P. Peixoto, E.C.S.P. Peixoto (Niterói, BR)
Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients
undergoing Percutaneous Coronary Intervention.
– M.J. Pietila, P.P. Karjalainen, T.O. Kiviniemi, A. Ylitalo, M. Niemela, S. Vikman, M. Puurunen, F. Biancari,
K.E.J. Airaksinen (Turku, Pori, Oulu, Tampere and Helsinki, FI)
Functional syntax score improves stratification of risk in patients with left main coronary artery disease.
– Y. Ntarladimas, M. Hamilos, L. Di Serafino, B. De Bruyne, E. Barbato (Aalst, BE)
P4815
P4816
P4817
IMAGING OF THE RIGHT VENTRICLE
P4818
P4819
P4820
P4821
P4822
P4823
P4824
P4825
P4826
P4827
P4828
P4829
P4830
P4831
Impact of real time 3D-echocardiography in the assessment of right ventricular volumes and function in
patients with pulmonary hypertension.
– I. Fabiani, L.C. Conte, C. Giannini, V. Barletta, L.A. Leo, P.L. Paggiaro, A. Palla, A. Balbarini, M. Marzilli,
V. Di Bello (Pisa, IT)
RV diastolic strain rate changes with age.
– J. Willis, D.X. Augustine, R. Shah, J. Easaw (Bath and Oxford, GB; Penang, MY)
Right ventricular dP/dt in normal subjects: feasibility and normal values.
– E. Spitzer, J. Moreno Uzcategui, N. Campos Jordan, M. Quezada Feijoo, E. Lopez Soberon, L. Dominguez
Perez, J. Guinea Esquerdo, G. Fuertes Ferre, L. Perez De Isla, C. Macaya (Madrid, ES)
Pulmonary artery stiffness and right ventricular function in children at risk for obesity.
– E. Farag, R. Mahfouz, T. Mostafa, I. Hosien (Zagazig, EG)
Non-invasive assessment of right ventricular preload by Doppler echocardiography.
– L. Halmai, T. Farkas, L. Rudas (Szeged, HU)
Impact of untreated obstructive sleep apnea on left and right ventricular myocardial function and effects
of CPAP therapy.
– R. Schueler, M. Wiesen, D. Momcilovic, S. Pabst, G. Nickenig, D. Skowasch, C.H. Hammerstingl (Bonn, DE)
Biomarkers and imaging in early diagnosis of right ventricular dysfunction.
– O. Vittos, B. Toana, A. Vittos, F. Halici, E. Moldoveanu (Bucharest, RO)
Echo derived tricuspid dP/dt as a marker of right ventricular function.
– Y. Singbal, L.T. Huynh, W. Vollbon, S. Ngai, W. Wang, A. Ng, S. Wahi (Brisbane, AU)
Tricuspid annular plane systolic excursion obtained in the right ventricular modified apical four chamber
view shows strong correlation with right ventricular fractional area change.
– S. Ugawa, H. Oe, N. Toh, Y. Kijima, R. Takemoto, N. Watanabe, Y. Tanabe, S. Sano, H. Ito (Okayama, JP)
Right ventricular systolic function is highly dependent on left ventricular dysfunction in patients with
previous myocardial infarction and high plasma brain natriuretic peptide levels.
– K. Konishi, K. Dohi, Y. Sato, E. Sugiura, T. Sawai, H. Nakajima, S. Nakamori, K. Onishi, M. Nakamura,
M. Ito (Tsu, JP)
Clinical and echocardiographic predictors of right ventricular functional changes after acute myocardial
infarction.
– E. Abate, G.E. Hoogslag, M.L. Antoni, G. Nucifora, E.R. Holman, M.J. Schalij, J.J. Bax, V. Delgado,
N. Ajmone Marsan (Leiden, NL)
Comparison of strain measurements with speckle tracking echocardiography and velocity vector imaging
in detection of RV dysfunction in patients with ischemic cardiomyopathy: a validation study with Ca.
– J.H. Park, D.H. Kwon, T.H. Marwick (Cleveland, US)
Right ventricular regional systolic function and dyssynchrony in patients with pulmonary hypertension
evaluated by three-dimensional echocardiography.
– D.H. Kong, X.H. Shu, C.Z. Pan, L.L. Cheng, D.X. Zhou, J.B. Ge (Shanghai, CN)
Evolution of classic parameters and deformation of right ventricular function 1 year after cardiac
transplant.
– E. Gonzalez Lopez, V. Monivas Palomero, S. Mingo Santos, P. Beltran Correas, M. Sanchez Garcia,
I. Garcia Lunar, M.A. Cavero Gibanel, J. Segovia Cubero, M. Gomez Bueno, L.A. Alonso Pulpon (Madrid,
ES)
AORTA AND AORTIC VALVE
A new morphological and quantitative approach of aortic atheroma: a preliminary 3D transesophageal
echocardiography study.
– N. Hammoudi, M. Ihaddaden, L. Boubrit, C. Meuleman, S. Ederhy, P.L. Michel, S. Alamowitch, A. Cohen
(Paris and Boulogne-Billancourt, FR)
Assessment of the valvuloarterial impedance calculated with the use of 3-dimensional transesophageal
echocardiography.
– T. Saitoh, J. Tanaka, A. Furugen, K. Harada, S. Gurudevan, K. Tolstrup, R. Siegel, T. Shiota (Los Angeles,
US)
Transtoracic echocardiography to study the ascending aorta: in search of the best approach.
– J.F. Rodriguez Palomares, G.T. Gisela Teixido, A.L. Ana Laynez, L.G. Laura Gutierrez, T.G. Teresa
Gonzalez-Alujas, S.M. Sergi Moral, A.C. Amelia Carro, A.E. Arturo Evangelista, D.G. David Garcia-Dorado
(Barcelona, ES)
Incremental accuracy of transoesophageal echocardiography over transthoracic approach for description
of functional anatomy of aortic regurgitation.
– I. Mendez Santos, A. Castro, O. Araji, J.M. Barquero, L. Gonzalez Torres, R. Gomez Dominguez, B. Munoz
Calero, J.M. Cruz Fernandez, P. Gallego Garcia De Vinuesa (Seville, ES)
P4832
P4833
P4834
P4835
281
Gender difference in regression of myocardial hypertrophy after aortic valve replacement.
– E. Maruyama, K.H. Hirata, T. Yamano, K. Ishibashi, T. Tanimoto, Y. Ino, T. Yamaguchi, T. Kubo,
T. Imanishi, T. Akasaka (Wakayama, JP)
Age-related increase in aortic stiffness affects longitudinal myocardial function and ventricular-arterial
coupling in both systolic and diastolic phase in normal subjects.
– C. Palombo, M. Kozakova, C. Morizzo, A.G. Fraser (Pisa, IT; Cardiff, GB)
Significant recovery of left ventricular systolic function after transcatheter aortic valve implantation (TAVI)
in aortic stenosis measured by longitudinal 2D strain echo after 1 year.
– G. Baldenhofer, S. Spethmann, H. Dreger, M. Laule, V. Stangl, G. Baumann, K. Stangl, F. Knebel (Berlin,
DE)
Relationship between three-dimensional speckle-tracking echocardiography-derived left ventricular
rotation and twist and aortic stiffness.
– A. Nemes, A. Kalapos, P. Domsik, C. Lengyel, A. Orosz, T. Forster (Szeged, HU)
A novel visualization of aortic arch stiffness using pulse wave tissue doppler imaging: correlation with
complicated aortic plaque.
– K. Kaneko, T. Takahashi, H. Saitou, N. Kiribayashi, K. Omi, T. Sasaki, T. Niizeki, S. Sugawara, I. Kubota
(Sakata and Yamagata, JP)
High-resolution vascular ultrasound imaging for accurate measurement of carotid intima-media
thickness.
– H. Taki, T. Sakamoto, K. Taki, M. Yamakawa, T. Shiina, M. Kudo, T. Sato (Kyoto and Otsu, JP)
Real-time evaluation of the local carotid pulse wave velocity using ultrafast echo imaging in healthy
population.
– M. Pernot, M. Couade, M. Frank, T. Mirault, A. Blanchard, R. Niarra, M. Azizi, J. Emmerich, M. Tanter,
E. Messas (Paris and Aix-en-Provence, FR)
P4836
P4837
P4838
P4839
P4840
P4841
P4842
ATRIAL FIBRILLATION AND ATRIAL FUNCTION
The relation between the CHADS2, CHA2DS2-VASc score and echocardiographic parameters of
thromboembolism in patients with atrial fibrillation.
– M.N. Kim, D.H. Cho, S.A. Kim, Y.H. Kim, J.I. Choi, S.M. Park, S.W. Park, Y.H. Kim, W.J. Shim (Seoul and
Ansan-Si, KR)
Assessment of left atrial deformation and dyssynchrony by three-dimensional speckle tracking imaging:
comparative studies in healthy subjects and patients with atrial fibrillation.
– A. Mochizuki, S. Yuda, Y. Oi, M. Kawamukai, J. Nishida, A. Muranaka, S. Shimoshige, K. Tsuchihashi,
N. Watanabe, T. Miura (Sapporo, JP)
Left atrial dyssynchrony in patients with paroxysmal atrial fibrillation - three-dimensional speckle tracking
analysis.
– A. Furukawa, H. Hoshiba, C. Miyasaka, H. Sato, T. Nagai, E. Tada, K. Kataoka, Y. Seino, K. Ishii (Osaka, JP)
Measurement of left and right atrial volume in patients undergoing ablation for atrial arrhythmias:
comparison of different algorithms of real-time 3D echocardiography.
– H. Mueller, S. Reverdin, H. Burri, D. Shah, R. Lerch (Geneva, CH)
Echocardiographic assessments of left atrial function in patients with chronic primary mitral regurgitation
by two-dimensional speckle tracking.
– Y. Ohara, Y. Fukuoka, I. Tabuchi, S. Sahara, S. Hosogi, M. Nishimoto, K. Yamamoto (Kochi, JP)
Reference values of right atrial area and volume in healthy adults by two-dimensional echocardiography.
– P. Henn, E. Gruenig, A. D’Andrea, M. Claussen, C. Nagel, N. Ehlken, F. Maier, F. Prange, E. Bossone,
C. Fischer (Heidelberg and Grosshansdorf, DE; Naples and Salerno, IT)
Reduced atrial reservoir function in fabry disease using Doppler strain imaging.
– A. Boyd, D. Sillence, K. Devine, M. Tchan, N. Sadick, L. Thomas (Sydney, AU)
Evaluation of left atrial appendage dysfunction by strain imaging using transthoracic echocardiography.
– Y. Lee, M. Nishino, M. Taniike, N. Makino, H. Kato, Y. Egami, R. Shutta, J. Tanouchi, Y. Yamada (Osaka,
JP)
Comparison between two-dimensional and real-time three-dimensional speckle tracking
echocardiography in the assessment of left atrial structure and function.
– Y. Goto, R. Tanaka, K. Ono, T. Watanabe, R. Matsuoka, N. Onishi, T. Noda, S. Watanabe, M. Kasawaki,
S. Minatoguchi (Gifu, JP)
Prolonged atrial electromechanical conduction in hypertrophic cardiomyopathy and cardiac amyloidosis.
– C. Iio, K. Inoue, K. Nishimura, A. Fujii, T. Nagai, J. Suzuki, A. Ogimoto, J. Higaki (Toon, JP)
Left atrium deformation and cardiac resynchronization therapy.
– N. Moreira, F. Soares, R. Teixeira, R. Martins, L. Elvas, N. Ribeiro, M.J. Ferreira, L.A. Providencia (Coimbra,
PT)
The role of 3D echo in accurate measurement of the left atrial appendage size.
– S.Z. Zielke, H. Clausen, J. Newton (Oxford and London, GB)
Evaluation of right atrial dysfunction using 3D echocardiography in patients with pulmonary artery
hypertension.
– K. Sakata, K. Sato, K. Takemoto, T. Minamishima, Y. Uesugi, J. Sueoka, K. Matsushita, M. Kataoka,
T. Sato, H. Yoshino (Tokyo, JP)
Supranormal diastolic function in elite endurance-athletes is related to left atrial geometry and function.
– M. Florescu, O.A. Enescu, D. Mihalcea, R. Mincu, R.C. Rimbas, L.S. Magda, M. Cinteza, D. Vinereanu
(Bucharest, RO)
Dependence of atrial strain and strain rate on ventricular function - implications for the assessment of left
atrial function.
– A.D. Margulescu, E. Rees, R.M. Hocking, D.A. Rees, A.G. Fraser, D. Vinereanu (Bucharest, RO; Cardiff, GB)
282
P4843
P4844
P4845
P4846
P4847
P4848
P4849
P4850
P4851
P4852
P4853
P4854
P4855
P4856
P4857
NEW ULTRASOUND TECHNOLOGY
Detection of pulmonary congestion using the newly-developed pocket-sized transthoracic
echocardiographic imaging device in patients with suspected heart failure.
– H. Oe, R. Takemoto, N. Toh, S. Ugawa, N. Watanabe, Y. Tanabe, S. Nagase, S. Sano, H. Ito (Okayama, JP)
Test accuracy of hand-held echocardiographic imaging.
– C. Prinz, J. Dohrmann, F. Van Buuren, T. Bitter, N. Bogunovic, D. Horstkotte, L. Faber (Bad Oeynhausen,
DE)
Effect of through plane motion for the accuracy of two-dimensional circumferential strain analysis.
– M. Takeuchi, K. Otani, M. Iwataki, H. Kuwaki, K. Kaku, N. Haruki, H. Yoshitani, Y. Otsuji (Kitakyushu, JP)
Diagnostic accuracy and cost-effectiveness of pocket-sized transthoracic echocardiography.
– R. Kitada, S. Fukuda, H. Watanabe, H. Oe, Y. Abe, K. Shimada, M. Yoshiyama, H. Ito, J. Yoshikawa (Sakai,
Osaka, Tokyo, Okayama and Nishinomiya, JP)
Diagnostic accuracy of pocket-size handheld echocardiographs used by cardiologists in the acute care
setting.
– A. Testuz, H. Muller, P.F. Keller, P. Meyer, T. Stampfli, L. Sekoranja, C. Vuille, H. Burri (Geneva, CH)
Inter-vendor variability for measurements of left ventricular strain using two-dimensional speckle tracking
analysis: a substudy of Japanese Ultrasound Speckle Tracking of the Left Ventricle (JUSTICE).
– K. Takigiku, M. Takeuchi, S. Nakatani, C. Izumi, S. Yuda, K. Sakata, N. Ohte, K. Tanabe (Nagano,
Kitakyushu, Osaka, Tenri, Sapporo, Tokyo, Nagoya and Izumo, JP)
Usefulness of automated function imaging to detect myocardial ischemia during dipyridamole stress
echocardiography.
– C. Zito, M. Cusma-Piccione, S. Tripepi, M. Mohammad, G. Di Bella, G. Oreto, P. Crea, A. Madaffari,
G. Falanga, S. Carerj (Messina, IT)
Changes in left ventricular strain during exercise stress echocardiography in healthy subjects: a speckle
tracking echocardiography study.
– M. Cameli, F.M. Righini, M. Lisi, S. Benincasa, S. Mondillo (Siena, IT)
P4858
P4859
P4860
P4861
P4862
P4863
P4864
P4865
CARDIOMYOPATHIES: GENETICS
P4866
P4867
P4868
P4869
P4870
P4871
P4872
Hypertrophic cardiomyopathy in Iceland: MYBPC3 founder mutation?
– B. Adalsteinsdottir, P. Teekakirikul, J.G. Seidman, C.E. Seidman, B.J. Maron, R. Danielsen,
G.T. Gunnarsson (Reykjavik, IS; Boston and Minneapolis, US)
Cause of cardiomyopathy in muscular dystrophy: genetically caused structural weakness vs. acquired
myocarditis? Answers based on a siblings study.
– H. Yildiz, E. Tanay, S. Roesch, U. Sechtem, A. Yilmaz (Stuttgart, DE)
Phenotype-genotype correlation in patients with mutations in the beta-myosin converter domain.
– D.A. Garcia-Giustiniani, X. Fernandez, M. Ortiz-Genga, R. Barriales-Villa, A. Mazzanti, I. Rodriguez,
L. Cazon, M. Perez-Barbeito, E. Maneiro, L. Monserrat-Iglesias (A Coruña, ES)
Is the gene MYOM2 encoding myomesin 2 involved in the pathogenesis of hypertrophic cardiomyopathy?
– A. Perrot, A. Barton, B. Kherad, L.H. Boldt, W. Haverkamp, S. Rickert-Sperling (Berlin, DE)
Unravelling mutation effects from secondary adaptations in cardiomyocytes of Familial Hypertrophic
Cardiomyopathy patients.
– T. Kraft, E.R. Paalberends, N.M. Boontje, S. Tripathi, J. Montag, A. Francino, F. Navarro-Lopez, B. Brenner,
G.J.M. Stienen, J. Van Der Velden (Hannover, DE; Amsterdam, NL; Barcelona, ES)
Lamin A/C mutation is independently associated with an increased risk of arterial and venous
thromboembolic complications.
– I.A.W. Van Rijsingen, A.J. Van Der Kooi, J.P. Van Tintelen, M.P. Van Den Berg, I. Christiaans, A.A.M. Wilde,
J.C.M. Meijers, R. Nieuwland, Y.M. Pinto, S.J. Pinto-Sietsma (Amsterdam and Groningen, NL)
New genetic determinants of disease phenotype in hypertrophic cardiomyopathy: high-throughput
sequencing reveals unexpected complexicity.
– L. Rocha Lopes, P. Syrris, M. Hubank, C. Giambartolomei, A. Zekavati, C. Dalageorgou, S. Jenkins,
V. Plagnol, P.M. Elliott (London, GB)
Missense mutations in titin-associated proteins identified in patients with dilated cardiomyopathy.
– V. Ruppert, T. Meyer, S. Ackermann, A. Perrot, M. Posch, A. Richter, B. Maisch, S. Pankuweit (Marburg,
Göttingen and Berlin, DE)
Tei index, a useful indicator for right ventricular involvement in fabry disease.
– H.A.C.M. Bruin De- Bon, B.E. Smid, B.J. Bouma, R.B.A. Van Der Brink, H.M. Eckmann, D.A. Samson,
J. Vleugels, C.E. Hollak (Amsterdam, NL)
Role of serum NT-proBNP measurement in the diagnosis of early cardiac involvement in patients with
anderson-fabry disease.
– C.J. Coats, V. Paresi, M. Ramos, K. Janagarajan, C. O’Mahony, A. Dawnay, A. Mehta, D. Hughes,
P.M. Elliott (London, GB)
Advanced left heart disease in cystic fibrosis: a distinct form of cardiomyopathy.
– L. Ruiz Bautista, J. Segovia, C. Salas, C. Prados, L. Maiz, R. Giron, M.T. Martinez, S. Mingo, J. Mirelis,
L.A. Alonso Pulpon (Madrid, ES)
Cardiac autonomic nervous system dysfunction in a cardiomyopathy mouse experimental model.
– N. Athanasiadis, M. Mavroidis, M. Katsiboulas, S. Nikolopoulos, I. Kostavassili, C. Dimitriou, Y. Capetanaki,
C.H. Davos (Athens, GR)
P4873
P4874
P4875
P4876
P4877
283
MYOCARDITIS
Left ventricular mechanics in acute myocarditis Correlation of 2D speckle tracking deformation and
rotation imaging with troponin release and cardiac magnetic resonance findings.
– E. Nyktari, A. Patrianakos, E. Zacharis, G. Solidakis, F. Parthenakis, P.E. Vardas (Heraklion, GR)
Adiponectin promotes coxsackievirus B3 myocarditis by controlling viral infection within the heart.
– A. Jenke, J. Stehr, S. Wilk, A. Weithaeuser, K. Klingel, H.P. Schultheiss, C. Scheibenbogen, C. Skurk (Berlin
and Tübingen, DE)
Clinical presenting patterns and CMR features of acute myocarditis predicting outcome.
– O.E. Rimoldi, D. Lanza, P. Pedrotti, A. Milazzo, S. Pedretti, A. Roghi (Milan and Verona, IT)
In vivo delivery of adenoviral vector containing interleukin-17 receptor A reduces cardiac remodeling and
improves myocardial function in CVB-3 -induced chronic myocarditis.
– R. Chen, Y.Q. Xie, P. Chen, X. Zhang, M.H. Li, X.G. Wang, T.Q. Peng, Y.Z. Zou, H.Z. Chen, J.B. Ge
(Shanghai, CN; Baltimore, US; London, CA)
Relationship between cardiac magnetic resonance criteria for acute myocarditis and biomarkers of
inflammation and myocardial damage.
– G. Nucifora, A. Di Chiara, D. Miani, G. Piccoli, M. Puppato, G. Slavich, D. Gasparini, A. Proclemer (Udine
and Tolmezzo, IT)
Immunoglobulin suppressed autoimmune myocarditis in severe combined immunodeficient (SCID) mice
by inducing T cell unresponsiveness.
– C. Kishimoto, K. Shioji, Z. Yuan (Kyoto, JP; Xi’an, CN)
Injectable collagen implant improves survival and early cardiac remodeling after fulminant myocarditis in
rat.
– S. Rinkevich-Shop, N. Landa-Rouben, R. Holbova, F.H. Epstein, T. Ben Mordechai, M.S. Feinberg,
O. Goitein, T. Kushnir, E. Konen, J. Leor (Tel Hashomer, IL; University of Virginia, US)
Matrix Metalloproteinase-13 is beneficial in viral myocarditis not only by preventing cardiac inflammation
but also reducing cardiac inflammation due to regulating chemokines.
– D. Westermann, D. Lindner, H.P. Schultheiss, C. Tschoepe (Berlin, DE)
No evidence of adenoviral genome in endomyocardial biopsy specimens in patients with new-onset
unexplained dilated cardiomyopathy.
– T. Palecek, P. Kuchynka, E. Nemecek, J. Horak, T. Kovarnik, I. Vitkova, A. Linhart (Prague, CZ)
Clinical, ECG and echocardiographic criteria are insufficient to reach a definite diagnosis in patients with
myocardial injury and normal coronary angiogram: insights from magnetic resonance-based.
– E. Perez-David, R. Colina, R. Yotti, M. Sanchez Alegre, J. Alarcon, J. De La Torre, A. Gonzalez Mansilla,
J. Bermejo, F. Fernandez Aviles (Madrid, ES)
Olmesartan, an angiotensin II type 1 receptor antagonist, suppresses cytotoxic myocardial injury in
autoimmune heart failure.
– C. Kishimoto, K. Shimada, Z. Yuan (Kyoto, JP; Xi’an, CN)
Secretome from mononuclear cells confers immunosuppression in a murine autoimmune myocarditis
model.
– K. Hoetzenecker, M. Zimmermann, T. Schweiger, D. Kollmann, M. Mildner, A. Mitterbauer, P. Birner,
M. Lichtenauer, H. Ankersmit (Vienna, AT)
Etanrecept treatment improves acute chagas disease outcome but alters cardiac conduction and
repolarization parameters.
– H.O. Rodriguez Angulo, E.J. Castillo, E.J. Cardenas, J.A. Marques, A.J. Mijares (Caracas and Barquisimeto,
VE)
Diagnostic and prognostic value of biomarkers in suspected myocarditis.
– C. Ukena, F. Mahfoud, M. Kindermann, J. Poess, P. Lepper, R. Kandolf, M. Böhm, I. Kindermann
(Homburg, Saarbrücken and Tübingen, DE)
P4878
P4879
P4880
P4881
P4882
P4883
P4884
P4885
P4886
P4887
P4888
P4889
P4890
P4891
MYOCARDIAL INVOLVEMENT IN SYSTEMIC DISEASES
Measurement of interatrial dyssynchrony using tissue doppler imaging predicts functional capacity and
cardiac involvement in systemic sclerosis.
– J.-C. Eicher, S. Berthier, J.-L. Philip, B. Lorcerie, B. Bernard, J.-E. Wolf (Dijon, FR)
Myocardial mechanics for the early detection of cardiac sarcoidosis.
– C. Aggeli, I. Felekos, E. Gialafos, E. Poulidakis, A. Katsaros, E. Venieri, A. Rapti, C. Stefanadis (Athens, GR)
Echocardiographic abnormalinies and their relation to exercise capacity in young unselected survivors of
Hodgkin’s lymphoma late after mediastinal irradiation.
– M.G. Poltavskaya, Y.V. Avdeev, I.V. Kuprina, S.B. Shornikov, A.L. Syrkin (Moscow, RU)
Prevalence of cardiomyopathy in an unselected population of adult patients with cystic fibrosis.
– L. Ruiz Bautista, J. Segovia, C. Prados, L. Maiz, R. Giron, M.T. Martinez, M. Gonzalez Estecha, S. Mingo,
M. Pastrana, L.A. Alonso Pulpon (Madrid, ES)
Adult patients with growth hormone deficiency have subclinical and related biventricular longitudinal
dysfunction due to intrinsic myocardial disease.
– S. Mihaila, R.C. Rimbas, R. Mincu, N. Patrascu, R.E. Dulgheru, R. Dragoi, R. Mihaila, C. Badiu,
D. Vinereanu (Bucharest, RO)
Impaired vascular elasticity and diastolic dysfunction in pseudoxanthoma elasticum.
– L. Campens, O. Vanakker, B. Trachet, P. Segers, A. De Paepe, J. De Backer (Ghent, BE)
Differential effect of antiretroviral drug regimens on aortic elastic properties in HIV infected individuals.
– A. Synodinos, C. Vlachopoulos, P. Xaplanteris, H. Sambatakou, E. Mariolis, N. Ioakeimidis,
D. Terentes-Printzios, D. Pektasidis, C. Stefanadis (Athens, GR)
Study of heart involvement in kawasaki disease: a multicenter study.
– Z.M. Amirimoghadam (Tehran, IR)
284
P4892
P4893
P4894
P4895
P4896
P4897
P4898
P4899
PULMONARY HYPERTENSION IMAGING
Right ventricular 2D-strain: a new tool to follow up pulmonary hypertension patients under vasodilator
therapy.
– I. Garcia Lunar, S. Mingo, V. Monivas, C. Mitroi, M.A. Cavero, E. Gonzalez Lopez, M. Sanchez Garcia,
M. Gomez Bueno, J. Segovia, L. Alonso Pulpon (Madrid, ES)
Right ventricular remodeling in idiopathic pulmonary arterial hypertension with three-dimensional
echocardiography and cardiac magnetic resonance. follow up within 2 years.
– J. Grapsa, I.Z. Cabrita, D. Dawson, D. O’Regan, G. Durighel, L.S.G.E. Howard, J.S.R. Gibbs,
P. Nihoyannopoulos (London, GB)
Echocardiographic prognostic factors for mortality in pulmonary hypertension: way beyond tricuspid
annular displacement.
– I. Garcia Lunar, S. Mingo, V. Monivas, C. Mitroi, D. Garcia Cosio, J. Gonzalez Mirelis, M.A. Cavero,
M. Gomez Bueno, J. Segovia, L. Alonso Pulpon (Madrid, ES)
Echocardiography of pulmonary vascular function in asymptomatic carriers of the bone morphogenetic
protein receptor type 2 mutation.
– A.T. Pavelescu, R. Vanderpool, J.L. Vachiery, E. Grunig, R. Naeije (Brussels, BE; Heidelberg, DE)
Survival in pre-capillary pulmonary hypertension: does echocardiography make the difference?
– J. Grapsa, L.S.G.E. Howard, B.V. North, D. Dawson, M.F. Bellamy, J.S.R. Gibbs, P. Nihoyannopoulos
(London, GB)
Improving echocardiography estimation of right atrial pressure: comparison among several models and a
new one based on right atrial evaluation.
– C. Magnino, P. Omede, W. Grosso Marra, M. Chiarlo, D. Presutti, C. Bucca, C. Moretti, F. Gaita, F. Veglio,
A. Milan (Turin, IT)
An echocardiographic score for evaluating the pre-test probability of having a pre-capillary rather than a
post-capillary pulmonary hypertension.
– M. D’Alto, E. Romeo, P. Argiento, A. Correra, B. Sarubbi, N. Grimaldi, M. Pignatiello, A. Caronna,
R. Calabro’, M.G. Russo (Naples, IT)
Pulmonary artery trunk dilation in symptomatic subjects referred for coronary artery calcium scoring by
means of a 64-raw cardiac computed tomography.
– M. Sosnowski, A. Czekaj, B. Korzeniowska, R. Mlynarski, Z. Gasior, M. Tendera (Katowice, PL)
Pulmonary vasculopathy assessed by intravascular ultrasound in patients with severe chronic respiratory
failure evaluated for lung transplantation: comparation to pulmonary arterial hypertension.
– E. Domingo Ribas, C.H. Arredondo Flores, N. Bouteldja, M. Vazquez, B. Garcia Del Blanco, M.L. Lopez,
A. Roman Broto (Barcelona, ES)
P4900
P4901
P4902
P4903
P4904
P4905
P4906
P4907
P4908
PULMONARY HYPERTENSION: MECHANISMS
P4909
P4910
P4911
P4912
P4913
Egr-1 expression is specific for neointimal development in both human and experimental PAH.
– M.G. Dickinson, B. Bartelds, M.A.J. Borgdorff, G. Molema, J. Sietsma, R.M.F. Berger (Groningen, NL)
A female model of severe neointimal pulmonary hypertension: evidence for increased susceptibility in a
female rat following pneumonectomy and monocrotaline?
– R.J. White, D.F. Meoli, D. Haight, W. O’Dell, F. Ahmaad (Rochester, Gainesville and Pittsburgh, US)
Increased pulmonary blood flow causes perivascular macrophage infiltration in experimental PAH.
– M.G. Dickinson, B. Bartelds, M.A.J. Borgdorff, R.M.F. Berger (Groningen, NL)
Nitrated fatty acids attenuate right ventricular dysfunction in hypoxia-induced pulmonary hypertension in
mice.
– T.K. Rudolph, A. Klinke, A. Moeller, T. Ravekes, K. Friedrichs, S. Blankenberg, V. Rudolph, S. Baldus
(Hamburg, DE)
Right ventricular hypertrophy and failure abolish cardioprotection by ischemic preconditioning.
– A. Andersen, J.A. Povlsen, H.E. Boetker, J.E. Nielsen-Kudsk (Aarhus, DK)
POPULATIONS GENETICS
New single nucleotide polymorphisms associated with altered platelet response to acetylsalicylic acid in
diabetic population: genome-wide association approach and pooled DNA strategy.
– M. Postula, P.K. Janicki, M. Rosiak, A. Kaplon-Cieslicka, K.J. Flipiak, D.A. Kosior, G. Opolski (Warsawa and
Warsaw, PL; Hershey, US)
Impact of clinical and genetic factors on acenocoumarol dose requirements in Polish patients - dose
calculation algorithm.
– J. Wolkanin-Bartnik, H. Pogorzelska, M. Szperl, A. Bartnik (Warsaw, PL; London, GB)
Low-frequency intermediate penetrance variants in the ROCK1 gene predispose to congenital heart
disease.
– J. Palomino Doza, A. Topf, J. Bentham, S. Bhattacharya, C. Cosgrove, J. Granados-Riveron, J. Goodship,
D. Henderson, J. O’Sullivan, B.D. Keavney (Valladolid, ES; Newcastle-upon-Tyne, Oxford and Nottingham,
GB)
Influence of genetic polymorphisms of alpha-adrenergic receptors, endothelial nitric oxide synthase and
bradykinin receptor B2 on treadmill exercise test responses.
– R.A. Belo Nunes, L.P. Barroso, R.T. Schmidt, D.D. Barreto, H.F. Freitas, A.C. Pereira, J.E. Krieger,
A.J. Mansur (São Paulo, BR)
Association between a genetic variant near adrenomedullin gene with left ventricular mass index.
– F. Beygui, P.S. Wild, T. Zeller, R. Castagne, T. Munzel, G. Montalescot, D.A. Tregouet, F. Cambien, L. Tiret,
S. Blankenberg (Paris, FR; Mainz and Hamburg, DE)
P4914
P4915
P4916
P4917
P4918
285
Systematic testing of literature reported genetic variation associated with restenosis after percutaneous
coronary intervention: results of the genetic determinants of restenosis study.
– J.J.W. Verschuren, S. Trompet, I. Postmus, M.L. Sampietro, B.T. Heijmans, J.J. Houwing-Duistermaat,
E.P. Slagboom, J.W. Jukema (Leiden, NL)
Chromosome 9p21.3 effect on CDKN2A/2B expression in human coronary atherosclerosis.
– F. Notarangelo, N. Marziliano, L. Foco, R. Giacalone, C. Tardio, L. Coppini, F. Bontardelli, C. Berzuini,
P.A. Merlini, D. Ardissino (Parma, Milan and Pavia, IT; Cambridge, GB)
Gene expression profiling in patients with myocardial infarction at young age.
– T. Zeller, C. Mueller, M.O. Scheinhardt, A. Schillert, R.B. Schnabel, P.S. Wild, K.J. Lackner, T. Munzel,
A. Ziegler, S. Blankenberg (Hamburg, Lübeck and Mainz, DE)
Synergistic effects of genetic variants of the apolipoprotein A-V gene and the butyrophilin, subfamily 2,
member A1 gene on dyslipidemia in east Asian populations.
– M. Oguri, Y. Shibata, H. Kamiya, M. Hiramatsu, H. Horibe, K. Kato, T. Murohara, J.H. Lee, Y. Jang,
Y. Yamada (Nagoya, Tajimi and Tsu, JP; Seoul, KR)
Genetic and non-genetic correlates of plasma MRproAdrenomedullin levels.
– F. Beygui, P.S. Wild, T. Zeller, R. Castagne, T. Munzel, G. Montalescot, D.A. Tregouet, F. Cambien,
S. Blankenberg, L. Tiret (Paris, FR; Mainz, DE)
Genetic polymorphisms of CYP2C19 and effect of CYP2C19*2 allele on clopidogrel P2Y12 inhibition in
healthy Malaysian volunteers.
– Y.N. Sani, S.C. Lim, L.H. Lim, N.E.Y. Edwin, N. Abdul Karim Khan, T.H. Goh, V.L. Serebruany, K.H. Yuen
(Penang, MY; Towson, US)
Matrix metalloproteinase; investigation from gene to protein as effective factor in myocardial infarction.
– A.S. Tabatabaei Panah, R. Akbarzadeh Najar, S.M.H. Ghaderian (Tehran, IR)
Blood pressure and renal function in relation to A-173G polymorphism of the epithelial sodium channel
gamma subunit (SCNN1G) on longitudinal observation in general population.
– K. Stolarz-Skrzypek, A. Olszanecka, W. Wojciechowska, D. Czarnecka, K. Kawecka-Jaszcz (Krakow, PL)
The CC variant (rs 1333049) of 9p21 influences the development of acute coronary disease, but not the
stable angina and doesn’t imply worst coronary morphology.
– R. Palma Dos Reis, M. Mendonca, B. Silva, A. Pereira, S. Gomes, H. Cafe, S. Freitas, G. Guerra, A. Brehm,
J.J. Araujo (Lisbon and Funchal, PT)
Influence of rs5065 atrial natriuretic peptide gene variant on Coronary Artery Disease.
– E. Barbato, S.A. Sciarretta, J. Bartunek, F. Mangiacapra, D. Lambrechts, P. Sinnaeve, F. Van De Werf,
K.A.A. Fox, M. Volpe, S.A. Rubattu (Aalst and Leuven, BE; Rome and Pozzilli, IT; Edinburgh, GB)
Coronary artery disease risk polymorphisms in Latvian patients and population controls.
– R. Peculis, G. Latkovskis, I. Kalnina, A. Erglis, J. Klovins (Riga, LV)
P4919
P4920
P4921
P4922
P4923
P4924
P4925
P4926
P4927
P4928
P4929
GENETICS AND GENE THERAPY
Cost-effectiveness of genetic studies in inherited cardiomyopathies.
– M. Sabater, J.R. Gimeno, F. Ruiz-Espejo, E. Garcia-Molina, M.J. Oliva, P. Pascual, I. Gomez, I. Perez,
I. Tovar, M. Valdes (Murcia, ES)
Secretoneurin gene therapy reverses the impairment of hindlimb post-ischemic recovery in Apo E -/mice.
– M. Theurl, K. Albrecht-Schgoer, W. Schgoer, I. Tancevski, R. Kirchmair (Innsbruck, AT)
Early AAV9-mediated over-expression of S100A1 ameliorates myocardial hypertrophy in
dystrophin-deficient mice.
– R. Bauer, H. Enns, C. Volz, P. Most, H.A. Katus, O.J. Mueller (Heidelberg, DE)
Adenovirus-Mediated gene transfer of a luciferase reporter gene by a cardiac-specific promoter through
direct injection into the left ventricular wall.
– Z. Xu, Z.X.T. Tao, Z.J.Y. Yang (Nanjing, CN)
Post-infarct treatment with microRNA145 reduces myocardia infarct size and improves cardiac
remodeling and function in rabbits.
– K. Higashi, Y. Yamada, E. Horibe, K. Nishigaki, G. Takemura, Y. Akao, S. Minatoguchi (Gifu and Takayama,
JP)
Identification of AAV6 as most efficient vector for transvascular gene transfer into porcine myocardium
based on an in vitro model for prediction of the cardiac gene transfer performance.
– J. Ksienzyk, P. Raake, S. Schlegel, H.A. Katus, O.J. Mueller (Heidelberg, DE)
R14Del, a Dutch phospholamban mutation in Spanish family. Genotype-phenotype aspects.
– I. Gomez Milanes, E. Garcia-Molina, M. Sabater-Molina, I. Perez, J.M. Ayala, F. Ruiz-Espejo, D. Lopez
Cuenca, P. Martinez, J.R. Gimeno, M. Valdes (Murcia, ES)
Penetrance study in SCN5A-mutations in brugada syndrome.
– E. Garcia-Molina, J. Lacunza, M. Sabater, P. Pascual, I. Gomez, D. Lopez-Cuenca, F. Ruiz-Espejo,
J. Gimeno, I. Tovar, M. Valdes (Murcia, ES)
Age-related penetrance in genetic carriers of hypertrophic cardiomyopathy.
– I. Perez, A. Romero-Puche, M. Sabater-Molina, E. Garcia-Molina, I. Gomez-Milanes, D. Lopez-Cuenca,
F. Ruiz-Espejo, J.R. Gimeno Jr, M. Valdes M (Murcia, ES)
Association of a matrix metallopeptidase 1 gene polymorphism with long-term outcome of thoracic aortic
aneurysm.
– K. Kato, N. Inagaki, T. Fujimaki, M. Oguri, T. Hibino, K. Yokoi, T. Murohara, Y. Yamada (Tsu, Tajimi, Inabe
and Nagoya, JP)
286
P4930
P4931
P4932
P4933
P4934
P4935
P4936
P4937
P4938
P4939
METABOLISM AND METABOLIC SYNDROME
P4940
P4941
P4942
P4943
P4944
P4945
P4946
P4947
P4948
P4949
P4950
P4951
P4952
P4953
P4954
P4955
NO from neuronal NO synthase increases after beta-adrenergic stimulation but does not control
mitochondrial respiration.
– S. Bergem, M. Kohlhaas, A. Nickel, M. Meiser, M. Hohl, R. Carnicer, U. Laufs, M. Böhm, B. Casadei,
C. Maack (Homburg/Saar, DE; Oxford, GB)
The onset of type 2 diabetes protects the heart against ischaemia-reperfusion injury by shutdown of
mitochondrial metabolism during early reperfusion.
– J.A. Povlsen, B. Lofgren, C. Dalgas, R.D. Birkler, M. Johannsen, N.B. Stoettrup, H.E. Botker (Aarhus, DK)
Obesity and metabolic syndrome aggravates myocardial diastolic dysfunction in obese spontaneously
hypertensive rat.
– D. Linz, M. Hohl, F. Mafhoud, J.S. Reil, W. Linz, T. Huebschle, H.P. Juretschke, C. Neumann-Haefelin,
H. Ruetten, M. Böhm (Homburg and Frankfurt/Main, DE)
Subclinical hyperthyroidism and cardiovascular mortality.
– C. Selmer, J.B. Olesen, J.C. Madsen, U. Schmidt, J. Faber, P.R. Hansen, O.D. Pedersen, M.L. Hansen,
C. Torp-Pedersen (Hellerup, Copenhagen, Herlev and Roskilde, DK)
Endothelial Microparticles derived under high Glucose concentrations increase monocyte adhesion on
endothelial cells through upregulation of adhesion proteins in a p38 dependent way.
– X. Yang, F. Jansen, B. Franklin, T. Schmitz, H. Slomka, G. Nickenig, N. Werner (Bonn, DE)
Effects of combined genotypes for polymorphisms of the apolipoprotein A-V gene and the butyrophilin,
subfamily 2, member A1 gene on metabolic syndrome in east Asian populations.
– M. Oguri, Y. Shibata, H. Kamiya, M. Hiramatsu, T. Fujimaki, K. Kato, T. Murohara, J.H. Lee, Y. Jang,
Y. Yamada (Nagoya, Inabe and Tsu, JP; Seoul, KR)
Clinical and prognostical implication of advanced glycation in acute coronary syndromes.
– S. Raposeiras Roubin, B.K. Rodino Kostka, B. Paradela Dobarro, L. Grigorian Shamagian, J.M. Garcia
Acuna, P. Aguiar Souto, M. Jacquet Hervet, M.V. Reino Maceiras, E. Alvarez Castro,
J.R. Gonzalez-Juanatey (Santiago de Compostela and Vigo, ES)
Acute cardiac ryanodine receptor loss-of-function leads to bradycardia, arrhythmia, heart failure and
transcriptional metabolic reprogramming.
– M.J. Bround, R. Wambolt, P. Asghari, D.S. Luciani, F. Taghizadeh, J. Kulpa, K.R. Boheler, E.D.W. Moore,
M.F. Allard, J.D. Johnson (Vancouver, CA; Baltimore, US)
Genetic deficiency of corticotropin releasing hormone influences cardiac function through fatty acid
metabolism.
– T. Tzanavari, A. Varela, S. Theocharis, C. Pantos, D. Cokkinos, K.P. Karalis (Athens, GR)
CD40L deficiency ameliorates diet-induced adipose tissue inflammation, but does not protect from insulin
resistance and hepatic steatosis in mice.
– D. Wolf, F. Jehle, P. Stachon, F. Willecke, C. Bode, K. Peter, A. Zirlik (Freiburg, DE; Melbourne, AU)
Stress-induced adipose inflammation promotes a procoagulant state and impairs insulin sensitivity by
adipocyte-derived monocyte chemoattractant protein-1.
– Y. Uchida, K. Takeshita, R. Kikuchi, T. Murohara (Nagoya, JP)
Chronic consumption of reheated vegetable oils increases cardiometabolic risk factors.
– O. Perez-Mendez, Y. Komera-Arenas, R. Bautista-Perez, A. Aranda-Fraustro, J. Vargas-Barron, M. Franco
(Mexico City, MX)
Significant association of the CYP27A1 polymorphism with adipocytokines, cholesterol profiles and
metabolic syndrome in middle-aged male.
– K.-H. Cheng, C.-C. Liu, C.-N. Huang, Y.-C. Lee, C.-S. Chu, E. Hsi, W.-T. Lai, S.-P. Huang (Kaohsiung, TW)
The heme oxygenase system reduces pericardial adiposity and improves diabetic cardiomyopathy in
zucker diabetic fatty rats.
– J.F. Ndisang (Saskatoon, CA)
Synergistic effect of human immunodeficiency virus and the metabolic syndrome on arterial stiffness.
– M. Asaad, O.J. Rider, N. Ntusi, R. Banerjee, G. Hancock, G. Clutton, E. Wainwright, L. Dorrell, K. Clarke,
C. Holloway (Oxford, GB)
The metabolic syndrome significantly affects the association between resting heart rate and all cause as
well as cardiovascular mortality.
– A. Vonbank, F. Schmid, P. Rein, C.H. Saely, H. Drexel (Fedlkirch, AT; St. Gallen, CH; Philadelphia, US)
Increased expression of tissue factor in intra-abdominal adipose tissue in a metabolic syndrome model: a
new link between metabolic syndrome and atherosclerosis?
– L. Pasquesoone, D. Corseaux, A. Elkalioubie, B. Joke, A. Ung, N. Grossin, C. Banfi, B. Jude, S. Susen,
E. Van Belle (Lille, FR)
Exercise affects insulin sensitivity in HCR and LCR-rats differentially.
– M. Schwarzer, A. Molis, A. Schrepper, T. Doenst (Jena, DE)
Multi compartment body composition analysis in chronic heart failure: air displacement plethysmography,
body impedance analysis, dual-x-ray-absorptiometry, and 3d-white light scan analysis.
– T.D. Trippel, A. Stahn, V. Tscholl, S. Inkrot, W. Doehner, S. Von Haehling, E. Tahirovic, W. Haverkamp,
H.D. Duengen, D. Obradovic (Berlin, DE)
Early-induced overweight causes rapid changes in heart genomic expression and long-term
cardiovascular, metabolic and oxidative alteration.
– A. Habbout, J. Lorin, E. Rigal, C. Fassot, L. Rochette, C. Vergely (Dijon and Angers, FR)
Longitudinal study of Advanced Glycation End product plasma levels in patients undergoing coronary
artery bypass grafting surgery: effects of statin treatment, gender and type-2 diabetes.
– V. Salpeas, J.N. Tsoporis, G. Proteau, S. Izhar, E. Sakadakis, T.G. Parker, I.A. Rizos, M. Anastasiou-Nana
(Athens, GR; Toronto, CA)
Increased expression of miRNA-223 during early reperfusion with ischemic postconditioning in pigs.
– T. Baars, A. Skyschally, G. Heusch, P. Kleinbongard (Essen, DE)
P4956
P4957
P4958
P4959
P4960
P4961 (W)
287
FULL APPRAISAL OF GLYCEMIC RISK
The DPP-IV inhibitor sitagliptin improves beta-cell function in patients with acute coronary syndromes
and newly diagnosed glucose abnormalities.
– C. Hage, K.B. Brismar, S.E. Efendic, P.L. Lundman, L.R. Ryden, L.G.M. Mellbin (Stockholm, SE)
Detection of subclinical left ventricular dysfunction in asymptomatic young adults with type-2 diabetes: a
cardiac magnetic resonance study.
– J.N. Khan, E. Wilmot, M. Davies, T. Gorely, K. Khunti, M. Leggate, M. Nimmo, A. Singh, T. Yates,
G.P. Mccann (Leicester and Loughborough, GB)
National cardiovascular risk assessment in type 2 diabetes in China.
– D.A.Y.I. Hu, L.N. Ji, C.S. Ma, Y. Huo, C.Y. Pan, G.W. Li, H.J. Zhuo, D. Zhang (Beijing and Shanghai, CN)
Heart rate variability, postprandial responses of glucose and insulin and beta-cell function: the NEO
study.
– S. Hillebrand, K.B. Gast, C.A. Swenne, J.W. Jukema, J.W.A. Smit, F.R. Rosendaal, M. Den Heijer, R. De
Mutsert (Leiden and Amsterdam, NL)
Diabetes is related to higher central blood pressure.
– D. Debicka-Dabrowska, P. Jankowski, M. Kloch-Badelek, J. Wilinski, M. Brzozowska-Kiszka,
K. Kawecka-Jaszcz, D. Czarnecka (Krakow, PL)
Omentin-1concentrations predict 10-year incidence of diabetes in Thai: the EGAT study, 1998-2008.
– D. Warodomwichit, W. Chaiyaratana, N. Thongmuang, M. Vanichapuntu, P. Sritara (Bangkok, TH)
Impaired glucose homeostasis in non-diabetic hypertensives with family history of diabetes.
– C. Liakos, G. Vyssoulis, E. Karpanou, A. Michaelides, C. Stefanadis (Athens, GR)
Current smoking and prediabetes in young and healthy adults.
– S. Aeschbacher, T. Schoen, M. Risch, L. Risch, D. Conen (Basel, CH; Schaan, LI)
Membrane type 1-matrix metalloproteinase correlates with the coronary plaque stability in patients with
postprandial hyperglycemia.
– H. Uzui, M. Yamamoto, A. Nakano, Y. Mitsuke, T. Geshi, N. Amaya, K. Ishida, T. Morishita, Y. Fukuoka,
J.D. Lee (Fukui, JP)
Prognostic impact of concurrence of metabolic syndrome and chronic kidney disease in patients
undergoing coronary intervention; involvement of coronary plaque morphology.
– A. Kunimura, T. Amano, K. Kitagwa, Y. Shimbo, H. Ando, K. Harada, T. Yoshida, T. Uetani, T. Matsubara,
A dipeptidyl peptidase-4 inhibitor, alogliptin, improves postprandial triglycemia and postprandial
endothelial dysfunction.
– Y. Noda, T. Miyoshi, H. Oe, Y. Ohno, K. Nakamura, H. Morita, K. Kohno, T. Toh, K. Kusano, H. Ito
(Okayama, JP)
7-year reduction of exercise max heart rate predicts new onset diabetes.
– K. Engeseth, P.T. Skretteberg, I. Grundvold, K. Liestoel, G. Erikssen, J. Erikssen, S.E. Kjeldsen,
J. Bodegard (Oslo, NO)
Metabolic syndrome in the Czech population. Current status and trends.
– J. Bruthans, R. Cifkova, Z. Skodova, Z. Adamkova, M. Jozifova, P. Wohlfarth, M. Galovcova, V. Lanska
(Prague, CZ)
Autonomic neuropathy is independently associated with new heart failure and atrial fibrillation in diabetic
patients with preserved ejection fraction: prognostic significance of heart rate recovery.
– K. Negishi, S. Seicean, T. Negishi, T. Yingchoncharoen, C. Gibby, T. Marwick (Cleveland, US)
Tight glycemic control after cardiac surgery reduces the incidence of post-surgical atrial fibrillation
regardless of existence of diabetes mellitus.
– A. Yoshida, H. Adachi, J. Tomono, N. Koike, S. Oshima (Maebashi, JP)
Low levels of IgM antibodies against phosphorylcholine are not associated with glucometabolic
disturbances in patients with acute ST-elevation myocardial infarction.
– E.C. Knudsen, I. Seljeflot, C. Muller, G.O. Andersen (Oslo, NO)
Chemerin is associated with the metabolic syndrome but is not linked to angiographically determined
– C.H. Saely, A. Muendlein, A. Vonbank, K. Geiger, P. Rein, H. Drexel (St. Gallen, CH; Feldkirch and
Fedlkirch, AT; Triesen, LI; Philadelphia, US)
The J-shaped relationship between coffee consumption and prevalence of diabetes mellitus in elderly
individuals. Ikaria study.
– C. Chrysohoou, C. Masoura, G. Vogiatzi, S. Lagoudakou, S. Kyvelou, N. Galiatsatos, E. Zoulia,
S. Mamatas, C. Pitsavos, C. Stefanadis (Athens, GR)
Comparable effects of pioglitazone and perindopril on circulating endothelial progenitor cells,
inflammatory process and oxidative stress in patients with diabetes mellitus.
– A.M. Kampoli, D. Tousoulis, N. Papageorgiou, Z. Pallantza, G. Paterakis, A. Miliou, G. Roulia,
E. Androulakis, C. Antoniades, C. Stefanadis (Athens, GR)
Copeptin and adrenomedullin in a large cohort of catheterisation laboratory patients with newly detected
diabetes or impaired glucose tolerance: the Silent Diabetes Study.
– R. Doerr, J. Stumpf, S.G. Spitzer, B. Krosse, S. Kusche, T. Lohmann, O. Hartmann, N. Morgenthaler,
D. Tschoepe, O. Schnell (Dresden, Hennigsdorf, Bad Oeynhausen and Munich, DE)
Impact of exercise training on waist circumference, glucose metabolism and endothelial function in
pre-diabetic, adipose patients with severe coronary heart disease.
– E.B. Beck, F.J. Woitek, S. Erbs, R. Hoellriegel, V. Adams, M. Blueher, M. Stumvoll, F.W. Mohr, G. Schuler,
A. Linke (Leipzig, DE)
288
P4962
P4963
P4964
P4965
P4966
P4967
P4968
P4969
P4970
P4971
P4972
P4973
P4974
P4975
P4976
P4977
P4978
P4979
P4980
P4981
P4982
P4983
P4984
P4985
P4986
P4987
P4988
P4989
P4990
P4991
P4992
P4993
P4994
P4995
P4996
P4997
Higher incidence of hypoglycaemia under oral anti-diabetic therapy in patients with type 2 diabetes and
manifest vascular disease: 12-months follow-up of DiaRegis.
– A.K. Gitt, P. Bramlage, E. Deeg, C. Binz, M. Krekler, D. Tschoepe (Ludwigshafen, Mahlow, Munich and Bad
Oeynhausen, DE)
Comparison between the effects of ivabradine and atenolol on heart rate variability in type II diabetic
patients.
– R. Nerla, M. Milo, G. Careri, P. Tarzia, G. Scavone, F. Zaccardi, D. Pitocco, G. Ghirlanda, G.A. Lanza,
F. Crea (Rome, IT)
Hyperglycaemia-induced oxidative stress mediates monocyte dysfunction in diabetes mellitus.
– R. Godfrey, F.-D. Boehmer, J. Waltenberger (Münster and Jena, DE)
Low rate of LDL-cholesterol target achievement in patients with type 2 diabetes with and without
manifest vascular disease in Germany: results of DiaRegis.
– A.K. Gitt, P. Bramlage, E. Deeg, C. Binz, M.G. Krekler, D. Tschoepe (Ludwigshafen, Mahlow, Munich and
Bad Oeynhausen, DE)
Can we predict the risk of glucose metabolism abnormalities in patients with previous percutaneous
coronary intervention?
– S.B. Baptista, P. Magno, C. Monteiro, E. Lourenco, P.F. Abreu, V. Gil (Amadora, PT)
The impact of diabetes mellitus according to gender difference on acetylcholine induced coronary artery
spasm.
(Seoul, KR)
Girls and boys with type 1 diabetes mellitus show different pathophysiology in premature atherosclerosis
assessed by carotid-intima media thickness.
– K. Nagl, B. Rami, E. Schober, A. Willfort-Ehringer, G. Schernthaner, T. Hoertenhuber, G.-H. Schernthaner
(Vienna, AT)
Prognostic impact of diabetes mellitus and hypertension for mid-term outcome of patients with Acute
Myocardial Infarction in the era of Percutaneous Coronary Intervention.
– M.G. Lee, M.H. Jeong, M.J. Kim, K.H. Lee, K.H. Park, D.S. Sim, Y.J. Hong, J.H. Kim, Y. Ahn (Gwangju, KR)
The influence of anemia on long-term prognosis in patients with acute myocardial infarction and
concomitant glucose abnormalities.
– M. Mazurek, J. Kowalczyk, R. Lenarczyk, T. Kurek, A. Swiatkowski, E. Jedrzejczyk-Patej, J. Gumprecht,
K. Strojek, L. Polonski, Z. Kalarus (Zabrze, PL)
Genetic variability of sCD40L reveals a novel pathophysiological role of sCD40L in insulin resistance, in
advanced atherosclerosis.
– A. Miliou, C. Antoniades, C. Bakogiannis, D. Tousoulis, A.S. Antonopoulos, M. Demosthenous,
M. Margaritis, K. Marinou, C. Psarros, C. Stefanadis (Athens, GR)
Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome,
endothelial dysfunction and arterial stiffness.
– T.W. Weiss, H. Arnesen, I. Seljeflot (Oslo, NO)
Genetic Susceptibility to type II Diabetes in a Portuguese population.
– M. Mendonca, S. Gomes, B. Silva, A. Pereira, A.C. Sousa, H. Cafe, S. Freitas, G. Guerra, J.J. Araujo,
R. Palma Dos Reis (Funchal and Lisbon, PT)
Determinants of the presence and extent of coronary artery disease in patients with type 2 diabetes and
nondiabetic subjects.
– A. Bechlioulis, K. Marini, K. Vakalis, M. Bougiaklli, S. Giannitsi, K. Nikolaou, K.K. Naka, G. Triantis, D. Sionis,
L.K. Michalis (Ioannina and Athens, GR)
Predictors of long-term cardiovascular outcomes in patients with type 2 diabetes mellitus.
– H. Bianco, T. Helfenstein, M.C. Izar, H.A. Fonseca, S.C. Fischer, C.E. Ferreira, H.T. Xavier, R.M. Povoa,
F.A. Fonseca (São Paulo and Santos, BR)
The association of the A3872G polymorphism with hs-c-reactive protein levels and peripheral arterial
disease in patients with type 2 diabetes mellitus.
– S. Papaoikonomou, D. Tousoulis, N. Tentolouris, D. Papadogiannis, A. Miliou, G. Hatzis, N. Papageorgiou,
Metabolic syndrome predicts incidence of coronary artery disease but not stroke in essential
hypertension: data from a Greek 6-year-follow-up study.
– K. Dimitriadis, C. Tsioufis, A. Kasiakogias, I. Anastasopoulos, P. Hatzigiannis, T. Katsimichas, V. Tzamou,
K. Kintis, C. Thomopoulos, C. Stefanadis (Athens, GR)
One-third of patients with diabetes mellitus do not have subclinical coronary atherosclerosis.
– M.L. Tofterup, O. Gerke, K. Egstrup, N.P.R. Sand, H. Munkholm, H. Mickley, A.C. Diederichsen (Odense,
Svendborg, Esbjerg and Vejle, DK)
Arterial elastic wall properties are similarly impaired in first degree relatives and diabetic patients on the
grounds of significant insulin resistance.
– I. Ikonomidis, V. Lambadiari, C. Koukoulis, F. Kousathana, T. Papadema, M. Varoudi, V. Tritakis,
H. Triantafyllidi, G. Dimitriadis, J. Lekakis (Athens, GR)
Suboptimal LDL-cholesterol control by atorvastatin monotherapy in high-risk patients with coronary heart
disease or atherosclerotic vascular disease in the UK.
– Q. Zhang, C. Zhao, D. Ramey, M.J. Davies, A.M. Tershakovec (Whitehouse Station, US)
Evaluation of the relationship between aortic elasticity and insulin sensitivity in healthy subjects with a
normal carbohydrate metabolism.
– R. Takacs, A. Nemes, H. Gavaller, A. Orosz, T. Varkonyi, I. Foldesi, T. Wittmann, T. Forster, C. Lengyel
(Szeged, HU)
Type 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular events.
– C.H. Saely, P. Rein, A. Vonbank, K. Huber, H. Drexel (St. Gallen, CH; Fedlkirch and Vienna, AT;
Philadelphia, US)
P4998
P4999
P5000
P5001
P5002
P5003
289
Preliminary observations of passive exercise using whole body periodic acceleration on coronary
microcirculation and glucose tolerance in patients with type 2 diabetes.
– M. Sakaguchi, S. Fukuda, K. Shimada, Y. Izumi, Y. Izumiya, Y. Nakamura, H. Ogawa, M. Fujita,
J. Yoshikawa, M. Yoshiyama (Osaka, Kumamoto, Kyoto and Nishinomiya, JP)
A novel anti-inflammatory adipokine, secreted frizzled-related protein 5, is associated with coronary
artery disease in non-elderly population.
– T. Miyoshi, M. Doi, M. Iwamoto, M. Kajiya, K. Nosaka, R. Nakayama, K. Takeda, S. Hirohata, S. Kusachi,
H. Ito (Okayama and Takamatsu, JP)
Predictors of Hypoglycaemia in patients with Type-2 Diabetes - an Analysis of the Prospective DiaRegis
Registry.
– D. Tschoepe, P. Bramlage, C. Binz, M. Krekler, E. Deeg, A.K. Gitt (Bad Oeynhausen, Mahlow, Munich and
Ludwigshafen, DE)
Blood pressure response to exercise is exaggerated in normotensive diabetic patients.
– M.G. Kaya, Y. Karavelioglu, M. Akpek, H. Karapinar, I. Gul, Z. Kucukdurmaz, A. Yilmaz (Kayseri and Sivas,
TR)
Serum adiponectin is a negative predictor of incident metabolic syndrome: a population-based follow-up
study.
– S.V. Ahn, J.Y. Kim, J.K. Park, S.B. Koh (Wonju, KR)
Impact of a cardiac diabetic nurse in reducing the incidence of hypoglycaemic events in cardiac patients
with type 2 diabetes mellitus.
– H. Eid, M.B. Bdeir, A. Fatouh, M. Ghidan, T. Conboy (Riyadh, SA)
Non-dipping heart rate and microalbuminuria in a type 2 diabetic population.
– C.J. Magri, R.G. Xuereb, S. Fava (Msida, MT)
P5004
P5005
P5006
P5007
P5008
P5009
P5010
TAKING INTO ACCOUNT THE ECONOMIC CRISIS IN CARDIOLOGY
Cost-effectiveness of cardiac resynchronization therapy in combination with an implantable cardioverter
defibrillator in mild heart failure based on Markov modeling using UK cost approach in MADIT CRT.
– V. Kutyifa, P. Aidelsburger, S. Schauer, B. Merkely, H. Klein, M. Kuniss, A. Kloppe, T. Kayser, R. Peppa,
A.J. Moss (Budapest, HU; Sauerlach, Bad Nauheim and Lüdenscheid, DE; Rochester, US; Brussels, BE)
Cost-effectiveness of the molecular autopsy in sudden unexplained death in the young.
– J. Ingles, C. Semsarian (Sydney, AU)
Economic analysis of the randomised assessment of treatment using panel assay of cardiac markers contemporary biomarker evaluation study (RATPAC CBE).
– P. Collinson, D. Gaze, P. Thokala, S. Goodacre (London and Sheffield, GB)
P5011
P5012
P5013
THE USE OF STATISTICS TO IMPROVE CARDIOVASCULAR CARE
Evolution of the incidence of myocardial infarction in France 2002-2008: the “younger women paradox”.
– C. De Peretti, F. Chin, P. Tuppin, N. Danchin (St. Maurice and Paris, FR)
Discharge status of atrial fibrillation patients hospitalized for ischemic or hemorrhagic stroke in the
United States.
– T. Simon, X. Pan, A. Kuznik (Princeton and New York, US)
Evidence-based medicine in the clinical practice guidelines of the European Society of Cardiology.
– A. Ciszewski, M. Kosek, K. Lech, L. Malek, C. Kepka (Warsaw, PL)
A retrospective cohort of long term all-cause mortality and recurrent cardiovascular events in patients
with acute coronary syndrome in Thailand.
– V. Thirawuth, T. Tangcharoen, P. Vathesatogkit, S. Yamwong, P. Sritara (Bangkok, TH)
P5014
P5015
P5016
P5017
AMBULATORY BLOOD PRESSURE MONITORING: FOCUS ON NOCTURNAL BLOOD PRESSURE
Non-dipping pattern in untreated hypertensive patients is related to increased pulse wave velocity
independent of raised nocturnal blood pressure.
– T. Erdogan, Y. Cicek, M.E. Durakoglugil, M. Cetin, A. Temiz, Y. Ugurlu, A. Canga (Rize, TR)
Ambulatory blood pressure monitoring affects sleep quality and blood pressure.
– V. Katsi, G. Souretis, S. Veioglanis, T. Gialernios, D. Tousoulis, C. Stefanadis, I. Kallikazaros (Athens, GR)
The relation between serotonin levels and insufficient blood pressure decrease during night-time in
hypertensive patients.
– M.G. Kaya, R. Topsakal, N. Kalay, E. Gunturk, A. Dogan, M.T. Inanc, M. Yarlioglues, A. Ergin (Kayseri, TR)
Circadian variation of blood Pressure is impaired in normotensive pregnant women with gestational
diabetes mellitus.
– E. Soydinc, V. Davutoglu, E. Sak, S. Evsen, H. Kaya, S. Ercan, I. Sari (Diyarbakir and Gaziantep, TR)
Dipping status is characterized by augmented administration of benzodiazepines and elevated arterial
stiffness.
– V. Katsi, G. Souretis, I. Vlasseros, D. Vrachatis, D. Tousoulis, C. Stefanadis, I. Kallikazaros (Athens, GR)
Incremental effects of restless legs syndrome (RLS) on nocturnal blood pressure in relatively young
untreated hypertensive patients and normotensive individuals.
– I. Erden, E. Cakcak Erden, Y. Turker, Y. Aslantas, H. Tibilli (Duzce, TR)
Inverse dose-response association between urinary melatonin excretion and nocturnal systolic blood
pressure in the elderly.
– K. Obayashi, K. Saeki, J. Iwamoto, N. Okamoto, K. Tomioka, S. Nezu, Y. Ikada, N. Kurumatani (Nara and
Mie, JP)
Characterization of isolated nocturnal hypertension in adolescents.
– E. Silva, G. Bermudez, J.J. Villasmil, A. Gonzalez, M. Bracho, C. Esis (Maracaibo, VE)
290
P5018
P5019
P5020
P5021
P5022
P5023
P5024
P5025
AMBULATORY BLOOD PRESSURE MONITORING AND TARGET ORGAN DAMAGE
Abnormal blood pressure rise post mild exercise protocol in newly diagnosed hypertensive subjects is
associated with significant cardiovascular functional/structural abnormalities.
– M. El Shahawy, M. Entcheva (Sarasota, US)
Does blood pressure variability influence the left ventricle mass index in patients with primary arterial
hypertension?
– M. Kurpesa, M. Zajac, E. Trzos, B. Uznanska-Loch, U. Cieslik-Guerra, T. Rechcinski, J.D. Kasprzak (Lodz,
PL)
Combined effects of blood pressure and aldosterone on cardiac left ventricular mass - ethnic differences
between Han, Kazakh and Uygur subjects.
– M. Ota, Y. Kasamaki, Y. Ozawa, A. Hirayama, T. Nakayama, H. Kawamura, D. Himit, A. Fukuda, M. Asano,
Y. Izumi (Tokyo and Kanazawa, JP; Urumuqi, CN)
Ambulatory blood pressure monitoring in hypertensive patients with chronic kidney disease.
– M. Derevjanchenko, M.E. Statsenko (Volgograd, RU)
The association of mean platelet volume levels with subclinic target organ damage in asymptomatic
hypertensives.
– M.G. Kaya, M. Yarlioglues, E. Gunturk, M. Akpek, R. Topsakal (Kayseri, TR)
Diastolic but not systolic blood pressure was more significantly affected by the gender in newly
diagnosed hypertensive patients with obesity.
– H.J. Yoon, Y.K. Ahn, K.H. Kim, J.C. Park, J.B. Park, J.H. Bae, S.J. Rim, H.J. Youn, J. Kwon, S.W. Park
(Gwangju, Seoul, Daejeon and Incheon, KR)
Antihypertensive treatment less efficacious when evaluated by Ambulatory Blood Pressure Monitoring.
– V. Gjini, G. Gjini (Fier, AL)
P5026
P5027
P5028
P5029
P5030
P5031
P5032
AMBULATORY BLOOD PRESSURE MONITORING
P5033
P5034
P5035
P5036
P5037
P5038
P5039
P5040
P5041
Masked hypertension and atherogenesis: the impact on apelin and relaxin plasma levels.
– D. Papadopoulos, O. Papazachou, I. Mourouzis, A. Kotrotsou, M. Daskalaki, C. Thomopoulos, E. Sanidas,
D. Perrea, T.H. Makris (Athens, GR)
The prevalance of masked hypertension and blood pressure variability in patients with renal
transplantation.
– M. Kayrak, E.E. Gul, C. Kaya, K. Turkmen, Y. Solak, R. Yazici, I. Gul, L. Altintepe, S. Turk, K. Ozdemir
(Konya and Samsun, TR)
Impact of nocturnal continuous positive airway pressure therapy on ambulatory blood pressure in
patients with obstructive sleep apnea and prehypertension.
– H. Yorgun, G. Kabakci, E. Kirmizigul, U. Canpolat, A.H. Ates, E.B. Kaya, K. Aytemir, A.U. Demir,
L. Tokgozoglu, A. Oto (Ankara, TR)
Metabolic syndrome increases morning blood pressure surge.
– E. Chatzistamatiou, G. Moustakas, E. Androulakis, D. Tousoulis, A. Avgeropoulou, N. Kalovidouris,
M. Divani, C. Liakos, C. Stefanadis, I. Kallikazaros (Athens, GR)
A novel non-invasive continuous system for estimating arterial blood pressure: first-in-man clinical
results.
– S. Bras, D. Ribeiro, J.P. Silva Cunha, R. Fontes-Carvalho (Aveiro and Vila Nova de Gaia, PT)
Establishment of reference values for central blood pressure estimated by Omron HEM-9000AI.
– S. Tanaka, H. Takase, T. Sugiura, S. Yamashita, Y. Dohi, G. Kimura (Nagoya and Hamamatsu, JP)
Enhanced external counterpulsation has no lasting effect on blood pressure.
– O. May, W.A.M. Khair (Herning, DK)
Effect of atmospheric pressure on blood pressure.
– U.I. Cieslik-Guerra, M. Kaminski, J. Chlapinski, W. Maranda, M. Piotrowicz, E. Trzos, B. Uznanska-Loch,
T. Rechcinski, M. Kurpesa, A. Napieralski (Lodz, PL)
Reproducibility of ambulatory blood pressure monitoring in patients with coronary heart disease.
– S. Roas, I. Sudano, F. Enseleit, P. Kaiser, A. Hirt, T.F. Luscher, F. Ruschitzka, G. Noll (Zurich, CH)
ST-ELEVATION MYOCARDIAL INFARCTION – FROM RISK STRATIFICATION TO THERAPEUTIC
STRATEGIES
Comparison of CRUSADE and ACUITY-HORIZONS risk scores for bleeding prediction in STEMI.
– D. Couto-Mallon, X. Flores Rios, J. Rodriguez-Garrido, M. Garcia-Guimaraes, P. Gargallo-Fernandez,
P. Pinon-Esteban, G. Aldama-Lopez, R. Calvino-Santos, N. Vazquez-Gonzalez, A. Castro-Beiras (Corunna,
ES)
Real-world primary PCI with bivalirudin: a report from the prospective, multi-centric EUROVISION
registry.
– U. Limbruno, A. Picchi, S. Hassani, S. Galli, B. Cortese, K. Huber, J. Lipiecki, F. Paganelli, M. Sangiorgi,
M. Hamon (Grosseto, Milan, Bergamo and Rome, IT; Niort, Clermont-Ferrand, Marseille and Caen, FR;
Vienna, AT)
Impact of one versus multiple heparins administration on clinical outcome after primary PCI for STEMI: a
prespecified analysis of the ATOLL trial.
– J.-P. Collet, U.Z. Zeymer, C.P. Pollack, M. Cohen, K. Huber, P. Goldstein, J. Silvain, M. Aout, E. Vicaut,
G. Montalescot (Paris and Lille, FR; Ludwigshafen, DE; Philadelphia and Newark, US; Vienna, AT)
Manual thrombus aspiration reduces plaque volume in non-ST elevation acute coronary syndromes: the
reduction of myocardial necrosis achieved with nose-dive manual thrombus aspiration study.
– B. Ruggieri, M. Zimarino, F. Angeramo, S. Malatesta, F. Imola, F. Prati, A. Marchetti, R. De Caterina (Chieti
and Rome, IT)
P5042
P5043
P5044
P5045
291
Evidence for benefit of ischemic post-conditioning in optimally treated patients with myocardial
P5046
infarction.
– H. Thibault, S. Soukeur, C. Bergerot, L. Ernande, M. Altmann, P. Croisille, M. Ovize, G. Derumeaux (Lyon
and Saint Etienne, FR)
Coronary revascularization in patients that become stable.
P5047
– O. Manfrini, M. Eskola, P. Karhunen, B. Xhyheri, K. Niemela, C. Pizzi, H. Huhtala, K. Nikus, R. Bugiardini
(Bologna, IT; Tampere, FI)
Enoxaparin is superior to unfractionated heparin in primary PCI for STEMI: results of the prespecified
P5048
per-protocol analysis of the ATOLL trial.
– J.-P. Collet, P. Ecollan, U. Zeymer, M. Cohen, P. Goldstein, C. Pollack, K. Huber, M. Aout, E. Vicaut,
G. Montalescot (Paris and Lille, FR; Ludwigshafen, DE; Newark and Philadelphia, US; Vienna, AT)
Effect of mechanical ischemic post-conditioning and thrombus aspiration on microvascular obstruction in P5049
patients with acute ST-segment elevation myocardial infarction.
– N. Mewton, O. Lairez, F. Roubille, G. Rioufol, D. Angoulvant, I. Sanchez, C. Bergerot, I. Sahraoui,
P. Croisille, M. Ovize (Bron, Toulouse, Montpellier and Lyon, FR)
Addition of ivabradine during beta-blockers titration improves systolic and diastolic LV function in
P5050
patients with recent Q-wave myocardial infarction.
– Y.A. Lutay, A.N. Parkhomenko, O.I. Irkin, A.A. Stepura (Kiev, UA)
The utility of thrombectomy and distal protection in patients with ST-segment elevation myocardial
P5051
infarction showing poor coronary artery flow prior to primary percutaneous coronary intervention.
– N. Suzuki, K. Kozuma, K. Tanabe, T. Muramatsu, Y. Ikari, T. Isshiki (Tokyo, Yokohama and Isehara, JP)
Chronic intermittent pacing therapy amends infarct geometry and composition.
P5052
– A. Uitterdijk, T. Springeling, V.J. De Beer, E. Mokelke, W.M. Blankesteijn, E.P. Doskalopoulos, F.W. Prinzen,
R.J. Van Geuns, W.J. Van Der Giessen, D.J. Duncker (Rotterdam and Maastricht, NL; St. Paul, US)
Gender differences in major bleeding with bivalirudin versus heparin during primary PCI in Acute
P5053
Myocardial Infarction: results from the HORIZONS-AMI trial.
– J. Yu, R. Mehran, L. Grinfeld, K. Xu, M. Fahy, E. Nikolsky, B.R. Brodie, A.J. Lansky, G.D. Dangas,
G.W. Stone (New York, Greensboro and New Haven, US; Buenos Aires, AR; Haifa, IL)
ADVANCES IN NON-ST ELEVATION MYOCARDIAL INFARCTION ACUTE CORONARY SYNDROMES –
DIAGNOSTICS AND TREATMENT
Prospective evaluation of the diagnostic accuracy of the novel ESC 2011 guidelines for rapid rule-out of
NSTEMI using high sensitive cardiac troponin T.
– B. Moehring, R. Twerenbold, K. Wildi, P. Haaf, T. Reichlin, N. Arenja, M. Wasila, T. Mosimann, M. Reiter,
C. Mueller (Basel, CH)
Usefulness of a 3-hour compared to a 6-hour blood sampling protocol using high-sensitivity cardiac
troponin T for rule-out and rule-in of non-STEMI in an unselected emergency department population.
– M. Biener, M. Mueller, M. Vafaie, T. Keller, S. Blankenberg, H.D. White, H.A. Katus, E. Giannitsis
(Heidelberg and Hamburg, DE; Auckland, NZ)
Who funds the evidence in the ESC guidelines: government or industry? Analysis of class I acute
coronary syndrome recommendations from 2011.
– P. Kohli, S.A. Murphy, C.P. Cannon (Boston, US)
Role of active coronary vasoconstriction in patients with NSTEMI.
– P. Capozza, G. Todiere, E. Orsini, F.L. Dini, M. Marzilli (Pisa, IT)
Release kinetics of cardiac biomarkers in patients with acute myocardial infarction.
– C. Liebetrau, H. Moellmann, S. Szardien, O. Doerr, C. Troidl, J. Hoffmann, D. Sedding, A. Rolf, C. Hamm,
H. Nef (Bad Nauheim and Giessen, DE)
Performance of high-sensitivity troponin T in the early diagnosis of non-ST-elevation myocardial
infarction in elderly patients presenting to an emergency department.
– P. Bahrmann, A. Bahrmann, M. Christ, T. Bertsch, C.C. Sieber (Nuremberg and Erlangen, DE)
Direct comparison of absolute and relative changes in high-sensitive cardiac troponin I in the early
diagnosis of AMI.
– K.S. Wildi, R. Twerenbold, M. Reiter, B. Moehring, P. Haaf, T. Reichlin, T. Mosimann, S. Osswald,
Cardiac magnetic resonance tissue characterization in the acute and chronic phase of reperfused
Non-ST elevation myocardial infarction.
– M. Mariyadas, T. Walcher, W. Rottbauer, P. Bernhardt (Ulm, DE)
Changing patterns of in-hospital management of acute coronary syndromes in the United Kingdom
1998-2008.
– G. Erdem, D. Babalis, W. Banya, J. Booth, F. Nugara, J. Colllinson, M. Flather (London and Norwich, GB)
Complementary intravenous Enoxaparin during percutaneous coronary interventions and NSTE-ACS. Is it
necessary?
– E. Bosch Peligero, V. Serra Garcia, A. Alonso Tello, I. Otaegui Irurueta, N. Bellera Gotarda, E. Domingo
Ribas, G. Marti Aguasca, C. Arredondo Flores, B. Garcia Del Blanco, D. Garcia-Dorado Garcia (Barcelona,
ES)
Early diagnosis of acute myocardial infarction in patients with kidney disease using more sensitive
cardiac troponin assays.
– R. Twerenbold, T. Reichlin, M. Reiter, P.H. Haaf, K. Wildi, M. Potocki, S. Osswald, C.H. Mueller (Basel, CH;
Boston, US)
Use of troponin testing in internal emergency medicine.
– J. Searle, A. Slagman, J.O. Vollert, H. Storchmann, P. Oestereich, R. Muller, M. Koch, R. Somasundaram,
M. Mockel (Berlin, DE; Townsville, AU)
292
P5054
P5055
P5056
P5057
P5058
P5059
P5060
P5061
P5062
P5063
P5064
P5065
Early strain echocardiography may exclude high-grade coronary artery stenosis in suspected
non-ST-elevation acute coronary syndrome.
– T. Dahlslett, B. Grenne, C. Eek, B. Sjoli, H. Skulstad, O.A. Smiseth, T. Edvardsen, H. Brunvand (Arendal
and Oslo, NO)
The diagnostic accuracy of novel biomarkers of myocardial injury in the unselected emergency room
population.
– P. Collinson, D. Gaze, P. Thokala, S. Goodacre (London and Sheffield, GB)
Reduction of medical consumption in low risk chest pain patients.
– A.E.C. Kingma, A.J. Six, B.E. Backus, M.J.M. Cramer, G.A. De Wit, A. Mosterd, P.J. Senden, T.P. Mast,
P.A. Doevendans (Utrecht, Woerden and Amersfoort, NL)
A significant proportion of patients with acute coronary occlusion lack ST elevation: implications for
diagnosis and provision of primary angioplasty services.
– A. Apps, A. Malhotra, O. Ali, R. Smith, R. Lane, T. Kabir, M. Mason, M. Whitbread, C. Ilsley, M. Dalby
(London, GB)
Mitral annular excursion in patients with suspected non-ST-elevation acute coronary syndrome can
identify coronary occlusion and predict mortality.
– W. Zahid, J. Johnson, C. Westholm, C. Eek, R. Skulstad, E. Fosse, R. Winter, T. Edvardsen (Oslo, NO;
Stockholm, SE)
Risk stratification in non-ST-elevation Acute Coronary Syndromes: utility of using both GRACE and
CRUSADE models.
– J. Ferreira Santos, S. Goncalves, P. Amador, F. Seixo (Setubal, PT)
Rapid rule-out of NSTEMI by using a high sensitive prototype assay for troponin I: a prospective
evaluation of the safety of the novel ESC 2011 guidelines.
– B. Moehring, R. Twerenbold, K. Wildi, N. Arenja, T. Mosimann, C. Zellweger, T. Reichlin, M. Reiter, P. Haaf,
The nature and clinical outcomes of total occlusion in non-ST elevation myocardial infarction; is it bad or
good?
– B.-H. Hwang, K.Y. Chang, K.B. Seung, Y.S. Koh, I.J. Choi, S.M. Lim, J.J. Kim, M.O. Chang, M.G. Kang,
J.E. Lee (Seoul, KR)
P5066
P5067
P5068
P5069
P5070
P5071
P5072
P5073
NEW INSIGHTS IN POST-MYOCARDIAL INFARCTION FOLLOW-UP
P5074
P5075
P5076
P5077
P5078
P5079
P5080
One-year risk of stroke following acute myocardial infarction.
– A. Ulvenstam, U. Kajermo, A. Modica, T. Mooe (Ostersund, SE)
Improving quality of care in the elderly after acute myocardial infarction? The Myocardial Ischaemia
National Audit Project (MINAP) 2004 - 2009.
– C.P. Gale, A.D. Simms, B.A. Cattle, P.D. Baxter, D.R. Greenwood, J. Deanfield, I.R. Pearson, K.A.A. Fox,
A.S. Hall, R.M. West (Leeds and Edinburgh, GB)
The rs12526453 polymorphism in intron of the PHACTR1 gene is associated with 5-year mortality of
patients with ST-elevation myocardial infarction.
– A. Kozieradzka, W. Pepinski, E. Waszkiewicz, D. Maciorkowska, M. Olszewska, M. Skawronska,
A. Niemcunowicz-Janica, S. Dobrzycki, W.J. Musial, K.A. Kaminski (Bialystok, PL)
High 3-year-mortality rates in females with newly diagnosed diabetes after acute STEMI and NSTEMI in
clinical practice in Germany: results of the Sweetheart-registry.
– A.K. Gitt, F. Towae, E. Deeg, A. Papp, U. Zeymer, J. Senges, R. Zahn (Ludwigshafen, DE)
The clinical significance of right ventricular dysfunction with or without pulmonary hypertension after
acute myocardial infarction.
– D. Aronson, K. Shahar, H. Hammerman, R. Dragu (Haifa, IL)
One year outcome in HIV-infected patients with myocardial infarction.
– G. Molins, J. Cottenet, M. Zeller, L. Lorgis, C. Touzery, H. Aube, Y. Cottin, C. Quantin (Dijon, FR)
Accuracy of high-sensitive cardiac troponins for long-term mortality.
– P. Haaf, K. Wildi, M. Reiter, C. Zellweger, R. Twerenbold, R. Hoeller, T. Reichlin, M. Rubini Gimenez,
B. Moehring, C. Mueller (Basel, CH)
Large differences between patients with acute myocardial infarction included in two Swedish health
registers.
– S. Aspberg, T. Kahan, M. Koster, U. Stenestrand (Stockholm and Linköping, SE)
Non-ST-segment elevation acute coronary syndrome caused by the left main stem stenosis - impact of
multivessel diseases on treatment strategy and 12-month. Analysis from the PL-ACS Registry.
– M. Gierlotka, M. Gasior, M. Hawranek, M. Tajstra, P. Buszman, J. Kubica, A. Lekston, M. Zembala,
G. Opolski, L. Polonski (Zabrze, Katowice, Bydgoszcz and Warsaw, PL)
Improve in survival after myocardial infarction: the impact of a universal health care reform in a
latin-american country.
– C. Nazzal, F. Lanas (Santiago and Temuco, CL)
Prognostic factors in chest pain patients: a quantitative analysis of the HEART score.
– B.E. Backus, A.J. Six, P.A. Doevendans, J.C. Kelder, E.W. Steyerberg, Y. Vergouwe (Utrecht, Woerden,
Nieuwegein and Rotterdam, NL)
Occurrence of major bleeding during long-term follow up of unselected patients with STE vs NSTE Acute
Coronary Syndromes.
– F. Vagnarelli, G. Melandri, N. Taglieri, F. Semprini, L. Cinti, G. Norscini, P. Ortolani, S. Nanni, C. Rapezzi,
A. Branzi (Bologna, IT)
Persistence of high events rate following STE vs NSTE acute coronary syndrome in the contemporary
era: 5-years outcome in a large real world registry.
– F. Vagnarelli, G. Norscini, N. Taglieri, L. Cinti, F. Semprini, S. Nanni, P. Ortolani, C. Rapezzi, A. Branzi,
G. Melandri (Bologna, IT)
P5081
P5082
P5083
P5084
P5085
P5086
293
High rate of bleeding complications in a real-life Swedish population with ACS.
– J. Alfredsson, S. Zolfagharian, A.C. Holm, E. Swahn (Linköping, SE)
Impact of contrast-induced nephropathy on long-term cardiovascular events in acute coronary syndrome
patients with Chronic Kidney Disease: results from icas registry.
– H. Watabe, A. Sato, T. Hoshi, D. Abe, E. Ojima, Y. Kakefuda, T. Harunari, D. Hiraya, Y. Noguchi,
K. Aonuma (Tsukuba and Tomobe, JP)
Pathological Q-wave development in myocardial infarction in patients treated by primary percuteneous
coronary intervention.
– R. Delewi, G. Ijff, A. Hirsch, L. Robbers, R. Nijveldt, A.M. Van Der Laan, J.G.P. Tijssen, A.C. Van Rossum,
F. Zijlstra, J.J. Piek (Amsterdam and Rotterdam, NL)
Long-term prognosis estimation after acute coronary syndrome: is there a role for angiographic scores?
– H. Dores, J. Ferreira, F.M. Costa, C. Aguiar, M. Trabulo, M.S. Carvalho, P.J. Sousa, P.A. Goncalves,
M.S. Almeida, M. Mendes (Lisbon, PT)
Bleeding complications in patients with acute myocardial infarction. A gender perspective.
– A.C. Holm, E. Swahn, J. Alfredsson (Linköping, SE)
Angiotensin receptor blockers as the first choice in patients with preserved left ventricular systolic
function after acute myocardial infarction from the Korean Acute Myocardial Infarction registry.
– J.H. Lee, J.K. Kang, S.Y. Jang, M.H. Bae, D.H. Yang, H.S. Park, Y. Cho, S.C. Chae, M.H. Jeong, Y.J. Kim
Prognostic implications of sleep duration in first months after ST-elevation myocardial infarction.
– F.M. Szymanski, G. Karpinski, A. Hrynkiewicz-Szymanska, A. Platek, M. Grabowski, F. Majstrak,
K.J. Filipiak, G. Opolski (Warsaw, PL)
Copeptin predicts long-term mortality in patients with non-st-elevation myocardial infarction.
– C. Liebetrau, O. Doerr, S. Szardien, C. Troidl, C. Horstmann, J. Rixe, D. Sedding, H. Moellmann, C. Hamm,
H. Nef (Bad Nauheim and Giessen, DE)
Predictive role of specific monocyte subsets for major adverse cardiac events after ST-elevation
– A. Ghattas, G. Lip, H. Griffiths, E. Shantsila (Birmingham, GB)
Prediction of late mortality after myocardial infarction by means of the GRACE Score in contemporarily
treated patients.
– P. Barthel, A. Mueller, K. Ulm, M. Malik, G. Schmidt (Munich, DE; London, GB)
Clinical outcomes after percutaneous or surgical revascularization of unprotected left main coronary
artery related myocardial infarction: a single-center experience.
– M.J.D. Grundeken, M.M. Vis, M.A. Beijk, J.J. Kloek, J.J. Wykrzykowska, J.G.P. Tijssen, J.J. Piek,
B.A.J.M. De Mol, J.P.S. Henriques, R.J. De Winter (Amsterdam, NL)
Impact of gender on clinical profile and long-term prognosis in patients with early-onset myocardial
infarction.
– F. Notarangelo, L. Foco, F. Bontardelli, M. Tubaro, N. Marziliano, P.M. Mannucci, L. Bernardinelli,
C. Caminiti, P.A. Merlini, D. Ardissino (Parma, Pavia, Rome and Milan, IT)
Probable effects of obstructive sleep apnea on plaque vulnerability and progression of coronary
atherosclerosis in patients with acute myocardial infarction.
– H. Nakashima, T. Henmi, Y. Uchida, Y. Shiraisi, T. Nunohiro, K. Maemura (Nagasaki, JP)
Prognostic impact of plasma aldosterone levels on long term outcome after myocardial infarction.
– K. Inoue, T. Tanigaki, Y. Tsubakimoto, T. Sakatani, S. Kimura, A. Matsuo, H. Fujita, M. Kitamura (Kyoto, JP)
Chest pain patients with false positive hs-TnT in emergency department have the same one year risk of
MACE as those who were hospitalized for acute coronary syndromes.
– M.T. Cardillo, L.M. Biasucci, M. Zaninotto, N. Gentiloni Silveri, G. Biasillo, M. Mion, G. Niccoli,
M. Gustapane, M. Plebani, F. Crea (Rome and Padua, IT)
Acute coronary syndromes in the elderly.
– P.C. Amador, S. Goncalves, F. Seixo, J. Ferreira Santos (Setubal, PT)
Baseline hypercalcaemia in acute coronary syndrome patients: a five-year outcome study.
– I. Rangel, C. Sousa, A. Goncalves, A. Sousa, A.S. Correia, M. Paiva, V. Ribeiro, F. Melao, R. Lopes,
Serum uric acid: a forgotten prognostic marker in acute coronary syndromes?
– A.T. Timoteo, A. Lousinha, J. Labandeiro, J.A. Oliveira, M.L. Ferreira, R. Cruz Ferreira (Lisbon, PT)
Prognostic role of flow mediated dilation in patients with no-ST-segment elevation acute coronary
syndrome.
– G. Careri, R. Nerla, A. Di Monaco, M. Milo, A. Di Franco, M. Laurito, G. Pinnacchio, G. Scalone, G.A. Lanza,
F. Crea (Rome, IT)
Predictive value of advanced glycation end products for the development of post-infarction heart failure.
– S. Raposeiras Roubin, B. Rodino Kostka, B. Paradela Dobarro, L. Grigorian Shamagian, J.M. Garcia
Acuna, P. Aguiar Souto, M. Jacquet Hervet, M.V. Reino Maceiras, E. Alvarez Castro,
J.R. Gonzalez-Juanatey (Santiago de Compostela, ES)
Mitral regurgitation in postmyocardial infarction patients.
– V.A. Kuznetsov, E.I. Yaroslavskaya, G.S. Pushkarev, M.G. Shahova (Tyumen, RU)
Risk stratification by killip class and left ventricular systolic function in patients with acute myocardial
infarction in modern era from korean acute myocardial infarction registry.
– J.H. Lee, J.K. Kang, S.Y. Jang, W.S. Choi, D.H. Yang, H.S. Park, Y. Cho, S.C. Chae, M.H. Jeong, Y.J. Kim
Early effects of ivabradine in combination with beta-blockers compared to beta-blockers uptitration on
systolic and diastolic function, NT-proANP and exercise capacity in pts after Q-MI with EF<45%.
– K. Amosova, I.U. Rudenko, I. Prudky, Y. Xu, A. Bezrodnyi (Kiev, UA)
294
P5087
P5088
P5089
P5090
P5091
P5092
P5093
P5094
P5095
P5096
P5097
P5098
P5099
P5100
P5101
P5102
P5103
P5104
P5105
P5106
P5107
P5108
P5109
Independent contribution of additional risk factors to GRACE score in after-discharge, long-term
prognosis.
– M. Grabowski, K.J. Filipiak, R. Glowczynska, G. Opolski (Warsaw, PL)
Prognosis importance of absence of angina in non-ST elevation myocardial infarction.
– J.Y. Takada, R.B. Ramos, S.D. Avakian, J.A.F. Ramires, A.P. Mansur (São Paulo, BR)
Is female gender a real independent predictor of mortality after acute coronary syndrome?
– A.T. Timoteo, J. Labandeiro, J.A. Oliveira, M.L. Ferreira, R. Cruz Ferreira (Lisbon, PT)
Peak Systolic Velocity (PSV) using colour-coded Tissue Doppler Imaging (TDI) is a strong and
independent predictor of outcome in acute coronary syndrome patients.
– C. Westholm, J. Johnson, T. Jernberg, R. Winter (Stockholm, SE)
P5110
P5111
P5112
P5113
PATHOPHYSIOLOGY – BASIC MECHANISMS AND ATRIAL FUNCTION
P5114
P5115
P5116
P5117
P5118
P5119
P5120
P5121
P5122
P5123
P5124
P5125
Left atrial volume and dynamics in chronic kidney disease.
– K. Kadappu, L. Hee, A. Aravindan, S.T. Spicer, G. Suryanarayanan, J.K. French, L. Thomas (Liverpool,
Sydney, AU)
Next generation sequencing approach for the diagnosis of heart disease patients using a panel of 72
genes.
– D. Cantalapiedra, P. Chevalier, A. Forteza, L. Moreno, A. Jamsheer, M. Martinez-Atienza,
V. Fernandez-Pedrosa, S. Zuniga-Trejos, M. Gil, S. Santillan (Paterna, Madrid, Pamplona and Granada, ES;
Bron, FR; Poznan, PL)
Relation between QRS duration and atrial synchronicity in systolic heart failure: a color tissue Doppler
imaging study.
– O. Turak, F. Ozcan, F. Basar, A. Isleyen, E. Sokmen, O. Tufekcioglu, K. Cagli, S. Aydogdu (Ankara, TR)
Prediction of the development of atrial fibrillation in patients With chronic heart failure: a comparative
study of atrial late potential, 6 minute-walk test and Seattle Heart Failure Model.
– T. Yamada, T. Morita, Y. Furukawa, M. Kawasaki, T. Fujimoto, T. Kondo, K. Ozu, K. Sengoku,
H. Yamamoto, M. Fukunami (Osaka, JP)
Nicorandil improved electrical and structural remodeling and prevented ventricular tachyarrhythmias in a
mouse model of desmin-related cardiomyopathy.
– M. Hirose, A. Sanbe, N. Matsushita, E. Taira (Shiwa-gun Yahabacho, JP)
Right atrial stretching does not inhibit fluid intake after myocardial infarction.
– M. Roscani, A.C.M. Omoto, L. Zornoff, L.S. Matsubara, B.B. Matsubara, J.I.F. Gobbi (Botucatu, BR)
Characterization of cyclophilin A in coxsackievirus B3-induced myocarditis.
– P. Seizer, K. Klingel, M. Sauter, T. Schonberger, C. Ochmann, R. Kandolf, M. Gawaz, A.E. May (Tübingen,
DE)
Left ventricular diastolic and systolic and atrial dysfunction in patients with hypertension might be related
to increased oxidative stress and inflammation-final results.
– Z.S. Szelenyi, G. Szenasi, M. Kiss, Z. Prohaszka, A. Patocs, A. Fazakas, I. Karadi, A. Vereckei (Budapest,
HU)
Decreased left ventricular compliance but preserved left ventricular relaxation in a risk factor-based
porcine model of heart failure with preserved ejection fraction (HFPEF).
– M. Schwarzl, S. Seiler, P. Steendijk, B. Pieske, H. Post (Graz, AT; Leiden, NL)
Olmesartan inhibits ventricular remodeling and arrhythmias in a mouse model of chronic heart failure.
– N. Matsushita, M. Hirose, Y. Takeishi, H. Shimojo, T. Kashihara, T. Nakada, E. Taira, U. Mende, M. Yamada
(Shiwa-gun Yahabacho, Fukushima and Matsumoto, JP; Providence, US)
Pitavastatin ameliorates experimental autoimmune myocarditis by decreased Th1/Th17 cytokines in mice.
– K. Tajiri, N. Shimojo, K. Aonuma (Tsukuba, JP)
Enhancement of cardiac histone deacetylase 6 (HDAC6) activity protects against cardiac disease in
alpha-B-crystallin arg120gly transgenic mouse.
– A. Sanbe, T. Marunouchi, M. Hirose, S. Aoki, Y. Tada, K. Tanonaka, H. Nishigori, A. Tanoue (Shiwa-gun,
Yahabacho, Hachioji and Tokyo, JP)
Nicorandil protects cardiomyocytes against alpha-B-crystallin arg120Gly-induced apoptosis.
– A. Sanbe, T. Marunouchi, M. Hirose, E. Koizumi, K. Tanonaka, H. Nishigori, A. Tanoue (Shiwa-gun,
Yahabacho, Hachioji and Tokyo, JP)
The mitochondrial translocator protein ligands, 4’-chlorodiazepam and TRO40303 protect cardiomyocytes
against doxorubicin toxicity.
– A. D’Anglemont de Tassigny, R. Assaly, S. Schaller, R. Pruss, A. Berdeaux, D. Morin (Créteil and Marseille,
FR)
Adrenomedullin, ghrelin and leptin as potential biomarkers of chronic heart failure: an experimental study.
– B. Sax, E.M. Vegh, K.V. Nagy, A. Kosztin, T. Barany, V. Kekesi, B. Merkely (Budapest, HU)
Study of vav3 ser298thr polymorphism in patients with heart failure.
– J.A. Andres Llamas, C. Cieza Borrella, M.J. Ruiz Olgado, J.A. Perez Rivera, P. Pabon Osuna, C. Martin
Luengo, R. Gonzalez Sarmiento (Salamanca, ES)
Soluble vascular endothelial growth factor receptor-2, but not vascular endothelial growth factor, is
decreased in sera from patients with left ventricular hypertrophy and systolic dysfunction.
– H. Wada, S. Ura, M. Akao, N. Masunaga, M. Abe, M. Ishii, T. Unoki, G. Osakada, A. Shimatsu,
K. Hasegawa (Kyoto, JP)
Matrix metalloproteinase level can predict left ventricular remodeling and systolic dysfunction after
– M. Abdelhamid, A. El Faramawy, H. Gabr, W. Ammar, F. Al Enezi (Cairo, EG)
Activation of agonistic proteins for toll-like receptor 4 in patients with dilated cardiomyopathy.
– A. Riad, J. Witte, M. Doerr, L.R. Herda, K. Weitmann, M. Busch, W. Hoffmann, S.B. Felix (Greifswald, DE)
P5126
P5127
P5128
P5129
P5130
P5131
P5132
295
Oxidative stress, inflammation and low levels of apelin as risk factors of left ventricular hypertrophy in
type 2 diabetics with renal disease.
– A.P. Silva, P.S. Sousa, A.T.P. Pinho, C. Silva, N. Santos, A. Camacho, N. Tavares, F. Rato, I. Jesus,
P. Neves (Faro, PT)
Cardiomyocyte structural deterioration and metabolic response in human DCM hearts.
– E. Czarnowska, L. Ziolkowska, M. Kaleta, M. Syczewska, W. Kawalec, E. Rejchman-Warmusz, R. Wojnicz
(Warsaw and Zabrze, PL)
Abrogation of S100B expression in S100A1 deficient mice improves survival post myocardial infarction.
– J. Tsoporis, J.-F. Desjardins, S. Izhar, F. Mohammadzadeh, G. Proteau, J. Baudier, T.G. Parker (Toronto,
CA; Grenoble, FR)
Impact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional
abnormalities in patients with cardiovascular risk factors.
– W. Kosmala, M. Cielecka-Prynda, L. Laczmanski, A. Orda, B. Karolko, A. Mysiak, M. Przewlocka-Kosmala
(Wroclaw, PL)
The involvement of peripheral regulatory T cells on the acute decompensated heart failure in the patients
with reduced EF.
– N. Ishihara, T. Noma, Y. Ishihara, Y. Miyauchi, K. Tada, W. Takabatake, C. Ikegami, K. Murakami,
K. Ohmori, M. Kohno (Kagawa, JP)
Circulating myeloid dendritic cells and interleukin-6 are predictors of heart failure in dilated and ischemic
cardiomyopathy.
– R. Pistulli, N. Hammer, D. Kretzschmar, I. Rohm, K. Schubert, M. Lichtenauer, H.R. Figulla, A. Yilmaz (Jena,
DE)
The bone morphogenic protein-antagonist Gremlin-1 serves as a new biomarker for structural heart
disease and predicts clinical outcome.
– K.A.L. Mueller, C.S. Zuern, U. Kramer, R. Kandolf, M. Gawaz, I.I. Mueller (Tübingen, DE)
P5133
P5134
P5135
P5136
P5137
P5138
P5139
PREDICTORS FOR OUTCOME
Lung ultrasound for the evaluation of pulmonary congestion in a pre-transplantation heart failure
outpatient clinic: comparison with natriuretic peptides.
– M.H. Miglioranza, L. Gargani, R.T. Sant’anna, M. Rover, A. Mantovani, C.J. Feldman, R.A. Kalil, R. Sicari,
T.L. Leiria (Porto Alegre, BR; Pisa, IT)
Depressed midwall fractional shortening is a powerful prognostic determinant in cardiac AL amylodosis.
– S. Perlini, F. Salinaro, F. Musca, R. Mussinelli, M. Boldrini, A. Raimondi, A. Alogna, P. Pesce, G. Merlini,
C. Rapezzi (Pavia, Milan and Bologna, IT)
The electrocardiographic/echocardiographic mass ratio in the diagnosis of cardiac amyloidosis.
– S. Perlini, F. Salinaro, F. Musca, R. Mussinelli, M. Boldrini, A. Alogna, C. Quarta, G. Palladini, G. Merlini,
C. Rapezzi (Pavia, Milan and Bologna, IT)
Evidence of subclinical perimyocardial involvement in patients with systemic lupus erythematosus: late
gadolinium enhancement study.
– A. Pastor, P. Choong, Z. Smith, B. Butzbach, R. Botnar, D. D’Cruz, E. Nagel, V. Puntmann (London, GB)
Cardiac myosin binding protein C gene polymorphisms and diastolic heart failure.
– C. Wu, J. Lee, C. Tsai, F. Chiang (Taipei and New Taipei City, TW)
Subclinical abnormalities of the arterial tree and left ventricular myocardial deformation, relaxation and
twist in chronic kidney disease.
– V. Panoulas, S. Sulemane, A. Bratsas, P. Nihoyannopoulos (London, GB)
Peak cardiac power output: a new hemodynamic tool to aid the diagnosis of heart failure with pre-served
ejection fraction? A pilot study.
– W. Dinh, W. Nickl, M. Coll Barroso, F. Kramer, T. Krahn, M. Doerner, R.M. Klein, C. Heming,
B. Bjarnason-Wehrens, M. Seyfarth (Wuppertal, Düsseldorf and Cologne, DE)
Relationship of pro-collagen biomarkers of myocardial fibrosis with myocardial dysfunction and
metabolic derangement in type 2 diabetes.
– C. Jellis, J. Sacre, C. Jenkins, B. Haluska, J. Martin, T. Marwick (Brisbane, AU; Cleveland, US)
Acute improvement of left atrial mechanics and left ventricular diastolic function after Transcatheter
Aortic Valve Implantation.
– S. Spethmann, H. Dreger, G. Baldenhofer, K. Stueer, D. Saghabalyan, V. Stangl, M. Laule, G. Baumann,
K. Stangl, F. Knebel (Berlin, DE)
Diagnostic value of pulsatile hemodynamics for heart failure with normal ejection fraction.
– T. Weber, S. Wassertheurer, M.F. Orourke, R. Zweiker, B. Hametner, A. Haiden, B. Eber (Wels, Vienna and
Graz, AT; Sydney, AU)
Perhexiline corrects energy deficiency and improves symptoms in chronic heart failure.
– R.M. Beadle, L.K. Williams, M. Kuehl, S. Bowater, K. Abozguia, K. Patel, Z. Yousef, F. Leyva-Leon,
M.P. Frenneaux (Aberdeen, Birmingham and Cardiff, GB; Toronto, CA)
Index of lectin-like oxidized low-density-lipoprotein receptor is independently associated with left
ventricular systolic dysfunction.
– H. Wada, N. Masunaga, S. Ura, M. Akao, M. Abe, Y. Fujita, Y. Satoh, A. Shimatsu, T. Sawamura,
K. Hasegawa (Kyoto and Osaka, JP)
Levosimendan improves contractility in post ischemic myocardium in patients with acutely revascularised
infarction complicated by decompensated heart failure.
– T. Husebye, J. Eritsland, H. Arnesen, I. Seljeflot, L. Sandvik, A. Mangschau, R. Bjornerheim, G.O. Andersen
(Oslo, NO)
296
P5140
P5141
P5142
P5143
P5144
P5145
P5146
P5147
P5148
P5149
P5150
P5151
P5152
P5153
P5154
P5155
P5156
P5157
P5158
P5159
P5160
P5161
P5162
P5163
P5164
P5165
P5166
P5167
P5168
The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with moderate heart
failure.
– E. Vizzardi, A. D’Aloia, P. Della Pina, C. Lombardi, I. Bonadei, R. Rovetta, F. Quinzani, B. Piovanelli,
M. Metra, L. Dei Cas (Brescia, IT)
The treatment in patients with chronic heart failure with erythropoietin failure.
– K. Zahidova (Baku, AZ)
Acute heart failure patients with high initial blood pressure shows paradoxical hemoconcentrateion on
admission.
– M. Konishi, K. Kimura, T. Ebina, K. Hibi, K. Tsukahara, M. Endo, N. Iwahashi, N. Maejima, K. Saka,
S. Umemura (Yokohama, JP)
Myocardial and vascular dysfunction in young subjects, are related to dyslipidaemia and abdominal
obesity but not to glycaemia.
– Y.K. Kyaw, A.W. Roberts, L.M. Evans, A.G. Fraser (Cardiff, GB)
Which adjunctive test to clinical evaluation is better to diagnose pulmonary congestion in a
pre-transplantation heart failure outpatient clinic?
– M.H. Miglioranza, R.T. Sant’anna, M. Rover, A. Mantovani, J.C. Haertel, P.A. Salgado Filho, A. Moraes,
C.J. Feldman, R.A. Kalil, T.L. Leiria (Porto Alegre, BR)
Sonographic pulmonary comet sign in diagnosis and monitoring of pulmonary congestion in HF.
– M. Tsverava, D. Tsverava (Tbilisi, GE)
Circadian variation of the occurrence of acute heart failure syndromes contributes to long-term
prognosis in patients with non-ischemic cardiomyopathy.
– H. Yasui, T. Hiroyuki, A. Funada, M. Amaki, T. Ohara, T. Hasegawa, M. Asakura, H. Kanzaki, T. Anzai,
M. Kitakaze (Suita, JP)
Correlations between hemodynamic parameters and serum high sensitive troponin-T.
– S. Koyama, Y. Sato, Y. Takahashi, T. Sawa, Y. Tanada, H. Fujiwara, Y. Takatsu (Amagasaki, JP)
A New Radiological Score for the verification of evolving pulmonary congestion-edema in the course of
Acute Myocardial Infarction.
– M. Shochat, M. Shotan, A. Asif, M. Kazatsker, Y. Levy, E. Noiman, I. Shochat, I. Dahan, D. Blondheim,
S. Meisel (Hadera, IL)
Predictors of augmented peripheral chemosensitivity in patients with systolic heart failure.
– P. Niewinski, Z.J. Engelman, M. Fudim, S. Tubek, E.A. Jankowska, W. Banasiak, P. Ponikowski (Wroclaw,
PL; Auckland, NZ; Düsseldorf, DE)
BNP is higher in OptiVol alert with intrathoracic impedance than at baseline: from MOMOTARO study.
– Y. Okamoto, S. Fujii, N. Nishii, A. Watanabe, S. Hiramatsu, K. Miyaji, Y. Tsushima, K. Kazushige,
K. Mitsudo, H. Ito (Okayama and Fukuyama, JP)
A classical clinical signs revised in 2012: echocardiographic assessment of jugular vein. A report from
SICA-HF study.
– P. Pellicori, J. Warden, A. Bennett, T. Mabote, S. Smith, E. Wright, P. Costanzo, A.L. Clark, J.G.F. Cleland
(Hull, GB)
Artificial neural network in early identification of heart failure progression in patients with telemonitoring
management of chronic heart failure.
– T. Heinze, A. Polze, M. Von Lowis, C. Sprenger, M. Oeff (Potsdam and Brandenburg an der Havel, DE)
Abnormal acetylcholine - induced vasoreactivity in Takotsubo cardiomyopathy, novel pathophysiology
insights onTakotsubo cardiomyopathy.
– G. Crimi, M. Previtali, D. Bartolini, A. Iannone, S. Bellotti, A. Valbusa, P. Rubartelli (Genoa-Sampierdarena,
Pavia and Genoa, IT)
Heart failure symptoms and sleep-disordered breathing in patients with chronic heart failure - results
from the SchlaHF-registry.
– O. Oldenburg, M. Arzt, E. Erdmann, H. Teschler, A. Graml, K. Wegscheider, H. Woehrle (Bad Oeynhausen,
Regensburg, Cologne, Essen, Martinsried, Hamburg and Blaubeuren, DE)
Heart rate control is important even in heart failure patients -an interim analysis of the CHART-2 study-.
– M. Miura, N. Shiba, J. Takahashi, K. Nochioka, T. Takada, H. Shimokawa (Sendai and Nasushiobara, JP)
Incident heart failure with preserved ejection fraction in the general population.
– F.P.J. Brouwers, R.A. De Boer, P. Van Der Harst, R.T. Gansevoort, S.J.L. Bakker, H.L. Hillege, D.J. Van
Veldhuisen, W.H. Van Gilst (Groningen, NL)
P5169
297
NOTES
298

TUESDAY, 28 AUGUST 2012 – MORNING SESSIONS

Transcription

Similar documents

Document 6425125

PHYTOBALNEOTHERAPY (“HAY BATHS”) : BETWEEN TRADITION

Diapositiva 1 - Capri Cardiovascular Conference 2.0 2015

Approccio Metodologico alla terapia dell`HCC

Presentazione standard di PowerPoint

Cardionephrology 2017 - ERA-EDTA

Presentazione di PowerPoint